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A woodcutting  attributed to Albrecht Dürer (1495). This woodcutting depicts a mercenary whose face and 
body are covered with multiple pustules due to syphilis.  
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A woodcutting  attributed to Albrecht Dürer (1495) and depicts a mercenary whose face and body are 
covered with multiple pustules due to syphilis.  
Source: https://i.redd.it/harxv7q34ef01.jpg  
HISTORICAL CONSIDERATIONS 
Syphilis 
The first descriptions in Europe of a disease that we now mention syphilis date back to the 
late 15th century, a period when this infectious process became epidemic (Pérez-Trullén et 
al., 2015). Several theories have been proposed to explain this epidemic (Tampa et al., 2014; 
Pérez-Trullén et al., 2015). The Columbian hypothesis states that syphilis was carried from 
America to Europe by Columbus’ crew, and subsequently to Naples by both sailors and 
mercenaries. From there, syphilis spread across Europe (Berger and Dean, 2014; Pérez-Trullén 
et al., 2015). The pre-Columbian hypothesis proposes evolution of the causative agent of 
syphilitic diseases, Treponema pallidum (T. pallidum), from the non-venereal treponematoses 
(yaws and bejel) already existing in Europe (Crosby, 1969; Tampa et al., 2014; Pérez-Trullén et 
al., 2015). The unitarian hypothesis advocates that the treponemal diseases have always had 
a global distribution (Tampa et al., 2014). 
The first recorded European outbreak of the disease, occurred in 1494 or 1495 in 
Naples, Italy, during a French invasion (Crosby, 1969). Initially, the people of Naples called 
it  the "French disease", since French troops were considered to have caused the spread of 
the disease (Crosby, 1969). At the time, the early stages of the disease were associated with 
mortality rates of 25% and more (Berger and Dean, 2014). Of all the miseries visiting Europe 
in his lifetime, philosopher/humanist Desiderius Erasmus (1466, 1467 or 1469 –1536) judged 
few more horrible than the "French disease" (Crosby, 1969). Engelbrecht II (1451-1504), a 
great-uncle of William of Orange, died shortly after the outset of the syphilis epidemic and 
probably was one of the first victims in the area that is now known as the Netherlands. The 
extensive deviations of his bones were typical of the treponematoses and characteristic of 
tertiary stage syphilis (Maat et al., 1997). 
Francisco Lopez de Villalobos (1473-1549) published the first book on the illness, El 
Sumario de la Medicina con un Tratado sobre las pestiferas Bubas, in 1498 (Berger and Dean, 
2014). In 1530 the Veronese physician and author Girolamo Fracastoro (1483-1553) published 
a Latin poem entitled "Syphilis, sive Morbus Gallicus" ("Syphilis, or the French disease"), 
describing the ravages of the disease in Italy (Berger and Dean, 2014). The name Syphilis is a 
Latinized form of ancient Greek Σύφιλος (Sýphilos), which can be translated as (σῦς (sŷs) pigs 
φιλεῖν (philéin) lover. Fracastoro used the term “syphilis” again in his medical treatise De 
Contagione, published in 1546. William Cullen (1710-1790) used the term “syphilis” to identify 
the disease as the major venereal disease, differentiating it from the minor venereal disease, 
known as gonorrhoea (Cullen, 1827). More than 100 different names have been used for 
syphilis, among which those referring to the alleged country of origin. Each country whose 
population was affected by the infection blamed the neighbouring (and sometimes enemy) 
countries for the outbreak (Tampa et al., 2014). The Dutch, for example, had a colonial war 
with the Spanish and referred to the disease as the "Spanish disease" (Tampa et al., 2014). 
Other names referred to the external appearance of the disease (for example “Great Pox”, 
“Evil Pox” and “Morbus pustulatus”), the affected body parts or the probable cause. As early 
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as at the end of the 15th century sexual transmission of the disease was suspected, hence the 
16th century designation “Lues venera" (meaning "venereal pest") (Tampa et al., 2014). 
The oldest known European representation of syphilis is a woodcutting attributed to 
Albrecht Dürer (1495) (Tampa et al., 2014). The woodcutting depicts a mercenary whose face 
and body are covered with multiple pustules (figure 1).  
 
Neurosyphilis 
General Paralysis of the Insane 
The Parisian physician Antoine Laurent Jessé Bayle (1799-1858) is honoured as the 
“discoverer” of General Paralysis of the Insane (GPI), because of his observations in 1822, that 
a certain constellation of psychological, physical and neuropathological manifestations 
constituted one disease entity (Artvinli, 2014). He termed this disease "arachnitis chronique" 
and gave a detailed description in his medical thesis “Recherches sur l’arachnitis chronique, la 
gastrite et la gastro-entérite chroniques, et la goutte, considérées comme causes de 
l’aliénation mentale.” As described extensively by Hare (Hare, 1959) and Pérez-Trullén and 
colleagues  (Pérez-Trullén et al., 2015), the disease recognized by English-speaking physicians 
as GPI, has, like syphilis, “suffered from a plurality of names” (Hare, 1959). Most terms refer 
to the 19th century observation that the disease progressed from psychiatric symptoms (such 
as cognitive decline, mania and psychosis) to neurological symptoms (such as motor 
alterations (paralysis)) (Pérez-Trullén et al., 2015). At the end of the nineteenth century many 
English and French synonyms existed, while the American writers favoured the term “general 
paresis” and the German writers “dementia paralytica” (Hare, 1959). 
Although as early as 1857 the Danish Esmarch and Jessen had statistically linked 
syphilis to the later appearance of GPI, at the end of the 19th century, the causes of GPI were 
still believed to be hereditary, head trauma, excessive cold, fright, alcoholism, venery or 
exhaustion (Pearce, 2012). Austrian psychiatrist Richard von Krafft-Ebing (1840-1902), 
summing up the aetiology of dementia paralytica, coined the motto: “syphilisation and 
civilisation” (Hauser, 1992). He regarded syphilis, rachitis and alcohol abuse as predisposing 
factors of dementia paralytica. He postulated that syphilitic infection led to premature ageing, 
an excessive use of the brain, which then, in turn, was more susceptible to the development 
of dementia paralytica when hit by a psychological or mechanical trauma (Hauser, 1992). 
Jean-Alfred Fournier (1832-1914), Professor of Dermatology at the University of Paris 
and Director of the internationally renowned venereal clinic at the Hospital of St Louis, 
introduced the concept of “parasyphilis” (tabes dorsalis (TD) and GPI) (Haas, 1998). In the 
Annales de Dermatologie et de Syphiligraphie of 1875-1876, Fournier put forward in two 
articles the idea of a syphilitic origin for TD (Waugh, 1974). He proposed that syphilis was the 
cause of the symptoms of paralysis, motor incoordination and locomotor ataxia (Waugh, 
1974). 
Only in the first few decades of the 20th century, serological and pathological 
confirmation of the syphilitic origin of GPI was definitely established (Pearce, 2012). 
Tabes dorsalis 
In the pre-antibiotic era, the most common form of neurosyphilis was tabes dorsalis (TD), or 
locomotor ataxia. The Latin term “tabes” means wasting, consumption and “disease which 
rots the blood” (Olry and Haines, 2018). The English writer Edward Phillips (1630 – ca. 1696), 
a nephew of the famous poet John Milton (1608-1674), already gave a definition of TD in the 
1706 sixth edition of his dictionary: “Tabes Dorsalis, a Consumption in the Marrow of the Back-
bone, which happens to those that are too much given to Venery” (Olry and Haines, 2018). 
TD typically manifested several decades after primary syphilitic infection. Moritz 
Heinrich Romberg (1795-1873) was the first to describe the classic manifestations of TD: 
progressive ataxia, lightning pains, paraesthesias, bladder dysfunction and failing vision (optic 
atrophy) (Romberg, 1839). Romberg included excessive drinking and sexual activity among the 
possible causes of the condition, but did not mention syphilis (Nitrini, 2000). It was in these 
patients in particular that he described the sign that now carries his name. The Romberg sign 
refers to the typical sway of a patient standing in upright position with eyes closed. (Keppel-
Hesselink and Koehler, 2000). A few years later, in 1858, Guillaume Duchenne (1806-1875) 
gave an almost complete clinical description of TD, which he named “progressive locomotor 
ataxia”. Duchenne mentioned syphilis as the only reasonable or apparent cause, but 
considered a causal relation uncertain (Nitrini, 2000). In 1869, Douglas Argyll Robertson (1837-
1909) described patients who lost pupillary reaction to bright light, but preserved 
accommodation, although he did not associate this with syphilis (Berger and Dean, 2014). The 
classic visceral crises of TD may result in severe gastrointestinal pains or laryngeal pains and 
hoarseness (Read and Donovan, 2012) and Charcot arthropathy, a neuropathic slowly 
progressive, chronic, destructive form of joint degeneration named after the famous French 
neurologist Jean Martin Charcot (1825-1893). TD is histologically characterized by  
demyelination of the posterior columns, posterior roots and posterior root ganglia. 
 
Treatment in the pre-antibiotic era 
Heavy metal chemotherapy 
 
“For one night with Venus, a lifetime with Mercury” (Morton, 1990)  
 
Mercury is the earliest known chemotherapy for syphilis. It was used in Arabic medicine in the 
treatment of several dermatological diseases as well as leprosy and succeeded to rapidly gain 
an important role in medical field at that time (Tampa et al., 2014). Mercury is easily absorbed 
through the skin, respiratory and gastrointestinal tract. As early as the late-15th century, 
mercury was administered both topically and orally, and remained the mainstay of antiluetic 
chemotherapy for nearly 500 years until the advent of penicillin in the 1940s (O'Shea, 1990). 
The attraction of mercury was based on two premises. The first and correct premise was the 
theory that syphilis was caused by invisible particles transmitted from one host to another. 
The second, incorrect, premise was based on the pharmacological properties of mercury salts. 
In harmony with the ancient humoral pathophysiology, it was thought that by inducing 
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diuresis and salivation the syphilitic ”agent” would be excreted, aborting the illness. However, 
diuresis is merely an unpleasant side effect of medication and salivation indicates toxicity 
(O'Shea, 1990). Although bismuth, less toxic and more spirochetocidal than mercury, was 
introduced in 1884, it was not widely used until after the First World War (O'Shea, 1990). 
In 1910, Paul Ehrlich (1854-1915) introduced the first scientifically designed drug 
against microbes: salvarsan (3-amino-4-hydroxyphenylarsenic), or arsphenamine, also known 
as "compound 606". His methodical search for a specific curative for an identified disease can 
be regarded as the introduction of targeted chemotherapy (Loyd et al., 2005). In 1908, Paul 
Ehrlich won the Nobel Prize for his work on salvarsan, nicknamed by Ehrlich "The Magic 
Bullet", and neosalvarsan that became available in 1912 and superseded the more toxic and 
less water-soluble salvarsan). Arsenicals were highly effective, less toxic compounds than 
mercury and, although difficult to administer during a lengthy and unpleasant treatment, 
arsenicals became the most widely prescribed drug in the world until penicillin came into use 
in the 1940's. "Heavy metal chemotherapy" (including the use of bismuth and arsenicals) was 
undoubtedly of use in the treatment of cutaneous lesions of syphilis (O'Shea, 1990). However, 
these heavy metals did not cross the blood-brain barrier well and were less effective against 
late stage neurosyphilis. 
 
Malaria Fever Therapy 
The healing effect of fever has been mentioned in antiquity: in the works of Hippocrates 
(“Quartana epilepsiae vindex appellator", on the beneficial influence of a malaria infection on 
epilepsy) and Galenus (129-199), who cited a case of melancholy cured as a result of an attack 
of quartan fever (Whitrow, 1990). On June 14, 1917, Julius Wagner-Jauregg (1857–1940) 
performed his first experiment on intentionally induced malaria for the treatment of patients 
with GPI in Vienna (Whitrow, 1990). The resulting spiking malarial fevers were supposed to 
kill the heat-sensitive treponemes. Fever spikes were managed and terminated after 10-12 
epochs by quinine and then followed either by salvarsan, neosalvarsan or bismuth as adjuvant 
therapy. In 1921 Wagner-Jauregg reported an impressive therapeutic success and malaria 
fever therapy became standard treatment for GPI worldwide. In 1927 Wagner-Jauregg was 
the first psychiatrist to be awarded the Nobel Prize in Physiology or Medicine “for his discovery 
of the therapeutic value of malaria inoculation in the treatment of dementia paralytica” 
(Whitrow, 1990). Despite the reported beneficial effect of malaria fever therapy its risks were 
considerable. Treatment mortality rates varied from 4% (Gambino, 2015) to 20% (Nicol, 1933; 
Winckel, 1938; Albert, 1999; Davis, 2008; Kragh, 2010). In 1921 malaria fever therapy was 
introduced in the Netherlands (Winckel, 1938). 
The final therapeutic breakthrough in the treatment of syphilis was the introduction of 
penicillin by John Mahoney and colleagues in the 1940s (Mahoney et al., 1943). Penicillin 
aims to bring about the in vivo destruction of T. pallidum subsp. pallidum and this antibiotic 
remains the drug of choice for treatment of syphilis. 
 
PATHOGENESIS AND TRANSMISSION OF SYPHILIS 
 
Syphilis, also known as “Lues venera” (“the scourge of Venus” (named after the Roman 
goddess of love)), or “Lues”, is caused by infection with T. pallidum subspecies pallidum 
(beyond simply referred to as T. pallidum).  T. pallidum is a spiral-shaped bacterium that 
cannot be continuously cultivated in vitro and that is usually transmitted by direct contact with 
an infectious lesion or by an infected pregnant woman to her fetus (Janier et al., 2014). In the 
20th century, Schaudinn and Hoffmann identified the causative agent of syphilis: a spiral-
shaped, Gram-negative, highly mobile bacterium that they initially labelled as Spirochaeta 
Pallida, and later renamed T. pallidum. This micro-organism measures 6-15 μm in length, but 
only 0.15 μm in width, a dimension below the resolution of light microscopy (Berger and Dean, 
2014). 
Four different Treponema spp. are human pathogens, including 3 subspecies of T. 
pallidum (T. pallidum subsp. pallidum [syphilis], subsp. pertenue [yaws], and subsp. 
endemicum [non-venereal epidemic syphilis]) and the pinta agent T. carateum. None of these 
pathogens has yet been successfully cultivated in axenic medium and isolation in pure culture 
is not a diagnostic option (Lagier et al., 2015). T. pallidum can be propagated only in laboratory 
animals (rabbits) by intratesticular, intradermal, intravenous, or intracisternal inoculation 
(Lagier et al., 2015). T. pallidum grows slowly, with a doubling time of 30 to 33 h, and a mean 
of 1010 bacteria has been harvested from the testis of a rabbit (Lagier et al., 2015). 
The infectivity of T. pallidum is exemplified by the fact that an individual inoculated 
with only 57 organisms has a 50% chance of being infected (Eccleston et al., 2008). Syphilis 
will develop in approximately 30% to 60% of those exposed to primary or secondary syphilis 
(Bhatti, 2007). T. pallidum is able to pass through intact mucous membranes or compromised 
skin (Kent and Romanelli, 2008; Stamm, 2010) and can be found intracellularly. The organisms 
invade interstitial spaces and chiefly proliferate there, with a doubling time of only 30-33 
hours (Berger and Dean, 2014). Shortly after infection, spirochetemia results in hematogenous 
dissemination of T. pallidum to virtually any organ, including the central nervous system (CNS) 
(Berger and Dean, 2014). 
Syphilis is transmissible during the primary and secondary stages. Transmission mainly 
occurs via sexual activities (Kent and Romanelli, 2008), however, maternal transmission during 
pregnancy and birth does occur, resulting in congenital syphilis (Woods, 2009; Janier et al., 
2014). Transmission of the disease to infants breast fed by affected wet nurses was already 
commented on in the early literature (Berger and Dean, 2014). Rarely syphilis can be 
transmitted by direct non-sexual contact with an infectious lesion or by (donated) infectious 
blood. T. pallidum is heat-sensitive and unable to survive more than a few days without a host. 
Humans are the only known natural reservoir (Berger and Dean, 2014). 
Clinical manifest neurosyphilis is the occurrence of neurological complications of 
syphilis and may occur during all stages of this disease (Berger, 2011). 
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In 1910, Paul Ehrlich (1854-1915) introduced the first scientifically designed drug 
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dissemination of T. pallidum to virtually any organ, including the central nervous system (CNS) 
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Syphilis is transmissible during the primary and secondary stages. Transmission mainly 
occurs via sexual activities (Kent and Romanelli, 2008), however, maternal transmission during 
pregnancy and birth does occur, resulting in congenital syphilis (Woods, 2009; Janier et al., 
2014). Transmission of the disease to infants breast fed by affected wet nurses was already 
commented on in the early literature (Berger and Dean, 2014). Rarely syphilis can be 
transmitted by direct non-sexual contact with an infectious lesion or by (donated) infectious 
blood. T. pallidum is heat-sensitive and unable to survive more than a few days without a host. 
Humans are the only known natural reservoir (Berger and Dean, 2014). 
Clinical manifest neurosyphilis is the occurrence of neurological complications of 
syphilis and may occur during all stages of this disease (Berger, 2011). 
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EPIDEMIOLOGICAL ASPECTS OF SYPHILIS 
 
Although curative modern antibiotics and public health measures were responsible for the 
dramatic decline in the prevalence of syphilis from the middle of the last century (Berger, 
2011), a worldwide increase in the incidence of syphilitic infections is reported since the turn 
of the millennium (Fenton et al. 2008). Although syphilis was nearly eliminated in China in the 
early 1960s, the incidence began to rise in the 1980s. An almost 16-fold increase occurred in 
the period 1991- 2005. In 2013, 444,952 cases of syphilis were reported with a rate of almost 
33 cases per 100,000 (Stamm, 2016).The annual incidence of syphilis in the United States was 
14.7 per 100,000 in 2009, after a 18-fold decline of the annual incidence rate from a peak of 
72 cases per 100,000 in 1943 to 4 per 100,000 in 1956 (Berger, 2011).  
Between 2010 and 2015, many European countries observed a sharp increase up to 
50% in the rates of reported syphilis infections (ECDC, 2017). In the European Union and 
European Economic Areas, 28,701 syphilis cases (6.0 per 100,000) were reported in 2015, 
mostly in patients older than 25 years of age (ECDC, 2017). Host-associated factors that drive 
the re-emergence and spread of syphilis include high-risk sexual activity, migration and travel, 
economic and social changes that limit access to health care (Fenton et al., 2008; Stamm, 
2016) and substance abuse (Fenton et al., 2008). 
Men are diagnosed with syphilis more often than women, especially men who have 
sex with men (MSM) (Bhai and Lyons, 2015; ECDC, 2017), probably related to changing sexual 
and social norms and to interactions with increasingly prevalent Human Immunodeficiency 
Virus (HIV) infection (Fenton et al., 2008). HIV and syphilis are often present as co-infections 
(Karp et al., 2009; Marra, 2009). Patients with HIV may be predisposed to neurosyphilis due 
to an inability to clear the initial neuroinvasion (Marra, 2009). The epidemiology of modern 
neurosyphilis is not well defined due to the paucity of population-based data (Ghanem, 2010). 
However, the majority of cases are reported in HIV-infected patients (Marra, 2009). 
Decreasing reports of late neurosyphilis have been encountered with increasing reports of 
early neurologic involvement (Ghanem, 2010). 
 
CURRENT CLINICAL PRESENTATION AND CLASSIFICATION OF SYPHILIS 
 
“There was a young man of Back Bay, 
Who thought syphilis just went away, 
And felt that a chancre, 
Was merely a canker, 
That went away in a week and a day. 
 
Now at first he got acne vulgaris, 
The kind that is rampant in Paris, 
It covered his skin, 
From forehead to shin, 
And his friends all ask where his hair is. 
 
With symptoms increasing in number, 
His aorta's in need of a plumber, 
His heart is cavorting, 
His wife is aborting, 
And now he's acquired a gumma. 
 
Consider his terrible plight, 
His eyes won't react to the light, 
His hands are apraxic, 
His gait is ataxic, 
And he's developing gun-barrel sight. 
 
His passions are strong, as before, 
But his penis is flaccid, and sore, 
His wife now has tabes 
And sabre-shinned babies, 
She's really worse off than a whore. 
 
There are pains in his belly and knees, 
His sphincters have gone by degrees, 
Paroxysmal incontinence, 
With all its concomitants, 
Brings on quite unpredictable pees. 
 
Though treated in every known way, 
His spirochetes grow day by day, 
He's developed paresis, 
Converses with Jesus, 




Sir William Osler (1849-1919) referred to syphilis as "the great imitator", due to its varied 
clinical presentations, mimicking in its various stages a wide variety of dermatological, 
internal, neurological and psychiatric disorders (Fitzgerald, 1951). 
The terminology surrounding different stages of syphilis and neurosyphilis can be 
confusing (Kulkarni and Serpa, 2018). Definitions for terms related to clinical stages of syphilis 
as presented by Kulkarni and Serpa are represented in table 1 (Kulkarni and Serpa, 2018). 
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Sir William Osler (1849-1919) referred to syphilis as "the great imitator", due to its varied 
clinical presentations, mimicking in its various stages a wide variety of dermatological, 
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Table 1: Definitions for terms related to clinical stages of syphilis as presented by Kulkarni PA and Serpa JA, 2018.  
 
Term  Definition 
Syphilis Generic term that refers to infection with the organism T. pallidum at any stage with or 
without the presence of any clinical signs or symptoms 
Early syphilis Generally thought to encompass primary syphilis, secondary syphilis and early latent syphilis 
Late syphilis Thought to represent late latent syphilis and tertiary syphilis 
Primary 
syphilis 
Initial stage of syphilis consisting of a genital chancre that appears at the site of inoculation 
approximately 10-90 days after acquisition of the infection 
Secondary 
syphilis 
Second stage of syphilis resulting in a wide spectrum of symptoms, including fevers, malaise, 
lymphadenopathy and rash (among myriad other possibilities) 
Early latent 
syphilis 
Evidence of infection due to T. pallidum as determined by serological testing but absence of 




Evidence of infection due to T. pallidum as determined by serological testing but absence of 




Last stage of syphilis thought to occur approximately 5-30 years after initial infection with 
major forms being cardiovascular syphilis and non-central nervous system gummatous 
syphilis 




Neurosyphilis that occurs in the initial months to years after infection; thought to affect 
cerebrospinal fluid, meninges, and vasculature more often and comprise the syndromes 
syphilis meningitis and meningovascular syphilis  
Late 
neurosyphilis 
Neurosyphilis that occurs years to decades after initial infection; affects brain and spinal 
cord parenchyma more often; comprises the clinical syndromes general paresis (also known 
as syphilitic dementia or dementia paralytica) and tabes dorsalis 
 
Primary syphilis 
Primary syphilis is typically acquired by direct, mostly sexual contact with the infectious lesions 
of another person (Janier et al., 2014). Classically, a single, firm, painless, non-itchy skin 
ulceration, called a chancre, appears at the site of infection, between 3 to 90 days after 
infection. Occasionally, more common in patients co-infected with HIV, multiple lesions may 
be present (40%) (Kent and Romanelli, 2008). 
Secondary syphilis 
“Know syphilis in all its manifestations and relations, 
 and all other things clinical will be added to you.” Sir William Osler (Bean, 1950) 
 
Secondary syphilis develops in 60-90% of untreated patients approximately four to ten weeks 
after primary infection (Kent and Romanelli, 2008) and is known for its many different clinical 
presentations. Classically, secondary disease manifests with skin rash, mucosal ulceration and 
lymphadenopathy. Condylomata lata, pearl-gray raised horny (hyperkeratotic) lesions on the 
genitals and anus, may also occur. All lesions contain spirochetes and are therefore infectious. 
Inflammation of the optic nerve, uveitis luetica, interstitial keratitis and otitis luetica are the 
most common complications at this stage of infection. Syphilitic meningitis, meningovascular 
syphilis, hepatitis, nephritis, gastritis and joint inflammation may also occur (Kent and 
Romanelli, 2008). 
Latent syphilis 
Even in untreated individuals signs of secondary syphilis often resolve spontaneously and 
patients become symptomless. This latent syphilis can last for several years until new 
manifestations of the disease develop. 
Tertiary syphilis 
Tertiary, non-transmissible, syphilis may occur approximately 3 to 15 years after the initial 
infection in a third of infected patients without treatment and may be divided into three 
categories: gummatous syphilis (15%), cardiovascular syphilis (10%) and late, parenchymatous 
neurosyphilis (6.5%) (Bhatti, 2007; Kent and Romanelli, 2008;). Gummatous syphilis is 
characterized by the formation of chronic gummatas that typically affect the skin, bone, and 
liver, but can occur anywhere (Kent and Romanelli, 2008). The most common complication of 
cardiovascular syphilis is syphilitic aortitis which may result in aneurysm formation (Kent and 
Romanelli, 2008). 
Asymptomatic neurosyphilis 
The most common form of neurosyphilis currently diagnosed is asymptomatic neurosyphilis 
(Berger and Dean, 2014), a stage of disease with cellular, biochemical and serological evidence 
of infection in the cerebrospinal fluid in the absence of neurological signs and symptoms. 
Cerebrospinal fluid abnormalities occur with a reported frequency of 16 - 48% in association 
with early (primary or secondary) syphilis (Berger and Dean, 2014). Although the presence of 
cerebrospinal fluid abnormalities does not necessarily predict the development of 
symptomatic neurosyphilis, the absence of cerebrospinal fluid abnormalities two years after 
initial infection has been considered to preclude the subsequent development of 
neurosyphilis (Berger and Dean, 2014). 
Asymptomatic (latent) neurosyphilis can reactivate at a later stage, probably related 
to decreased immunity of the host. Two infamous studies of untreated syphilis have provided 
data on the frequency with which neurosyphilis develops in untreated syphilis patients. In the 
Oslo study, 9.4% of the men and 5.0% of the women ultimately developed neurosyphilis in 30 
years (Clark and Danbolt, 1955). In the 40-year Tuskegee study, 6.5% developed neurosyphilis 
(Berger, 2011). Since then, the widespread use of of antibiotics, with beta-lactamase 
dominating usage (Bhai and Lyons, 2015), HIV co-infection (Bhai and Lyons, 2015), and 
variation in the incidence of different strains of T. pallidum (Marra, 2010) may have altered 
the course of the disease. However, there is only limited recent data on the natural course of 
syphilis. 
General introduction | 19
1
Table 1: Definitions for terms related to clinical stages of syphilis as presented by Kulkarni PA and Serpa JA, 2018.  
 
Term  Definition 
Syphilis Generic term that refers to infection with the organism T. pallidum at any stage with or 
without the presence of any clinical signs or symptoms 
Early syphilis Generally thought to encompass primary syphilis, secondary syphilis and early latent syphilis 
Late syphilis Thought to represent late latent syphilis and tertiary syphilis 
Primary 
syphilis 
Initial stage of syphilis consisting of a genital chancre that appears at the site of inoculation 
approximately 10-90 days after acquisition of the infection 
Secondary 
syphilis 
Second stage of syphilis resulting in a wide spectrum of symptoms, including fevers, malaise, 
lymphadenopathy and rash (among myriad other possibilities) 
Early latent 
syphilis 
Evidence of infection due to T. pallidum as determined by serological testing but absence of 




Evidence of infection due to T. pallidum as determined by serological testing but absence of 




Last stage of syphilis thought to occur approximately 5-30 years after initial infection with 
major forms being cardiovascular syphilis and non-central nervous system gummatous 
syphilis 




Neurosyphilis that occurs in the initial months to years after infection; thought to affect 
cerebrospinal fluid, meninges, and vasculature more often and comprise the syndromes 
syphilis meningitis and meningovascular syphilis  
Late 
neurosyphilis 
Neurosyphilis that occurs years to decades after initial infection; affects brain and spinal 
cord parenchyma more often; comprises the clinical syndromes general paresis (also known 
as syphilitic dementia or dementia paralytica) and tabes dorsalis 
 
Primary syphilis 
Primary syphilis is typically acquired by direct, mostly sexual contact with the infectious lesions 
of another person (Janier et al., 2014). Classically, a single, firm, painless, non-itchy skin 
ulceration, called a chancre, appears at the site of infection, between 3 to 90 days after 
infection. Occasionally, more common in patients co-infected with HIV, multiple lesions may 
be present (40%) (Kent and Romanelli, 2008). 
Secondary syphilis 
“Know syphilis in all its manifestations and relations, 
 and all other things clinical will be added to you.” Sir William Osler (Bean, 1950) 
 
Secondary syphilis develops in 60-90% of untreated patients approximately four to ten weeks 
after primary infection (Kent and Romanelli, 2008) and is known for its many different clinical 
presentations. Classically, secondary disease manifests with skin rash, mucosal ulceration and 
lymphadenopathy. Condylomata lata, pearl-gray raised horny (hyperkeratotic) lesions on the 
genitals and anus, may also occur. All lesions contain spirochetes and are therefore infectious. 
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The specific neurological manifestations of syphilis are, in some respects, a function of the 
time from infection, and classically neurosyphilis is divided in asymptomatic, early and late 
neurosyphilis (Flood et al., 1998). However, several forms of neurosyphilis may coexist in any 
patient (Berger, 2011). 
 
Early neurosyphilis 
Early neurosyphilis may be asymptomatic or manifest within months to several years after the 
initial infection. The pathophysiology involves an acute meningovascular and ocular 
inflammation resembling other infectious, inflammatory or autoimmune processes of the 
CNS. Clinical manifestations include meningitis, stroke, vertigo, optic neuritis or uveitis. 
 
Meningeal neurosyphilis 
Within a year of initial infection involvement of the meninges may result in meningitis with 
headache, and / or cranial nerve palsies, in particular VII, VIII, VI and II, with or without 




Meningovascular disease typically occurs after six to seven years and consists of endarteritis 
of vessels anywhere in the CNS, resulting in thrombosis and infarction (Ghanem, 2010) About 
10% of patients with neurosyphilis and almost 3% of all syphilis patients present with a stroke. 




Syphilitic uveitis is defined by symptoms of decreased vision, eye pain or photophobia with 
diagnosis confirmed by slit-lamp examination (Flood et al., 1998). 
 
Late neurosyphilis 
“Walking on air 
Never a care 
When you’ve met Lues... 
Get her on the brain and she’ll drive you insane, 
She’ll touch your heart with her own special art, 
A light in your eyes, 
And we realize, 




Late neurosyphilis primarily affects the CNS parenchyma and occurs 15-30 years after initial 
infection and results most commonly in the clinical syndromes of General Paralysis of the 
Insane and tabes dorsalis (Berger and Dean, 2014). 
 
General Paralysis of the Insane 
 
“Know paretic neurosyphilis in all its aspects and you know all of psychiatry” 
Hiram Houston Merritt, Jr (Merrit et al., 1946)  
 
General Paralysis of the Insane (GPI) usually presents with a wide array of progressive 
neuropsychiatric symptoms, ranging from cognitive dysfunction to psychoses and mood 
disorders. Merritt paraphrased Osler’s dictum on syphilis to “Know paretic neurosyphilis in all 
its aspects and you know all of psychiatry” (Merrit et al., 1946). 
 
Tabes dorsalis 
Pupillary abnormalities, including Argyll-Robertson pupils (pupils that are small, asymmetric, 
irregular, and poorly responsive to direct light with maintained appropriate constriction on 
accommodation) were once a hallmark symptom of TD. Other signs include diminished 
reflexes, impaired vibratory sense and proprioception, ocular palsies and Charcot’s joints. 
Congenital syphilis 
Congenital syphilis, transmitted during pregnancy or birth, is a preventable disease, easily 
diagnosed in laboratory and treatable with a high probability of arresting infection. 
Nevertheless it remains a major problem in developing countries and globally 0.7 million to 
1.5 million cases occur annually. The majority of cases result in stillbirth or perinatal death 
(Douglas, 2009). Deficiency in health education and prenatal care, poor diagnosis, 
inappropriate treatment of pregnant women and their sex partners, disadvantaged 
socioeconomic conditions, difficult access to health services and poor guidelines might 
contribute to the incidence of congenital syphilis (Teixeira et al., 2017). In the Netherlands, 
the number of congenital syphilis infections found in neonates and young infants (<1 year) 
ranged from 0 or 1 per year from 2008 to 2017, but increased to 3 in 2017 (Visser et al., 2018). 
The number of congenital syphilis in non-neonates in the Netherlands is unknown. More than 
half of syphilitic infants are born without symptoms. Therefore patients may remain 
undiagnosed. In 20% of cases, neurosyphilis develops. Other symptoms that develop during 
the first couple of years of life include enlargement of the liver and spleen (70%), rash (70%), 







General introduction | 21
1
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The diagnosis "neurosyphilis" is based on a combination of clinical features and laboratory 
findings. However, at present there are no uniform clinical diagnostic criteria and a perfect 
"gold standard" diagnostic test is not available (Marra, 2009). Moreover, the diagnostic tests 
are unable to distinguish between the various stages of the disease. 
Therefore, serological tests of the cerebrospinal fluid are the most specific tests to 
confirm a diagnosis of neurosyphilis. Currently, in the Netherlands, Treponemal tests (TT), for 
example the Treponemal pallidum hemagglutination (TPHA) test, Treponemal pallidum 
particle agglutination (TPPA) test and enzyme-linked immunosorbent assays (ELISA) based on 
specific recombinant T. pallidum membrane proteins, are used to screen for syphilitic 
infection. Since these tests remain reactive for years, even after successful treatment, non-
Treponemal tests (nTT) test are often applied to confirm active syphilitic infection and to 
evaluate treatment outcome (Peeling, 2006). Although a diagnosis of neurosyphilis is 
confirmed with a positive VDRL (Venereal Disease Research Laboratory test) in cerebrospinal 
fluid (CSF), this finding is observed in only about one third of neurosyphilis cases. Nevertheless 
a positive test can be considered as indicative of neurosyphilis in late syphilis in the absence 
of substantial blood contamination. However, in early syphilis the significance of a positive 
CSF VDRL test is less clear (Janier et al., 2014). A positive CSF TT does not confirm the diagnosis 
of neurosyphilis but a negative CSF TT result is highly unlikely in neurosyphilis. 
Peripheral treponemal antibodies can result in measurable CSF levels due to passive 
passage through an intact blood-brain barrier. Antibody leakage from blood to CSF can be 
distinguished from intrathecal antibody production by calculating an IgG serum / CSF index: 
the Reiber or TPPA index (Reiber, 1994a; Reiber, 1994b; Luger et al., 2000). In neurosyphilis 
these indexes are elevated. Several authors have proposed the use of pleiocytosis with 
predominantly mononuclear cells or an elevated protein level. However these abnormalities 
are nonspecific (Kulkarni and Serpa, 2018). Moreover, protein level as well and number of 
mononuclear cells in CSF can be normal in neurosyphilis, especially in parenchymatous 
neurosyphilis (tabes dorsalis, general paresis of the insane) (Janier et al., 2014). 
As mentioned before, in the Oslo study, 9.4% of men and 5.0% of women eventually 
developed neurosyphilis after syphilitic infection (Clark and Danbolt, 1955). No symptoms 
developed in the remaining patients; thus the presence of CSF abnormalities does not 
necessarily predict the development of clinically manifest neurosyphilis. Conversely, the 
development of neurosyphilis is not to be expected if CSF abnormalities are lacking (Berger 
and Dean, 2014). 
Although neuroimaging is not specifically required for the diagnosis of neurosyphilis, 
radiologic studies can provide adjunctive information in different circumstances and are 
helpful in excluding other pathologies (Berger and Dean, 2014; Kulkarni and Serpa, 2018). 
Cranial magnetic resonance imaging (MRI) manifestations of neurosyphilis include meningeal 
enhancement or CSF enhancement in the case of syphilitic meningitis and ischaemia and 
infarction in meningovascular syphilis (Berger and Dean, 2014; Kulkarni and Serpa, 2018). 
Central nervous system gummatous syphilis can be seen in neuroimaging in the form of space 
occupying lesions (Kulkarni and Serpa, 2018). Rarely, the radiographic appearance of 
neurosyphilis may mimic the appearance of normal pressure hydrocephalus or herpes 
encephalitis (Berger and Dean, 2014). Cranial MRI of patients with GPI has demonstrated 
frontal and temporal atrophy, subcortical gliosis and increased ferritin in the basal ganglia 
(Berger and Dean, 2014). Lesions on T2-weighted and fluid attenuated inversion recovery 
(FLAIR) MRI in the temporal lobes, particularly the mesial region, are also reported in patients 
with neurosyphilis (Leypoldt et al., 2015), necessitating exclusion of autoimmune antibody 
encephalitis in cases suspected of neurosyphilis and vice versa. In TD, spinal imaging can show 
increased signal intensity in the spinal cord (Kulkarni and Serpa, 2018). 
PENICILLIN TREATMENT OF NEUROSYPHILIS 
 
Since controlled, randomized, prospective studies for optimal dose and duration of therapy 
are lacking, as yet no uniform worldwide recommended treatment regimen for neurosyphilis 
is available (Berger and Dean, 2014). The European guidelines recommend inpatient 
management and daily administration of benzylpenicillin 18–24 million units intravenously, 
divided over 3–4 million units dosages every four hours for 10–14 days, as first line therapy 
(Janier et al., 2014). Second line therapy options are ceftriaxone 1–2 g intravenously daily for 
10–14 days and, if hospitalization and / or intravenous administration of antibiotics is 
impossible, procaine penicillin 1.2–2.4 million units intramuscular once daily combined with 
probenecid 500 mg four times daily, both during 10–14 days (Janier et al., 2014). 
Follow-up examination of cerebrospinal fluid should be performed six weeks – to six 
months after treatment of neurosyphilis (Janier et al., 2014). In general, the clinical prognosis 
after completion of treatment with intravenous aqueous crystalline penicillin G depends on 
the clinical manifestation of neurosyphilis (Kulkarni and Serpa, 2018). Patients with GPI and 
TD will most likely experience residual cognitive and sensory disturbances respectively, while 
patients with a syphilitic meningitis or gummata have a good prognosis (Kulkarni and Serpa, 
2018). 
AIM AND OUTLINE OF THE THESIS 
 
The aim of this thesis threefold. First, to describe the clinical presentation of General Paralysis 
of the Insane (GPI) in the first half of the 20th century. Second, to investigate malaria fever 
therapy, the only therapy considered effective in neurosyphilis in that era in patients with GPI. 
And last, to examine the epidemiology and clinical presentation of neurosyphilis in the current 
era.  
In Chapter 2 the clinical presentation of 105 patients with GPI admitted to a Dutch 
psychiatric hospital in the period 1924-1954 is described. In Chapter 3, malaria fever therapy 
for GPI is investigated in the same cohort of patients. In Chapters 4 and 5 current 
epidemiological and clinical aspects of neurosyphilis are presented. In Chapter 4 the 
epidemiology of neurosyphilis in Dutch general hospitals in the period 1999-2010 is 
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investigated in a nationwide study. The clinical data of a series of patients with laboratory 
confirmed neurosyphilis are analysed in Chapter 5. In Chapter 6 a case of neurosyphilis 
mimicking autoimmune encephalitis is presented. A general discussion and conclusions, 
including future perspectives, are presented in Chapter 7 and Chapter 8 respectively. Finally, 
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General paralysis of the insane (GPI) or dementia paralytica was once a fatal complication of 
syphilitic infection and a major reason for psychiatric hospitalization. Nowadays, physicians 
consider GPI to be exceptional. It should be noted, however, that syphilis re-emerged 
worldwide at the turn of the 20th to 21st century and a revival of GPI can, therefore, be 
expected. Advanced diagnosis is crucial in that treatment in the early, inflammatory phase is 
warranted before irreversible tissue damage occurs. Therefore, a renewed clinical awareness 
of the broad spectrum of psychiatric and neurologic signs and symptoms of GPI is needed. In 
this historical cohort study, comprising 105 patients with GPI admitted to the Dutch Vincent 
van Gogh Psychiatric Hospital in the period 1924–1954, the clinical presentation of this 






Given the dramatic decline of the incidence of syphilis after the introduction of antibiotic 
treatment, general paralysis of the insane (GPI), also termed dementia paralytica, a late 
complication of untreated syphilis, was expected to become ‘something of a neuropsychiatric 
rarity’ [1, 2]. However, GPI has not yet disappeared and should, therefore, still be considered 
in the diagnostic workup of psychiatric and neurological patients [3]. 
In the 19th century, GPI was described by Clouston, a Scottish ‘alienist’ (as physicians 
specialized in the treatment of mental illness were referred to at that time [4]) and 
superintendent of the Royal Edinburgh Asylum between 1873 and 1908, as the ‘most terrible 
of all brain diseases’ [5, 6]. About 2 decades after an untreated syphilitic infection, GPI 
presented with progressive mental and physical decline in 3–5% of the patients. In the first 
phase of the disease, the so-called medico-legal period, ill-judged actions due to 
neurocognitive dysfunctions could result in serious social and legal repercussions. No cure was 
known as yet, and most patients with GPI deteriorated and died within 6 years after diagnosis, 
albeit that remissions did occur [7]. 
Although in the first half of the 19th century, the clinical and pathological features of 
GPI as well as its syphilitic origin were described, at the end of the 19th century, GPI was 
considered ‘parasyphilitic’, that is, syphilis was not the exclusive causative factor [8, 9]. The 
Austrian psychiatrist von Krafft-Ebing referred to ‘civilization and syphilization’ as the most 
important factors in the development of GPI [10]. He postulated that environmental and 
psychological factors associated with urban life, the ‘civilization’ (e.g. stress, hard work, 
tobacco and ‘excesses in Baccho et Venere’), in combination with syphilitic infection led to 
premature aging. The latter resulted in increased susceptibility to the development of GPI in 
case of a psychological or mechanical trauma [11]. Subsequent to the hypothesis of von Krafft-
Ebing, during the first few decades of the past century, the syphilitic origin of GPI could be 
established definitely and serologically confirmed [9]. 
At the turn of the 19th to 20th century, GPI was a worldwide problem with considerable 
social and economic impact and had become a heavy burden on the health-care system [12]. 
Although exact figures are unknown, asylums throughout the world reported, in the first 
decades of the 20th century, an increase in admission rates up to 20% [2, 13]. At the Royal 
Edinburgh Asylum, Scotland’s largest asylum, up to 17% of admissions and 34% of deaths 
concerned the patients with GPI [6]. Death from GPI in all Scottish asylums increased from 8.9 
to 12.5 per 1,000 resident patients [5]. In the period from 1875 to 1915, the proportion of GPI 
patients in the total asylum population in The Netherlands increased from over 2 to nearly 7% 
[14]. 
In order to understand the longitudinal development of GPI in the late pre-antibiotic 
era, here, the clinical presentation at asylum admittance as described in the historic patient 
records of the Vincent van Gogh Institute for Psychiatry (VvGI) in Venray, The Netherlands, is 
investigated. 
 
Clinical presentation of General Paralysis of the Insane | 31
2
ABSTRACT 
General paralysis of the insane (GPI) or dementia paralytica was once a fatal complication of 
syphilitic infection and a major reason for psychiatric hospitalization. Nowadays, physicians 
consider GPI to be exceptional. It should be noted, however, that syphilis re-emerged 
worldwide at the turn of the 20th to 21st century and a revival of GPI can, therefore, be 
expected. Advanced diagnosis is crucial in that treatment in the early, inflammatory phase is 
warranted before irreversible tissue damage occurs. Therefore, a renewed clinical awareness 
of the broad spectrum of psychiatric and neurologic signs and symptoms of GPI is needed. In 
this historical cohort study, comprising 105 patients with GPI admitted to the Dutch Vincent 
van Gogh Psychiatric Hospital in the period 1924–1954, the clinical presentation of this 
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Patients were included if they had died while being hospitalized at the VvGI in the period 
1924–1954 and had an established diagnosis of GPI. Identification was performed by using 
annual hospital reports and the corresponding individual patient’s records, as stored at the 
Social Historical Centre of Limburg in Maastricht. Data were anonymized before evaluation. 
Since megalomania and dementia are symptoms of what is usually called ‘classical GPI’ [15], 
special attention was given to the mentioning of dementia and/or delusions of grandeur, that 
is, grossly exaggerated belief of self-worth, power, knowledge or identity or of an exceptional 
relationship with a divinity or famous person [16]. The protocol was approved by the Vincent 
van Gogh Institutional Review Board (number: 13.034). 





A total of 2,731 patients (1,460 men and 1,271 women) died while being hospitalized in the 
VvGI. From this cohort, 180 patients (6.6%; 137 men and 43 women) had been diagnosed with 
GPI. The individual clinical records of 105 patients (58.3%; 91 men and 14 women) out of the 
total of 180 GPI patients were available for evaluation. From the total of 105 patients, 9 (8 
men and 1 woman) had previously been admitted to the VvGI. Only data concerning last 
admissions were used for analysis. 
 
Demographic Data 
Mean age at admission was 50.6 years, which was significantly lower in females than in males 
(45.0 vs. 51.4; p = 0.03; Student’s t test) with a median age for men and women of 50.4 and 
43.2 years, respectively. Information on education was available for 84 patients of whom 95% 
had completed elementary school only. Women were mainly housewives, and all but 1 male 
patient belonged to lower working class. In 4 patients, the spouse also had a diagnosis of 












Table 1. Demographics of the patients (n = 105; 91 men and 14 women) 
Mean age at admission, years (median) 50.6 (49.7) 
Range  31.5-82.1* 
Median duration of disease at admission (known for n = 84), years 1.1 
Range 0.02-12 





Residence before admission, n  
General hospital ward 52 
Own home 35 
Another asylum 5 
Other institutes 11 
Unknown 2 
*Mean age females (n = 14): 45 years; males (n = 91): 51.3 years 
 
Diagnosis 
In 96 out of 105 patients, a diagnosis at admission was available (table 2). A history of 
treatment for syphilis or neurosyphilis was known for 14 and 36 patients, respectively. Data 
on the positive results of the Wassermann test in serum and/ or cerebrospinal fluid could be 
retrieved in 68 patients (55 men and 13 women). In two male patients, a negative result of 
the Wassermann test in serum was documented, but both had a known history of 
neurosyphilis and had probably received anti-syphilitic treatment in a general hospital prior 
to admission to the VvGI. In 33 patients, a diagnosis of GPI had been made in a general hospital 
in an earlier phase of their disease. In two patients, no results of serological tests were present 
in their clinical records; however, they were reported to be diagnosed with GPI. Both patients 
resided at home before admittance and displayed aggressive behaviours. 
 
Table 2. Diagnosis at admission known for 96 patients (84 men and 12 women) 
 All patients Male Female 
Dementia paralytica 67 60 7 
Taboparalysis 8 6 2 
Other forms of dementia 7 7 0 
Schizophrenia 5 4 1 
Paranoia 2 2 0 
Mania 2 0 2 
Religious delusion 1 1 0 
Manic depressive psychosis 1 1 0 
Acute hallucinosis 1 1 0 
Epilepsia 1 1 0 
Imbecillitas 1 1 0 
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Symptoms and Signs 
Concerning the neuropsychiatric syndrome, the most frequently observed symptoms at 
admission were lack of judgment and insight, dementia and hyperactivity (table 3). 
 
Table 3. Psychiatric symptoms reported at admission in 105 patients (91 men and 14 women) 
 Total Males Females 




3 94 90 2 82 90 1 12 86 
Dementia 5 86 82 5 77 85  9 64 
Hyperactivity 4 80 76 4 69 76  11 79 
Mania 5 74 70 5 64 70  10 71 
Confusion 14 71 68 11 63 69 3 8 57 
Delusions 9 66 63 9 54 59  12 86 
Irritability 12 63 60 10 58 64 2 5 36 
Aggression 9 61 58 8 55 60 1 6 43 
Restlessness 
at night 
21 47 45 21 40 44  7 50 
Hallucinations 21 42 40 19 32 35 2 10 71 
Depression 10 42 40 10 34 37  8 57 
Euphoria  10 38 36 10 29 32  9 64 
Memory 
problems 
37 33 31 34 26 29 3 7 50 
Emotional 
lability 
12 23 22 11 16 18 1 7 50 
*Number of patients with insufficient information in the patient’s record. 
 
 
Delusions of grandeur were documented in 46 patients (table 4). About half of the patients (n 
= 52) were referred to the VvGI because of their challenging behaviours in the general hospital 
ward. In 11 patients living at home, prior to admission, behavioural problems had resulted in 
judicial contacts. 
As to neurological manifestations, key symptoms were disordered speech (including 
dysarthria, mutism and stuttering), pupillary abnormalities and micturition disorders (table 5). 
In 43 patients, information on examination of pupils was available. In six patients, a complete 
description of Argyll Robertson pupils was given. Anisocoria and small pupils that reacted very 





Table 4. Delusions reported at admission in 105 patients (91 men and 14 women), classified according to Wing 
et al., 1980 
 Total Males Females 
Delusions of grandiose ability and/or identity 44  36 8 
Delusions of persecution 5 3 2 
Nihilistic delusions 1 1 0 
Hypochondriacal delusions 7 7 0 
Delusions of guilt 3 2 1 
Delusions of reference 1 1 0 
Religious delusions 1 1 0 
Delusions of pregnancy 1 0 1 
Unspecified delusions 7 6 1 
Some patients presented with several kinds of delusions. 
 
 
Table 5. Neurological symptoms reported at admission in 105 patients (91 men and 14 women) 
 Total Males Females 













47 50 48 44 38 42 3 12 86 
Micturition 
disorders 
24 46 44 24 37 41  9 64 
Cranial nerve 
involvement 
69 25 24 66 17 19 3 8 57 
Tremors 66 20 19 60 17 19 6 3 21 
Cerebrovascular 
accidents 
73 8 8 69 6 7 4 2 14 




Patient 1 is a 42-year-old married woman, referred to the VvGI in August 1931. She had a 1-
year history of epileptic seizures followed by short periods with difficulties in speaking and 
swallowing. For several weeks, she believed herself to be related to the royal family and 
thought the queen would visit her for dinner. She bought very expensive clothes and 
distributed several of these to workmen in the street. In addition, she complained about 
‘hearing voices’ and she felt ‘manipulated by electricity’. 
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At admission, psychiatric examination disclosed memory deficits with marked 
disorientation and impaired imprinting and judgment. There were persistent paranoid 
delusions and delusions of grandeur. Euphoria alternated with episodes of depression. Speech 
was strongly disturbed by so-called ‘Sylbenstolpern’, that is, the omission and transposition of 
syllables. Neurological examination showed mildly miotic, angular, even-sized pupils with 
decreased pupillary light and accommodation reflexes. Tendon reflexes on the lower 
extremities were brisk. Wassermann tests performed in blood and cerebrospinal fluid 
confirmed the diagnosis of GPI. 
Following treatment with malarial fever, mood swings became less prominent but the 
delusions of grandeur persisted. The patient showed rapid physical decline, became 
bedridden, developed urinary incontinence and pressure ulcers and died 13 months after 
admission. 
 
Patient 2 is a 44-year-old male construction worker, re-admitted to the VvGI in February 1940. 
As stated in a letter written by his sister, his behaviour had changed in the previous 3 weeks. 
Shortly after the death of his wife, he had become increasingly anxious and violent, verbalizing 
‘strange language’. He was known to suffer from GPI and had been admitted two years earlier 
for malaria fever therapy. Upon the request by his family, he was discharged one year later as 
‘sufficiently recovered’ and subsequently functioned adequately at home. 
On re-admittance, the patient was very confused, irritable, restless and aggressive. He 
experienced vivid visual hallucinations and feelings of depression with suicidal ideation. 
Neurological examination showed unspecified pupillary abnormalities and brisk knee tendon 




In the present study, the clinical presentation of GPI at asylum admission is described in a 
group of 105 patients, who died while they were hospitalized in the VvGI over a period of 
three decades in the first half of the past century. In this late pre-antibiotic era, fever therapy 
induced by malaria was used as a treatment for GPI [8]. Based on the observation that 
psychotic patients occasionally showed great improvement after an intercurrent feverish 
illness, patients were treated with intentionally induced malaria, a method developed by 
Wagner - Jauregg, who was awarded with the Nobel Prize in Physiology or Medicine in 1927 
for his work on the treatment of GPI by malaria inoculation. As early as in 1921, treatment for 
malarial fever was introduced in The Netherlands [8] and soon afterwards was also 
implemented in the VvGI, as is reflected in the two case descriptions above. 
Although case notes of the Dutch GPI patients have been evaluated from the social 
and historical perspective [14, 17], this is the first retrospective study aimed at evaluating the 
signs and symptoms on asylum admittance systematically. Most patients were referred to the 
VvGI because of behavioural problems that were too difficult to manage at home or at a 
general hospital ward, that is, aggression and challenging behaviour. The majority of patients 
were middle-aged men, an observation also made by other investigators [5, 6, 14, 17, 18].  
The finding that all patients were from the lower working class is in accordance with the results 
of the study by Slijkhuis and Oosterhuis [14] on GPI patients in Dutch psychiatric hospitals in 
the period 1870–1920. These observations suggest that in The Netherlands, patients from 
higher socioeconomic classes were treated in private institutes or received nursing care at 
home. Therefore, the finding that syphilis was less likely to be diagnosed in wealthy female 
patients [5] could not be examined in this study. 
Like in other studies, an under-representation of farmers is observed, which has been 
interpreted previously as a consequence of life and work in rural areas far from the turbulent 
city life [3, 5, 7, 18]. In general, records retrieved in this historical series were rather short and 
not always complete regarding the description of symptomatology. The best documented 
were those on female patients. As stressed by other investigators, this brevity was most 
probably related to the legal rules in that era  [19]. In accordance with the 1884 Dutch insanity 
law, medical records also served a legal purpose and, in fact, diagnostic justification for 
(forced) admission and/or prolonged hospitalization was considered superior to detailed 
description of symptoms and disease course. From the juridical viewpoint, the medical 
diagnosis of dementia referred to a state of intellectual failure, causing psychosocial 
incompetence and, therefore, legalized forced psychiatric hospitalization [19, 20]. However, 
brevity of patient records may also have resulted in incompleteness of clinical data leading to 
the under-rating of the incidence of symptoms and signs. Nonetheless, an array of psychiatric 
and neurologic symptoms could be established.  
As can be inferred from table 3, female patients presented mainly with a variety of 
psychotic symptoms (predominantly an array of delusions of grandeur), whereas dementia 
was more prevalent in male patients. In both male and female patients, fleeting ideas of 
grandiosity were common (table 4). In many patients, abrupt alteration of emotions was 
noticed, a feature considered as a core symptom by Kraepelin. 
According to Kraepelin’s taxonomy, the majority of patients can be classified as the 
‘demented type of GPI’ [21]. He observed that this type of GPI patient ‘usually ceases to 
concern himself regarding his obligations’ and ‘often (he) comes into conflict with the public 
regulations or with the law’.  
Although ‘the demented type of psychosis’ has been reported as the most frequent 
presentation of GPI in clinical patients [1], the preponderance of dementia in the total patient 
group should be interpreted with caution. In the records, the term ‘dementia’ was probably 
used in its 19th century meaning, that is, terminal states of a wide variety of mental disorders 
[22]. Deterioration of intellectual functioning and personality in GPI patients may also have 
been the result of other long lasting and untreatable psychiatric disorders that would 
nowadays be diagnosed as delirium or psychotic depression.  
As of neurological symptoms, speech disorders, pupillary abnormalities, and tremors 
were among the most common signs, in accordance with the clinical description of GPI in the 
pre-antibiotic era [7, 23]. The speech disorders documented here comprised problems with 
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were among the most common signs, in accordance with the clinical description of GPI in the 
pre-antibiotic era [7, 23]. The speech disorders documented here comprised problems with 
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articulation and phasic disturbances. In some patients, tremor of the lips and tongue and a 
‘facies paralytica’ (i.e. facial muscle hypotonia with flattening and smoothing out of the facial 
lines caused by disappearance of motor nerve cells of the cerebral cortex) contributed to 
dysarthria. In about half the patients, pupillary abnormalities were recorded, most often 
anisocoria and the absence of reaction of the pupils to bright light. In 6 patients, a full 
description of the Argyll Robertson pupil was recorded: a miotic pupil with defective reaction 
to light and preserved contraction on accommodation [24]. Since most patients showed 
restlessness and/or aggressive behaviour on admittance, they were most probably unable to 
cooperate on a complete pupillary assessment. 
Although disturbance of the sphincters is not an integral part of GPI except in the 
terminal stages, micturition disorders were noted in about half of the patients [7]. These 
dysfunctions may have been related to tabes dorsalis and dementia. 
At admission, nine patients had a history of epileptic seizures and ten patients of 
cerebrovascular disease (table 3), the latter probably caused by syphilitic vascular disease. 
Cranial nerve abnormalities, as observed in several patients (table 5), may have been the 
sequelae of syphilitic meningitis. 
Summarizing, the clinical presentation of GPI in patients, in the first half of the past 
century, includes a wide range of psychotic and mood disorders accompanied by impaired 
judgment. Prevailing neurological symptoms comprised impaired speech, pupillary 
abnormalities and cranial nerve dysfunction. Since at present, unfamiliarity with GPI is 
proverbial and screening for (neuro)syphilis is no longer obligatory, physicians from various 
disciplines should be aware of this disorder that presents with a marked heterogeneity. This 
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Background / Aims: This year* marks the 100th anniversary of the first malaria fever treatment 
(MFT) given to patients with general paralysis of the insane (GPI) by the Austrian psychiatrist 
and later Nobel laureate, Julius Wagner-Jauregg. In 1921 Wagner-Jauregg reported an 
impressive therapeutic success of MFT and it became the standard treatment for GPI 
worldwide. In this study, MFT practice in the Dutch Vincent van Gogh psychiatric hospital in 
GPI patients who had been admitted in the period 1924–1954 is explored. 
 
Methods: To identify patients with GPI, cause-of-death statistics was used. Data on MFT were 
retrieved from annual hospital reports and individual patient records. 
 
Results: Data on MFT were mentioned in the records of 43 out of 105 GPI patients. MFT was 
practiced in a wide range of patients with GPI, including those with disease duration of more 
than one year, up to 70 years of age, and those with a broad array of symptoms and 
comorbidities, such as (syphilitic) cardiac disease. Inoculation with malaria was done by 
patient-to-patient transmission of infected blood. 
 
Conclusions: MFT practice and mortality rates in MFT-treated patients correspond to similar 






General paralysis of the insane (GPI), also designated as “general paralysis” and “dementia 
paralytica”, is a chronic syphilitic meningoencephalitis that causes the progressive 
degeneration of the central nervous system and a general dissolution of mental and physical 
capacities. Isolated reports of this previously undescribed and uniformly fatal form of insanity 
first arose in the late 18th century [1]. 
On June 14, 1917, Julius Wagner-Jauregg (1857–1940) performed his first experiment 
on intentionally induced malaria for the treatment of patients with GPI in Vienna [2]. In 1921, 
he reported an impressive therapeutic success and thereafter this became the standard 
treatment for GPI worldwide. In 1927, Wagner-Jauregg was the first psychiatrist to be 
awarded the Nobel Prize in Physiology or Medicine “for his discovery of the therapeutic value 
of malaria inoculation in the treatment of dementia paralytica” [2]. Despite the reported 
beneficial effect of malaria fever treatment (MFT), its risks were considerable. Treatment 
mortality rates varied from 4, 3% [3] to 20% [4–8]. 
While in Denmark introduction of MFT was hampered by the risk of reintroducing an 
extinct disease [7], Plasmodium vivax  tertian malaria was still endemic in the Netherlands [9]. 
Already in 1921, K.H. Bouman (Dutch neuropsychiatrist) was the first to treat neurosyphilitic 
patients with MFT in the Netherlands [8]. In 1922, promising results were reported [10] and 
soon afterwards, MFT was introduced in the treatment of psychiatric patients in Venray, the 
Netherlands. 
Although research on the history of MFT in GPI patients has been performed in the 
United States [11– 13], Britain [14], Scotland [6], and Denmark [7], no historic study on MFT 
in GPI patients in a psychiatric hospital in the Netherlands has as yet been reported. Therefore, 
in this retrospective cohort study, we investigated MFT-practice in GPI patients who were 





For this study, the practice of MFT was investigated in patients with an established diagnosis 
of GPI, who had been admitted during the period 1924–1954 and died while hospitalized in 
either the psychiatric hospital for male or for female patients in Venray, the Netherlands, at 
present together known as Vincent van Gogh Institute for Psychiatry (VvGI). 
To identify patients with GPI, cause-of-death statistics collected over the period 1924–
1954, as stored in the institute’s historical archive, located at the Social Historical Centre of 
Limburg in Maastricht, was used. Individual medical case records of GPI patients, collected at 
the same archive, were scrutinized. 
Data on MFT were retrieved from annual hospital reports and individual patient 
records. The admission age of first hospitalization was used. For each patient, data on the first 
application of MFT were analysed. In case the date of inoculation was not mentioned in the 
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than one year, up to 70 years of age, and those with a broad array of symptoms and 
comorbidities, such as (syphilitic) cardiac disease. Inoculation with malaria was done by 
patient-to-patient transmission of infected blood. 
 
Conclusions: MFT practice and mortality rates in MFT-treated patients correspond to similar 






General paralysis of the insane (GPI), also designated as “general paralysis” and “dementia 
paralytica”, is a chronic syphilitic meningoencephalitis that causes the progressive 
degeneration of the central nervous system and a general dissolution of mental and physical 
capacities. Isolated reports of this previously undescribed and uniformly fatal form of insanity 
first arose in the late 18th century [1]. 
On June 14, 1917, Julius Wagner-Jauregg (1857–1940) performed his first experiment 
on intentionally induced malaria for the treatment of patients with GPI in Vienna [2]. In 1921, 
he reported an impressive therapeutic success and thereafter this became the standard 
treatment for GPI worldwide. In 1927, Wagner-Jauregg was the first psychiatrist to be 
awarded the Nobel Prize in Physiology or Medicine “for his discovery of the therapeutic value 
of malaria inoculation in the treatment of dementia paralytica” [2]. Despite the reported 
beneficial effect of malaria fever treatment (MFT), its risks were considerable. Treatment 
mortality rates varied from 4, 3% [3] to 20% [4–8]. 
While in Denmark introduction of MFT was hampered by the risk of reintroducing an 
extinct disease [7], Plasmodium vivax  tertian malaria was still endemic in the Netherlands [9]. 
Already in 1921, K.H. Bouman (Dutch neuropsychiatrist) was the first to treat neurosyphilitic 
patients with MFT in the Netherlands [8]. In 1922, promising results were reported [10] and 
soon afterwards, MFT was introduced in the treatment of psychiatric patients in Venray, the 
Netherlands. 
Although research on the history of MFT in GPI patients has been performed in the 
United States [11– 13], Britain [14], Scotland [6], and Denmark [7], no historic study on MFT 
in GPI patients in a psychiatric hospital in the Netherlands has as yet been reported. Therefore, 
in this retrospective cohort study, we investigated MFT-practice in GPI patients who were 





For this study, the practice of MFT was investigated in patients with an established diagnosis 
of GPI, who had been admitted during the period 1924–1954 and died while hospitalized in 
either the psychiatric hospital for male or for female patients in Venray, the Netherlands, at 
present together known as Vincent van Gogh Institute for Psychiatry (VvGI). 
To identify patients with GPI, cause-of-death statistics collected over the period 1924–
1954, as stored in the institute’s historical archive, located at the Social Historical Centre of 
Limburg in Maastricht, was used. Individual medical case records of GPI patients, collected at 
the same archive, were scrutinized. 
Data on MFT were retrieved from annual hospital reports and individual patient 
records. The admission age of first hospitalization was used. For each patient, data on the first 
application of MFT were analysed. In case the date of inoculation was not mentioned in the 
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medical record, it was set at 14 days before the first fever spike was recorded. Epidemiological 
data and clinical course of all patients were collected to analyse selection criteria and 
treatment results. Influence of MFT on survival was analysed with a Kaplan-Meier survival 
curve. Data were anonymized before evaluation. Study approval was obtained by the Vincent 
van Gogh Institutional Review Board (Number: 13.034). 




Data from the Annual Hospital Reports 
Annual reports for the years 1929–1954, except those from 1936 to 1950, were available for 
evaluation. In those years, approximately 750 male and 750 female patients resided in the 
psychiatric hospital and each year approximately 140 male and 130 female patients were 
admitted. 
 
Data from the Cause-of-Death Registers 
During the period 1924–1957, 180 patients (137 men, 43 women) with an established 














Fig. 1. Number of general paralysis of the insane (GPI) patients deceased during 1924–1957 based on cause-of-
death statistics, number of patients whose clinical record was available, and number of patients with malaria 
fever therapy (MFT+) and without (MFT–). 
 
 
The clinical records of 105 (58%) (91 men and 14 women) of the total of 180 GPI patients were 
available for analysis. Of these 105 patients, 10 (9.5%) had been admitted more than once (9 
men, 1 woman). Data on MFT were mentioned in the records of 43 out of 105 patients (41%: 
39 men; 4 women; figure 1). Two patients received MFT twice. In this study, only data on the 
first MFT were analysed. 
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No differences were found with respect to disease duration before admission, earlier MFT, 
and other antineurosyphilitic treatments in patients with and without MFT. Details on patient 
characteristics are presented in table 1. 
Age of MFT-treated patients varied from 31.5 to 69.0 years (n = 43; mean 48.0 years) 
vs. 32.9–82.1 years (n = 62; mean 51.9 years) of untreated patients. Pre-treatment screening 
comprised a thorough clinical examination, laboratory tests, and X-ray of the chest. In five of 
these patients, an enlarged configuration of the ascending aorta was noticed, suggestive of a 
syphilitic aortic aneurysm. One additional MFT-treated patient had a medical history of a 
syphilitic aortic aneurysm, but the data on the chest X-ray of this patient are unknown. 
 
Table 1. Characteristics of patients with general paralysis of the insane treated with malaria fever therapy 
(MFT+) or without (MFT-) 
 MFT+ (n = 43) MFT– (n = 62) 
Gender, female, n (%)  4 (9.3)  10 (16.1)  
Age at admission, mean (range) 48.0 (31.5–69.0) 51.9 (32.9–82.1) 
With known duration of disease before admission, n (%) 34 (79)  49 (79) 
Duration of disease before admission, years, mean (range); 
median 
 1.6 (0.1–8.0); 1.0   2.0 (0.1–9.0); 1.0 
Treated for (neuro) syphilis before current admission, n (%) 16 (37)  25 (40) 
None or unknown earlier treatments, n (%) 27 (63)  37 (60) 
Earlier MFT treatment, n (%)   4 (9)    7 (11) 
Symptoms, n (%)   
       Abnormal mood fluctuations 17 (40)  21 (34) 
       Depression   9 (21)  16 (26) 
       Mania 33 (77)  40 (65) 
       Dementia 33 (77)  52 (84) 
       Speech disorders 38 (88)  43 (69) 
       Tremors   7 (16)  13 (21) 
       Abnormal pupil (reflexes) 19 (44)  30 (48) 
Age at death, mean (range) 52.4 (33.8–70.5)  54.1 (33.1–82.1) 
Survival from admission to death, years, mean (range); median   4.3 (0.0–25.4); 1.8   2.1 (0.0–20.6); 0.9 
Duration of disease until death, years, mean (range); median   6.5 (0.2–25.6); 4.4   3.8 (0.2–21.2); 3.0 
 
The interval between admission and the start of MFT (known for 42 patients) ranged 
from two days to six months. Thirty patients were treated with MFT within one month after 
admission. Patients were inoculated by subcutaneous injection between the shoulder blades 
with 1–3 cm3 blood containing malaria parasites. Infected blood was usually obtained from 
another patient who underwent MFT. In none of the medical records, transmission of malaria 
by infected mosquitoes was noted. For nine patients, the Plasmodium species was recorded: 
seven were treated with P. malariae and two with P. vivax. 
Typically, the first febrile attack occurred after an incubation period of about two 
weeks. After 8–12 paroxysms of high fever (39–40°C = 102–104°F) in a period of 10– 14 days, 
patients were treated with quinine sulphate to terminate the malaria infection. In two 
patients, MFT fever spikes discontinued spontaneously. Following malaria treatment with 
180 GPI patients
(137 men; 43 women)
105 GPI patients
(91 men; 14 women)
For 75 GPI patients clinical
records not available
43 MFT + GPI patients
(39 men; 4 women)
62 MFT- patients
(52 men; 10 women)
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medical record, it was set at 14 days before the first fever spike was recorded. Epidemiological 
data and clinical course of all patients were collected to analyse selection criteria and 
treatment results. Influence of MFT on survival was analysed with a Kaplan-Meier survival 
curve. Data were anonymized before evaluation. Study approval was obtained by the Vincent 
van Gogh Institutional Review Board (Number: 13.034). 
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The interval between admission and the start of MFT (known for 42 patients) ranged 
from two days to six months. Thirty patients were treated with MFT within one month after 
admission. Patients were inoculated by subcutaneous injection between the shoulder blades 
with 1–3 cm3 blood containing malaria parasites. Infected blood was usually obtained from 
another patient who underwent MFT. In none of the medical records, transmission of malaria 
by infected mosquitoes was noted. For nine patients, the Plasmodium species was recorded: 
seven were treated with P. malariae and two with P. vivax. 
Typically, the first febrile attack occurred after an incubation period of about two 
weeks. After 8–12 paroxysms of high fever (39–40°C = 102–104°F) in a period of 10– 14 days, 
patients were treated with quinine sulphate to terminate the malaria infection. In two 
patients, MFT fever spikes discontinued spontaneously. Following malaria treatment with 
| Chapter 348
quinine, patients received additional anti-syphilitic treatment with metals like arsenic and 
bismuth. 
 
MFT Complications  
In 14 patients, premature termination of MFT was recorded and four of those died within one 
month of malaria inoculation. In 13 cases, one or more reasons for premature termination 
were mentioned: occurrence of daily fever spikes without fever-free, restorative days (n = 5), 
diarrhea (n = 3), anemia (n = 2), exhaustion (n = 2), pneumonia (n = 1), jaundice (n = 1), and/or 
pyelocystitis (n = 1). 
 
Survival and Cause of Death 
Patients treated with MFT had a significantly longer survival after admission (p = 0.02; log-
rank test; figure 2). 
 
Fig. 2. Survival after admission (Kaplan-Meier) per treatment category. Curves shown till 8 years follow-up. 
















Cause of death was recorded in 24 (56%) MFT-treated patients and in 33 (53%) non-MFT-
treated patients. In both groups, pneumonia, epileptic seizures and pressure ulcers were 
contributing factors to the cause of most deaths. One non-MFT-treated patient died from 
malaria. It is not known whether malaria in this case was a relapse of a prior spontaneous 







Table 2. Causes of death of patients with general paralysis of the insane treated with malaria fever therapy 
(MFT+) or without (MFT–) 
 
 MFT+ MFT- Total 
Number with cause of death mentioned in files  24 33 57 
Epileptic insults, n (%) 7 (29) 10 (30) 17 (25) 
Pneumonia, n (%) 7 (29) 9 (27) 16 (28) 
Other infections, n (%)  2  (8) 6 (18) 8 (14) 
Decubital lesions, n (%) 3 (13) 4 (12) 7 (12) 
Heart failure, n (%) 2  (8) 5 (15) 7 (12) 
MFT, n (%) 3 (13)  3  (5) 
Haematemesis, n (%) 1  (4) 1  (3) 2  (4) 
Jaundice, n (%) 2  (8)  2  (4) 
Nephritis, n (%)  1  (4) 1 (3) 2  (4) 
Cerebro vascular accident, n (%)  2  (6) 2  (4) 
Gastric cancer, n (%) 1  (4)  1  (2) 





A 43-year-old married man was admitted to the hospital in June 1938 because of progressive 
confusion and aggressive impulsive behaviour. His medical history revealed a short episode of 
confusion two years earlier. 
On admission, he showed confused, agitated, and destructive behaviours with 
frequent shouting, singing and spitting. He had a reduced need for sleep and persistently 
refused food and medical examination. Neurological observation demonstrated gait 
disturbances, but no obvious motor or sensory deficits. 
Routine laboratory testing revealed a positive Wassermann test in blood and 
cerebrospinal fluid and the diagnosis of GPI was made. Subsequently, the patient was 
inoculated with malaria parasites and he developed daily fever spikes. After nine fever spikes, 
the malaria infection was treated with quinine. Following MFT, salvarsan and bismogenol 
were prescribed. His physical condition recovered rapidly and, although he occasionally 
showed aggressiveness toward his wife, gradually some improvement of his mental condition 
was noted too. Since his mental and neurological states were sufficiently improved, he was 
discharged nine months after admission. 
One year later, the patient was readmitted. His sister wrote in a letter to his physician 
that he had been functioning rather well until the unexpected death of his wife. Thereafter, 
he became frightened and depressed. Psychiatric examination at readmittance revealed a 
depression with suicidal ideations and visual hallucinations. He was confused, restless and 
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In August 1938, a 58-year-old barkeeper, who had been a widower for nearly ten years, was 
admitted to the hospital. For over one year, he progressively developed depressive symptoms 
and became introverted, often mumbling to himself. Occasionally, there were aggressive 
outbursts during which he chased his customers out of his bar. Mental status examination on 
admission revealed a depressed man with suicidal ideations and a gloomy appearance. He 
frequently showed episodes with intensive crying and fears of financial ruin. Mild 
psychomotor retardation was noticed, but memory and intellectual function were intact. His 
behaviour was characterized by paranoia without reporting hallucinatory experiences. At 
medical examination his pupils were regular, equal and slowly reacting to light. Achilles 
tendon reflexes were absent bilaterally. Laboratory tests demonstrated a positive 
Wassermann reaction in blood (+7 on a scale from 0 to 10) and cerebrospinal fluid (+8 on a 
scale from 0 to 10). A diagnosis of GPI was made and MFT was started within one month of 
admission. The patient developed several spikes of high fever. Due to severe anemia and 
decubital lesions, MFT had to be discontinued prematurely. For several months, he remained 
depressive and severely restricted in performing the activities of daily living. Four months after 
MFT, however, his mood changed and he became manic with delusions of grandeur. In the 
following months, he showed several mood swings. In April 1940, he was discharged on parole 
on request of his family. 
Two years later, the patient became confused and agitated. He quarrelled with his 
children and customers at daytime and wandered the streets at night. His general physician 
requested readmission and suggested retreatment with MFT because of the partial success 
ascribed to the first treatment. On readmission, the patient was very confused and 
disoriented. Although his speech was severely dysarthric, he was able to express his delusional 
belief that all close to him had deceased. His mood changed rapidly from euphoric to 
depressive and periodically he was very anxious. Within two weeks of admission, MFT was 
started and the patient was subcutaneously injected with 3 mL blood containing P. malariae 
(quartan malaria). Fourteen days later, regular spikes of fever started. Severe anemia and 
heart failure necessitated treatment with digitalis. After six fever spikes within two weeks, the 
patient became exhausted. MFT was terminated with quinine and he received neo-salvarsan 
and bismogenol. His clinical condition remained unchanged until his death one year later. No 




To the best of our knowledge, this paper is the first historical study on MFT in GPI in a 
psychiatric hospital in the Netherlands. In this cohort study focusing on MFT in the period 
1924–1957, MFT practice was analysed in 43 patients with GPI. Although MFT has been used 
for thousands of patients across the world and has greatly contributed to the knowledge of 
malariology [8], its value for treatment of GPI remains doubtful. The reported magnitude of 
success of MFT was highly variable and the rapid and widespread acceptance of this therapy 
probably reflects the absence of an effective treatment for this disease at the time [5]. 
Comparative, well-controlled, trials of MFT versus standard therapy, or MFT versus 
other types of fever have not been reported. Only observational studies are available with 
many differences in often poorly described patient characteristics, criteria of diagnosis, 
response to therapy, and follow-up. Although many cases were treated in general hospitals, 
complex behavioural problems, probably related to more advanced stages of the disease, 
often necessitated referral to a psychiatric hospital [6, 15]. Therefore, patient characteristics 
of those treated in a psychiatric hospital may differ from those treated in a general hospital. 
Differences in malarial strains used, number of fever spikes and pharmacological 
treatments preceding or following MFT, particularly tryparsamide or bismuth, may also have 
influenced the results [16]. Moreover, detailed evaluation of treatment outcome and 
differentiation between treatment outcome and spontaneous remission requires a long 
follow-up period. Factors influencing clinical decision for initiating MFT are rarely noted in the 
medical records. However, perceived favourable results may have influenced this decision. 
 
MFT-Procedure 
The typical MFT practice is described in case A. 
No patient aged over 69 received MFT, which is in concordance with MFT practice in 
Amsterdam [8] and Scotland [6]. 
Prior to MFT, all patients underwent a detailed examination, since high spikes of 
malarial fever could be exhausting, especially in conditions like (syphilitic) heart disease, 
cachexia, diabetes mellitus, obesity and tuberculosis [5, 6]. Noteworthy, in 8 of 43 cases 
treated with MFT, an indication of syphilitic aortic heart disease existed. This illustrates that 
these comorbid diseases were not always considered contraindications. Bed rest, nursing care 
and nourishing diet were often applied to improve health status prior to MFT [8]. This may 
explain why MFT sometimes started more than two months after admission. 
Disease duration exceeded one year in half of the MFT treated patients, while in other 
Dutch hospitals and Scottish asylums, specific therapy was rarely used in patients who had 
been insane for over a year prior to admission [10, 17]. Due to irreversible tissue damage, 
complete remission of symptoms was not to be expected in these cases. Nevertheless, partial 
recovery of neurological and psychiatric symptoms was described [4] and this may explain the 
application in a rather heterogeneous group of patients. 
Patients with all kinds of neuropsychiatric symptoms at admission received MFT, 
including almost half of the patients with manic symptoms. Studies from this period reported 
contradictory observations on the relationship between clinical presentation and treatment 
outcome [4, 6]. 
Inoculation with malaria was done by patient-to-patient transmission of infected 
blood, as was the most common method worldwide [3, 6, 7]. In the Netherlands, the malarial 
species P. vivax, Madagascar strain (malaria tertiana), and since 1933 even P. malariae 
(quartan malaria) were most often used [8]. In general, P. vivax , due to its supposed benign 
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Case B 
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characteristics, high and regular cycles of fever and quinine sensitivity, was considered the 
most suitable species. P. malariae was reserved for GPI patients who were not susceptible 
to  P. vivax (probably due to immunity acquired by an earlier infection [8]), for those requiring 
re-inoculation, such as in the above described case B, and for older and more debilitated 
patients [5]. 
 
Complications and Survival 
The complications of MFT reported in this study, that is, severe headache, malaise, 
anaemia, cardiovascular collapse, jaundice and renal disease, were in part related to the 
malaria infection. MFT could provoke a daily recurrence of high fevers instead of the aimed 
recurrence every third or fourth day. In this study, MFT was prematurely terminated in 10 
patients, predominantly because of such protracted, daily fevers. 
Since no register of diagnosis on admission was available, death statistics was used to 
identify GPI patients, which may have biased the study to some extent. Patients who improved 
sufficiently to be discharged could not be included except for those who were readmitted to 
VvGI and died while hospitalized. Since survival in all GPI patients (MFT- and non-MFT-treated) 
was longer than in the pre-MFT era, improved medical care may have contributed to 
prolonged survival. Nevertheless, patients treated with MFT had a significantly longer survival 
after admission and a prolonged total survival after onset of disease, both one year (70 vs. 
48%) and five years (28 vs. 8%) after admission. This effect of therapy on survival still exists 
after excluding patients who died within three weeks after admission. 
It should be kept in mind that on admission the group of MFT-treated patients was 
possibly in a better medical condition than the group of non-treated patients and it is likely 
that this has affected the survival time. However, this is not reflected by differences in baseline 
conditions that may be associated with higher risk of death (table 1). 
The most important cause of death in MFT and non MFT-treated patients was 
progression of the syphilitic disease process, resulting in epileptic seizures, confinement to 
bed, pressure lesions and increased risk of pneumonia. 
Since only clinical records of deceased patients were examined, the finding of a death 
rate of 16% within two months of MFT could be an overestimation of the actual risks. It has to 
be emphasized here that several factors contributed to the broad range of reported mortality, 
such as different criteria for MFT-related mortality, great variation in patient populations, as 
well as selection criteria for therapy, malarial species and strains used, number and height of 
fever spikes. Nicol, for instance, reported a mortality rate varying from 10 to 15%, depending 
on the stage of disease and plasmodium strain used [4]. Moreover, MFT-related mortality may 
have decreased over time due to accumulated experience or increased due to expansion of 
inclusion criteria as a result of presumed effectiveness [7]. 
MFT remained the standard therapy for GPI until the discovery of penicillin in the mid-
1940s as an effective and safer treatment for syphilis in all stages [6]. However, penicillin 
therapy was not immediately widely accepted and often applied in combination with MFT to 
ensure bactericidal antibiotic levels in the central nervous system in the United States and in 




MFT was practiced in a wide range of patients with GPI, including those with disease duration 
of more than one year, up to 70 years of age, with a broad array of symptoms and 
comorbidities, such as (syphilitic) cardiac disease. Notwithstanding these broad inclusion 
criteria, practice and mortality rates in MFT-treated patients correspond to findings 
worldwide. MFT was well tolerated and MFT-treated patients had a significantly longer 
survival. Main causes of death in patients with GPI were epileptic seizures and infectious 
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Objective: Neurosyphilis is caused by dissemination into the central nervous system of 
Treponema pallidum. Although the incidence of syphilis in the Netherlands has declined since 
the mid-1980s, syphilis has re-emerged, mainly in the urban centres. It is not known whether 
this also holds true for neurosyphilis. 
 
Methods: The epidemiology of neurosyphilis in Dutch general hospitals in the period 1999–
2010 was studied in a retrospective cohort study. Data from the Dutch sexually transmitted 
infection (STI) clinics were used to analyse the number of patients diagnosed with syphilis in 
this period. 
 
Results: An incidence of neurosyphilis of 0.47 per 100,000 adults was calculated, 
corresponding with about 60 new cases per year. This incidence was higher in the western 
(urbanised) part of the Netherlands, as compared with the more rural areas (0.6 and 0.4, 
respectively). The number of patients diagnosed with syphilis in STI clinics increased from 150 
to 700 cases in 2004 and decreased to 500 new cases in 2010. The sex ratio was in favour of 
men, yielding a percentage of 90% of the syphilis cases and of 75% of the neurosyphilitic cases. 
The incidence of neurosyphilis was highest in men aged 35–65 years, and in women aged 75 
years and above. The most frequently reported clinical manifestation of neurosyphilis was 
tabes dorsalis. In this study, 15% of the patients were HIV-seropositive. 
 
Conclusion: The incidence of neurosyphilis in a mixed urban–rural community such as the 
Netherlands is comparable to that in other European countries. Most patients are young, 
urban and men, and given the frequent atypical manifestations of the disease reintroduction 




● In this first nationwide study on neurosyphilis in the Netherlands, a mean annual 
incidence of 0.47 per 100,000 adults was found, with predominantly male subjects. 
● The highest incidence of neurosyphilis was found in the most urbanised part of the 
Netherlands (0.6 per 100,000 adults). 
● Tabes dorsalis is the most frequently registered subclassification of neurosyphilis, 




● Given the sometimes very long latent period, the increased incidence of syphilis 
could still be followed by an enhanced incidence of neurosyphilis in the near future. 
● Underdiagnosis and underrepresentation of neurosyphilis and HIV should still be 
taken into account. 
INTRODUCTION 
 
Neurosyphilis is defined as any involvement of the central nervous system (CNS) at any stage 
of syphilitic infection, caused by Treponema pallidum subspecies pallidum (1). On the basis of 
clinical manifestations, it is classified in early, late and asymptomatic neurosyphilis. Early 
neurosyphilis is characterised by meningitis, cranial nerve abnormalities and cerebrospinal 
accidents. The most common clinical syndromes of late neurosyphilis are tabes dorsalis and 
general paralysis of the insane, of which the former was the most prevalent form in the pre-
antibiotic era (2). 
After the introduction of penicillin therapy in the 1940s and the expansion of 
screening, treatment and prevention programmes, the incidence of both syphilis and 
neurosyphilis decreased significantly in high-income countries (3,4). Given the subsequently 
rapid decrease of syphilis-associated dementia, the American Academy of Neurology omitted 
standard screening for syphilis in the diagnostic workup of dementia, except for the high-
incidence regions (5). 
It should be stressed, however, that, despite the post-antibiotic reduction of syphilis 
incidence, re-emergence of the disease occurred at several time points in the United States, 
Australia and many European countries (4,6). In the latter, such as the Netherlands, the 
increase of syphilis incidence was most pronounced in major urban centres, particularly in 
populations of men who have sex with men (4,7,8). Other factors contributing to this increase 
are HIV infection, intravenous use of illegal drugs and immigration into western European 
countries of people from countries with endemic syphilis (9–11). The number of 
hospitalisations because of syphilis increased in large urban areas in Spain between 1997 and 
2006 (12), whereas in the United Kingdom resurgence was initially observed in the larger cities 
but later progressed to the suburban and rural settings (13). 
In the western European countries, there is an ongoing debate about the utility of 
routine serological screening for syphilis in the workup of neurological and psychiatric 
conditions (14–16). Consequently, clinicians are increasingly unaware of syphilis – a disease 
referred to as ‘the great imitator’ by Sir William Osler (1849–1919) because of its varied 
presentations – and less experienced in the interpretation of serological values. This relative 
unfamiliarity with neurosyphilis may lead to a marked delay in case detection, as had 
happened with other infectious diseases that were assumed to be under control (17). In the 
Netherlands, 11 cases of neurosyphilis with neurological and/or psychiatric phenomena have 
been recently published (table 1). Analysis of these reports showed that neurosyphilis was 
often not included in the differential diagnosis but incidentally detected by routine blood 
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Table 1. Case reports on neurosyphilis in the Netherlands over the last decade 









F, 50 ? > 1 year Dementia paralytica 
Overbeek et al. (19) M, 34 ? > 1 year Dementia paralytica 
 F, 24 - Several days Dementia paralytica 
 M, 46 + ? Dementia paralytica 
Van Coevorden et al. 
(20) 
M, 44 - 4 months Tabes dorsalis and uveitis 
luetica 
Blok et al. (21) M, 39 - 1 month Meningitis with cranial nerve 
involvement 
 M, 38 + Several days Meningitis with cranial nerve 
involvement 
Niermeijer et al (22)  M, 69 ? Several 
months 
Dementia paralytica and ocular 
syphilis 
Zoons and van de 
Beek (23) 
M, 45 ? > 1 year Meningovascular neurosyphilis 
Lens-Daey Ouwens et 
al. (24) 
M, 45 - Several 
months 
Meningovascular neurosyphilis 




+ > 1 year Dementia paralytica 
F, female; M, male; ?, unknown 
 
As the efficacy of antibiotic treatment depends on the stage of neurosyphilis, early 
diagnosis is highly important (1). In general, all symptoms completely resolve after antibiotic 
treatment in patients with early, meningeal neurosyphilis, with the exception of HIV-infected 
patients who may have persistent signs and symptoms for more than a year after such a 
therapy (26,27). However, owing to parenchymal brain damage, complete remission of 
symptoms does not always occur in patients with late neurosyphilis, albeit that disease 
progression may be prevented (28–30). 
In Europe, a yearly neurosyphilis incidence varying from 0.16 to 2.1 per 100,000 
inhabitants is documented (31–33). As the incidence of syphilis is probably related to 
demographic parameters such as the urban–rural balance, a small country with a high 
population density such as the Netherlands is suitable for investigating the epidemiology of 
syphilis and neurosyphilis. 
 
AIMS OF THE STUDY 
 
In the absence of a nationwide surveillance programme for neurosyphilis, data on syphilis and 
neurosyphilis in the Netherlands over a 12-year period (1999–2010) were analysed in the 
present study, by their epidemiological and clinical characteristics. 
 
 
MATERIALS AND METHODS 
 
Hospital data 
In this retrospective cohort study, hospital data of neurosyphilis cases admitted to general 
hospitals were collected from the Dutch National Medical Registration over a 12-year period. 
In 1999–2004, this register had a coverage of 99%, whereas in the period 2005–2010 this 
figure was about 80–90% (population 16 million). All the patients included were aged 20 years 
or above, with a primary or secondary discharge diagnosis of neurosyphilis. 
Neurosyphilis was defined according to the International Classification of Diseases, 
ninth revision Clinical Modification (ICD9-CM) using the ICD9-CM code 094 and subcategory 
codes for all manifestations of neurosyphilis and 91.81 for acute syphilitic meningitis. The 
hospital data comprised age, gender, date of discharge and a four-digit zip code. These data 
combined with patient identifiers were used to exclude duplicate hospitalisations. Incidence 
was defined as the number of cases with a discharge diagnosis (primary or secondary) of 
neurosyphilis per 100,000 of the Dutch population, aged 20 years or above in the period from 
1999 to 2010. Demographic parameters were analysed for all neurosyphilitic patients. 
Comorbidity with HIV infection was recorded according to ICD9-CM codes for HIV-
seropositivity (042 to 044 and 795.8). Zip codes were used for geographic classification. 
 
Data from centres for sexually transmitted infections (STI) 
Data from the Dutch STI centres were used to analyse the number of syphilis cases diagnosed 
between 1999 and 2010. Until 2002, STI surveillance was based on voluntary registration by 
these centres. In 2003, a surveillance system comprising the most important centres became 
operational, yielding an 80% coverage. One year later, all existing STI centres were connected, 
providing national coverage. These clinics offer STI and HIV testing and treatment, free of 
charge, for high-risk groups and people who want to be tested anonymously. All new STI 
consultations and corresponding diagnoses are reported anonymously to the Centre for 
Infectious Disease Control for surveillance purposes. Attendees of a STI clinic are offered 








Although the number of syphilis cases diagnosed in the STI clinics increased to 700 cases in 
2004, followed by a decrease to 500 new cases in 2010 (figure 1), no time trend for incidence 
of neurosyphilis could be found. In the period from January 1999 to December 2010, 695 
discharge diagnoses of neurosyphilis were registered in the Dutch National Medical 
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Although the number of syphilis cases diagnosed in the STI clinics increased to 700 cases in 
2004, followed by a decrease to 500 new cases in 2010 (figure 1), no time trend for incidence 
of neurosyphilis could be found. In the period from January 1999 to December 2010, 695 
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Registration, varying from 41 to 72 cases per year. A primary discharge diagnosis of 
neurosyphilis was recorded in 560 cases (81%) and a secondary in 135 cases (19%). 
  
 
Figure 1. Number of syphilis diagnoses, number of hospitalisations because of neurosyphilis (left axis) and 
incidence of neurosyphilis (right axis) in the Netherlands (1999–2010). 
 
 
The annual incidence of neurosyphilis varied from 0.34 to 0.59 per 100,000 of the population 
aged 20 years or above. Of all the patients recorded with syphilis (n = 5311) in the STI clinics 
or neurosyphilis () in the Dutch National Medical Registration (n = 695), the majority were men 
(91% and 76%, respectively). With respect to neurosyphilis, the mean annual incidence per 
100,000 was 0.7 in men and 0.2 in women. Median age for men was 47 years (oldest 86 years) 
and 54 years for women (oldest 92 years) (figure 2). 
 
 
Figure 2: Mean incidence of hospitalisations because of neurosyphilis in the Netherlands by age group and sex 
(1999–2010). 
As presented in table 2, the incidence of neurosyphilis differed per age group and 
gender, with the highest incidence for men in the age range of 30–50 years, and for women 
in the age range of 70 years and above. The mean annual incidence of hospitalisation for 
neurosyphilis was significantly higher in the western, most urbanised part of the Netherlands 
(0.6 per 100,000 of the population). In the rest of the Netherlands, the incidence was 0.4 per 
100,000 of the population. 
 















Syphilis 5836 - 10.1/1 Unknown Unknown Unknown 
Neurosyphilis  695 -  4.2/1 15 21-92 49 
Asymptomatic 38 5 2.8/1 13 22-78 40 
Early 11 2 10/1 18 26-86 42 
Late 204 29 2.3/1 1 20-92 59.2 
NOS/ NEC 427 61 4.6/1 21 20-84 46 
Others 15 2 4.0/1 20 26-75 48 
 
Hospital data of all patients revealed a diagnosis of late neurosyphilis in 204 cases (29%), 
asymptomatic neurosyphilis in 38 (5%), early neurosyphilis in 11 (2%) and other forms of 
neurosyphilis in 15 (2%) cases. Clinical characteristics are summarised in table 2. 
Clinical manifestation was not specified (neurosyphilis NEC or NOS) in 427 cases (61%). 
Tabes dorsalis (170 cases) was the most frequent registered form of neurosyphilis.  
Median age did not differ significantly between patients with general paresis of the 
insane (59.5 years) and patients with tabes dorsalis (59.0 years). Patients with early 
neurosyphilis were significantly younger (median age 42 years) than those with late 
neurosyphilis (median age 59 years). Gender was not correlated with any clinical 
manifestation. An additional HIV-positive status was reported in 101 patients (15%) who had 




This is the first nationwide study on neurosyphilis in the Netherlands, covering a recent period 
of 12 years, in which a mean annual incidence of 0.47 per 100,000 adults was found from a 
retrospective analysis of hospital data, with predominantly male subjects. The mean annual 
incidence of hospitalisation for neurosyphilis was significantly higher in the western, most 
urbanised part of the Netherlands (0.6 per 100,000 of the population). In the rest of the 
Netherlands, the incidence was 0.4 per 100,000 of the population. 
Neurosyphilis in the mixed urban-rural society of the Netherlands | 63
4
Registration, varying from 41 to 72 cases per year. A primary discharge diagnosis of 
neurosyphilis was recorded in 560 cases (81%) and a secondary in 135 cases (19%). 
  
 
Figure 1. Number of syphilis diagnoses, number of hospitalisations because of neurosyphilis (left axis) and 
incidence of neurosyphilis (right axis) in the Netherlands (1999–2010). 
 
 
The annual incidence of neurosyphilis varied from 0.34 to 0.59 per 100,000 of the population 
aged 20 years or above. Of all the patients recorded with syphilis (n = 5311) in the STI clinics 
or neurosyphilis () in the Dutch National Medical Registration (n = 695), the majority were men 
(91% and 76%, respectively). With respect to neurosyphilis, the mean annual incidence per 
100,000 was 0.7 in men and 0.2 in women. Median age for men was 47 years (oldest 86 years) 
and 54 years for women (oldest 92 years) (figure 2). 
 
 
Figure 2: Mean incidence of hospitalisations because of neurosyphilis in the Netherlands by age group and sex 
(1999–2010). 
As presented in table 2, the incidence of neurosyphilis differed per age group and 
gender, with the highest incidence for men in the age range of 30–50 years, and for women 
in the age range of 70 years and above. The mean annual incidence of hospitalisation for 
neurosyphilis was significantly higher in the western, most urbanised part of the Netherlands 
(0.6 per 100,000 of the population). In the rest of the Netherlands, the incidence was 0.4 per 
100,000 of the population. 
 















Syphilis 5836 - 10.1/1 Unknown Unknown Unknown 
Neurosyphilis  695 -  4.2/1 15 21-92 49 
Asymptomatic 38 5 2.8/1 13 22-78 40 
Early 11 2 10/1 18 26-86 42 
Late 204 29 2.3/1 1 20-92 59.2 
NOS/ NEC 427 61 4.6/1 21 20-84 46 
Others 15 2 4.0/1 20 26-75 48 
 
Hospital data of all patients revealed a diagnosis of late neurosyphilis in 204 cases (29%), 
asymptomatic neurosyphilis in 38 (5%), early neurosyphilis in 11 (2%) and other forms of 
neurosyphilis in 15 (2%) cases. Clinical characteristics are summarised in table 2. 
Clinical manifestation was not specified (neurosyphilis NEC or NOS) in 427 cases (61%). 
Tabes dorsalis (170 cases) was the most frequent registered form of neurosyphilis.  
Median age did not differ significantly between patients with general paresis of the 
insane (59.5 years) and patients with tabes dorsalis (59.0 years). Patients with early 
neurosyphilis were significantly younger (median age 42 years) than those with late 
neurosyphilis (median age 59 years). Gender was not correlated with any clinical 
manifestation. An additional HIV-positive status was reported in 101 patients (15%) who had 




This is the first nationwide study on neurosyphilis in the Netherlands, covering a recent period 
of 12 years, in which a mean annual incidence of 0.47 per 100,000 adults was found from a 
retrospective analysis of hospital data, with predominantly male subjects. The mean annual 
incidence of hospitalisation for neurosyphilis was significantly higher in the western, most 
urbanised part of the Netherlands (0.6 per 100,000 of the population). In the rest of the 
Netherlands, the incidence was 0.4 per 100,000 of the population. 
| Chapter 464
The yearly incidence found in this study is higher than that observed in the 1970s in 
Leicester (0.18 per 100,000 inhabitants) (32) and in the 1980s in Greater Copenhagen (0.16–
0.46) (31), but lower than in the northern area of the island of Gran Canaria and the whole 
island of Lanzarote in the 1990s (0.2–2.1 per 100,000) (33). As for the sex ratio, it was found 
that the higher syphilis infection rate in men is comparable to that reported in most European 
countries (8). This also holds true for neurosyphilis (31–36). Similarly, neurosyphilis affected 
men twice as often as women (10% and 5%, respectively) in the pre-antibiotic era (37). 
However, comparison of the incidence rates of neurosyphilis in the various European 
countries is difficult because of the considerable variability in case definitions. 
Interestingly, although a marked increase in syphilis is documented nationwide in STI 
clinics in the Netherlands up to 2004, no change in neurosyphilis incidence is observed over 
the past 12 years. This might be the result of continued efforts towards earlier and improved 
syphilis screening and treatment in STI clinics, and routine screening of pregnant women and 
blood donors (38,39). As standard screening for syphilis in psychiatric and neurological 
patients is no longer routinely included in laboratory testing, there is a risk for underdiagnosis 
and subsequent underregistration of neurosyphilis. It should be stressed, however, that 
because of the long latency between syphilis and neurosyphilis, a rise in the documented 
incidence of neurosyphilis may still occur in the decades to come. 
Although tabes dorsalis is the most frequently registered subclassification of 
neurosyphilis in the present study, comparable to observations in the pre-antibiotic era, a 
correct interpretation of this finding cannot be given as 54% of cases was classified as 
neurosyphilis NOS. In contrast, other studies have reported that tabes dorsalis has become 
increasingly rare in the antibiotic era (31,35,40). In an earlier Dutch clinical cohort study, the 
overall figures of early and late neurosyphilitic syndromes were more or less the same in the 
pre- and post-antibiotic eras, with the exception of an increased incidence of asymptomatic 
neurosyphilis (1930–1940: n = 518; 1970–1984: n = 121). The rise in incidence of tabo paralysis 
and decline in tabes dorsalis in the post-antibiotic era group was interpreted as the result of 
a more accurate neuropsychological patient investigation (35). As can be inferred from this 
study on a relatively large group of patients, neurosyphilis in the Netherlands is not restricted 
to HIV-positive patients, a finding that corroborates results from a smaller sample Danish 
study (36). In some studies, HIV-positive patients are reported to not only have a higher 
incidence of early rather than late neurosyphilis, but also a shorter period before the 
manifestation of late forms of neurosyphilis (27,41,42). This may be explained by their 
compromised immune system. In the pre antibiotic era, the majority of cases with acute 
syphilitic meningitis occurred after an unsuccessful therapy for early syphilis. It was 
hypothesised that exposure to drugs that did not reach treponemocidal levels in the CNS 
resulted in diminished immune response and clinically manifest neurosyphilis (1). 
In line with these observations, the median age of HIV-seropositive neurosyphilitic 
patients in the present study was significantly lower than the overall median age. As 
subclassification of neurosyphilis was registered in only 24% of the HIV-positive neurosyphilitic 
patients, the relationship between early versus late neurosyphilis and HIV-seropositivity 
cannot be fully elucidated. The high number of cases with an ICD9-CM neurosyphilis NOS/NEC 
code may result from atypical clinical manifestations of the disease. In contrast, in a recent 
Danish study, only 13% of the cases were reported with the classification of neurosyphilis NOS 
(36). 
In the present study, cases with early neurosyphilis were significantly younger than 
those with late forms of the disease as could have been expected, assuming that 
manifestations of neurosyphilis occur in a consecutive order. In contrast, however, no 
significant difference in median age in patients with tabes dorsalis and general paralysis of the 
insane (considered the last stage of neurosyphilis) was found in the present study. Moreover, 
previous studies in the Netherlands and Denmark did not disclose any differences in age 
between cases classified with ‘early’ and ‘late’ neurosyphilis (35,36). Although the traditional 
classification is based on the idea that syphilitic meningitis, meningovascular syphilis, tabes 
dorsalis and general paresis of the insane occur in a sequential order, these forms rarely exist 
in pure form at autopsy (43). Classifying the clinical manifestations of neurosyphilis might be 
complicated by the overlap between the clinical syndromes (44), thus explaining the high rate 
of cases without clinical classification (neurosyphilis NOS and NEC) in this study. 
Although it seems unlikely that new cases of neurosyphilis are missed out as all 
patients with a new diagnosis of neurosyphilis are treated with intravenous antibiotics in a 
general hospital, underdiagnosis and therefore underregistration of neurosyphilis and HIV 
should still be taken into account. As stated before, the low incidence of neurosyphilis co-
occurs with less familiarity of clinicians with the asymptomatic and atypical manifestations of 
the disease. Reintroduction of screening for neurosyphilis should therefore be considered 
seriously (45). Further research on the frequent atypical clinical symptomatology is needed to 
improve both diagnosis and management of patients with neurosyphilis. 
Summarising, over the past 12 years, neurosyphilis was diagnosed in about 60 Dutch 
hospitalised adult patients per year, indicating that neurosyphilis is yet to be considered in the 
differential diagnosis. The incidence of neurosyphilis is highest in young, urban men, although 
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Objectives: The worldwide increase in the incidence of syphilis necessitates alertness to the 
occurrence of neurosyphilis. Early recognition of neurosyphilis allows for timely treatment, 
leading to a better treatment outcome. This retrospective study aims to describe the clinical 
presentation of neurosyphilis in a recent series of neurosyphilis patients. 
 
Methods: All patients were included with a new, laboratory confirmed, diagnosis of 
neurosyphilis in the period 2004-2018. The clinical data were analysed. 
 
Results: 34 neurosyphilis patients (1 woman and 33 men) were identified. Age varied from 31-
84 years (median age: 44 years). A history of syphilis infection was known for 11 (32%) 
patients; 12 (35%) patients were HIV seropositive. The distribution of the clinical syndromes 
was as follows: 16 patients with early neurosyphilis (acute meningitis, meningovasculitis and 
/ or uveitis), 9 patients with late neurosyphilis (General Paralysis of the Insane and / or Tabes 
Dorsalis), 2 patients with symptoms of both early and late neurosyphilis, 6 patients with 
asymptomatic neurosyphilis and in 1 patient insufficient data were available to determine a 
clinical syndrome. Early neurosyphilis was seen in all age categories, late neurosyphilis only 
occurred in patients > 40 years. 
 
Conclusion: Neurosyphilis occurs in adults in all age groups, in men more frequent than in 
women, often in HIV-infected patients, and can present with a wide range of clinical 
syndromes. Usually no previous infection with syphilis is known. 
INTRODUCTION 
 
A worldwide increase in the incidence of syphilitic infections is reported since the turn of the 
21st century (Fenton et al. 2008). In 2008, the World Health Organization estimated 10.6 
million cases among adults worldwide. In the European Union and European Economic Areas, 
28,701 syphilis cases (6.0 per 100,000 population) were reported in 2015, mostly in patients 
older than 25 years of age (ECDC 2017). Between 2010 and 2015, many countries observed a 
sharp increase of over 50% in the rates of reported syphilis infections, mainly in man having 
sex with men (MSM) (ECDC 2017), probably related to changing sexual and social norms and 
to interactions with increasingly prevalent Human Immunodeficiency Virus (HIV) infection 
(Fenton et al. 2008). Syphilis seems to occur more frequently in the context of substance 
abuse, migration and underinvestment in public-health services (Fenton et al. 2008). 
The causative bacterium of syphilitic infection, the neurotropic Treponema pallidum 
subspecies pallidum, probably enters the central nervous system (CNS) shortly after infection 
in up to one-quarter of patients with early syphilis (Marra 2004). In 16-48% of cases with early 
(primary or secondary) syphilis, abnormalities in the cerebrospinal fluid (CSF) have been 
detected (Berger and Dean 2014). In a minority of the cases, those unable to spontaneously 
eradicate the infection from the CSF, asymptomatic or symptomatic neurosyphilis will develop 
within months or decades (Berger and Dean 2014). In the pre antibiotic era, the Oslo study on 
the natural history of untreated syphilis demonstrated that 9.4% of the men and 5.0% of the 
women ultimately developed neurosyphilis (Clark and Danbolt 1955). Since then, early 
treatment of syphilitic infection with penicillin, antibiotic treatment for intercurrent 
infections, variation in the incidence of different strains of syphilis, and HIV co-infection, may 
have changed the course of the disease. However, recent data on the natural history of syphilis 
are unavailable as yet. 
The clinical manifestations of neurosyphilis are traditionally divided into ‘early’ and 
‘late’ neurosyphilis. Early neurosyphilis, presenting as meningitis or meningovascular disease, 
typically manifests within months to several years after the initial infection. Within a year of 
initial infection involvement of the meninges may result in meningitis with headache, 
meningismus and cranial nerve palsies, in particular VII, VIII, VI and II. Meningovascular disease 
typically occurs after 6-7 years. About 10% of patients with neurosyphilis and almost 3% of all 
syphilis patients present with a stroke. In one study, up to 74% of this category of patients 
were under the age of 50 (Abkur et al. 2015). 
Late neurosyphilis primarily affects the CNS parenchyma and occurs 15-30 years after 
initial infection and results most commonly in the clinical syndromes of General Paralysis of 
the Insane (GPI) (also termed General Paralysis or Dementia Paralytica) and Tabes Dorsalis 
(TD) (also known as syphilitic myelopathy) (Berger and Dean 2014). GPI presents with 
progressive neuropsychiatric symptoms. TD, which affects the dorsal roots, posterior column 
of the spinal cord, and optic nerves, presents as sensory ataxia with incontinence, pain, and 
optic atrophy (Marra 2004). Pupillary abnormalities, including Argyll-Robertson pupils (pupils 
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that are small, asymmetric, irregular, and poorly responsive to direct light with maintained 
appropriate constriction on accommodation) were once a hallmark symptom of TD. 
The clinical diagnosis of neurosyphilis is challenging, since neurosyphilis can affect 
every part of the CNS and may mimic a wide variety of neurological and mental disorders. 
Moreover, at present no uniform clinical diagnostic criteria have been established. Therefore, 
CSF analysis is considered crucial for a diagnosis of neurosyphilis. However, a perfect “gold 
standard” diagnostic test is not available. Treponemal tests, for example the Treponemal 
pallidum hemagglutination (TPHA) and Treponemal pallidum particle agglutination (TPPA) 
tests, are used to screen for syphilitic infection. Since these tests may remain reactive for 
years, even after successful treatment, non-treponemal tests as the Veneral Disease Research 
Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) test are often used to confirm active 
syphilitic infection (Peeling 2006). As treponemal antibodies can passively pass an intact 
blood-brain barrier, higher IgG levels in serum results into higher CSF levels. This leakage of 
antibodies through the serum-CSF barrier can be distinguished from additional intrathecal 
production of antibodies by the IgG-serum/CSF index, using the Reiber or TPPA index (Reiber 
1994a; Reiber 1994b; Luger et al. 2000). 
The present study aims to investigate the clinical characteristics of patients in whom 
cerebrospinal fluid tested positive for neurosyphilis in the period 2004-2018 in a country with 
a relatively low syphilis incidence. 
 
MATERIAL AND METHODS 
 
In this retrospective case series, all patients with a clinical diagnosis of neurosyphilis, 
confirmed with a CSF VDRL or PRP ≥ 4, a CSF TPHA ≥ 500, and/or a TPHA CSF-serum index ≥ 70 
during the period 2004 to 2018 were examined. 
The study protocol was reviewed and approved by the Medical Ethics Committee of 
the University Medical Centre Groningen, the Netherlands (Number: 2009/333). 
CSF serological tests to confirm neurosyphilis were performed by the department of 
medical microbiology of Certe. Certe is a reference laboratory for syphilis serology, covering a 
catchment population of 1.1 million inhabitants and nine hospitals in the northeast part of the 
Netherlands, including the University Medical Centre Groningen. In results and tables of this 
paper titres, such as 1:250, will be represented as dilutions only, e.g. 250, and the term VDRL 
will be used instead of VDRL/RPR. In the Certe laboratory the CSF VDRL was completely 
replaced by the RPR test in 2014 after a lengthy comparison of both methods showed 
essentially similar results. The TPPA serum-CSF index was calculated as follows: (TPPA 
cerebrospinal fluid/1000)*(albumin serum/albumin cerebrospinal fluid) (Luger et al. 2000). A 
TPPA CSF-serum index of ≥ 70 was considered to demonstrate laboratory evidence for a 
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A total of 34 patients (33 men and 1 woman) were identified with neurosyphilis confirmed 
with CSF serology. Median age was 44.1 (range 31.3 - 84.0) years. For 30 patients the referring 
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psychiatric disease was present including substance abuse (n=6), depression (n=4) and /or 
psychosis (n=2). No patient had a history of dementia. For twelve (35 %) patients a positive 
HIV serology was documented. The median interval between the diagnoses of HIV infection 
and neurosyphilis was 2,5 years. The median age of neurosyphilis patients with a documented 
HIV-infection was significantly lower as compared to those without a documented HIV 
infection (41.1 years versus 45.1 years; p=0.03). 
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Table 1: Presenting symptoms in patients with laboratory confirmed neurosyphilis (n=34). 
*fatigue, dysphagia, headache, myalgia. 
 
Symptoms       n (%) 
Memory or cognitive complaints 8 (25%) 
Visual complaints 6 (18%) 
Psychiatric complaints 6 (19%) 
Hemiparesis 5 (16%) 
 Gait disturbances 5 (16%) 
Dizziness 4 (13%) 
Non-specific symptoms*  10 (31%) 
None 3   (9%) 
 
 
Table 2: Neurological signs in patients with laboratory confirmed neurosyphilis (n=34). 
 
Neurological signs    n (%) Missing 
Cognitive dysfunction 12 (39%) 3 
Cranial nerve abnormalities 6 (20%) 4 
Abnormal reflexes 5 (17%) 5 
Motor abnormalities 5 (17%) 4 
Sensory abnormalities 5 (17%) 5 
Gait disturbances 4 (14%) 6 
Pupillary abnormalities 3 (10%) 5 
Epilepsy not otherwise explained 1   (3%) 5 
 
Cognitive dysfunction or psychiatric signs at the time of neurosyphilis diagnosis were present 
in 12 (39%) and 8 (24%) patients, respectively. Delirium was the most common psychiatric 
disorder at presentation (n=4). Three patients had pupillary abnormalities. 
 
Classification of symptoms 




Table 3:  Age, HIV status and interval between positive syphilis serology in serum and CSF per classification in 
patients with laboratory confirmed neurosyphilis (n=34). 
 






Interval between positive 
syphilis serology in the serum 
and the CSF in days (range)  
Early neurosyphilis 16 41 (31-84)  97 (4-1642) 
   Acute syphilitic meningitis 5  3  
   Meningovascular syphilis 5  1  
   Uveitis 5  3  
   Acute syphilitic meningitis 
and  uveitis 
1  1  
Late neurosyphilis 9 61 (43-70)  214 (28-601) 
   General Paralysis of the Insane 6  1  
   Tabes Dorsalis 2  0  
   General Paralysis of the Insane 
and Tabes Dorsalis 
1  0  
Combined early and 
late  neurosyphilis 
2 44 (43-46)  Not available 
  General Paralysis of the 
Insane   and  acute syphilitic      
meningitis 
2  0  
Asymptomatic 6 43 (34-45) 2 Not applicable 
Unclassifiable due to incomplete 
data 




Due to incomplete data classification was not possible for one patient. Age at diagnosis per 
clinical syndrome is presented in figure 1. 
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Figure 1: Average age (years) at diagnosis per classification (n=34). 
 
GPI was the most frequent syndrome (n=9, 27%), followed by acute syphilitic meningitis (n=6; 
18%). Early neurosyphilis was noticed in all age categories. Late neurosyphilis was not present 








Duration of syphilitic disease 
The interval between positive syphilis serology in the serum and the CSF was less than one 
year in 24 patients. Of those, ten presented with early neurosyphilis, seven with late 
neurosyphilis, four were asymptomatic and two patients presented with combined early and 
late neurosyphilis. In 10 patients, the interval between positive syphilis serology in the serum 
and the CSF was more than one year, in that six presented with early neurosyphilis, two with 
late neurosyphilis whereas two were asymptomatic. 
Median interval between positive syphilis serology in the serum and the CSF was 138 
days (ranging from 4 days to 4.5 years). Date of first symptoms of neurosyphilis was reported 
for 17 (61%) out of 28 patients with symptomatic neurosyphilis. As presented in figure 3, 
disease duration of neurosyphilis prior to diagnosis differed between age categories (43 days 





Figure 3: Disease duration of neurosyphilis prior to diagnosis per age category in days (n=34) 
 
All patients had a TPPA CSF-serum index of ≥ 70. Additional laboratory results are presented 
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Table 4: Laboratory data in patients with a clinical diagnosis and laboratory confirmed neurosyphilis (n=34) 
CSF = cerebrospinal fluid; TPHA = Treponema Pallidum Haemagglutination Test; VDRL = Venereal Disease 
Research Laboratory 
 
 Median (interquartile range) Missing 
Total CSF protein 0.52  (0.38-0.98 ) g/l 10 
Number of mononuclear cells in CSF 21 (4-48) 11 
VDRL in CSF 2 (0-4) 9 
TPHA index 345 (163-1292) 0 
 
Treatment 
Information on antibiotic treatment was available for 28 (82%) patients. All but one patient 
were initially treated with penicillin; one received doxyxycline. Information on dosing was 
available for 17 patients. Three patients were treated with less than 18 million units per day. 
Information on duration of penicillin treatment was available in 23 patients in that 21 received 
antibiotic   days, one for 10 days and one for six days. Additional treatment with steroids was 
known for three patients of whom two had uveitis and one GPI. 
 
Case description 
A 40-year-old Caucasian man, married and working full time as a circus employee, was 
admitted to a psychiatric hospital with acute onset of confusion. His medical history was 
characterized by chronic episodic alcohol abuse and sporadic epileptic seizures. Recently, the 
patient had been diagnosed with cerebral infarction in the left parieto-occipital region. Apart 
from alcohol misuse, no specific etiology of a suspected stroke could be identified. His EEG 
recording showed epileptiform discharges and since the patient was known to have had 
several epileptic seizures, alcohol withdrawal epileptic seizures were suspected. Treatment 
with antiepileptic drugs and secondary stroke prevention measures were initiated. 
One day prior to admission to the psychiatric hospital, the patient was referred to the 
emergency department of a general hospital because of tonic-clonic epileptic seizures within 
the past 24 hours. Against medical advice, he left the hospital after one day. However, later 
that day he was admitted to a psychiatric hospital with acute onset of confusion, 
hypermotility, altered behavior, and irritability. 
At psychiatric admission, a poorly groomed, right-handed man was seen with a blood 
pressure of 127/74 mmHg at a pulse rate of 94 / min. The patient was without fever and 
systemic examination was unremarkable. Albeit that he was alert and attended to the 
examiner when his name was called, there was disorientation in time and place. He did not 
understand all the questions and did not follow commands. He showed paucity of speech, 
often answered monosyllabically, was unable to concentrate and was not able to recall 
anything from the days prior to admission. In addition, there were gaps in his long-term 
memory. There were no indications of delusions or hallucinations. His mood was neutral, with 
no indication of suicidal ideation or ideas of self-harm. The fingertip nose test and the knee 
heel test were performed correctly. The tendon reflexes on the arms were low and on the legs 
lively. His walking pattern was slow and broad-based. He was incontinent for urine and feces. 
Initially, the patient was cooperative, later he became irritable and refused further physical 
examination. On the second day of admission, the patient developed a delirium with vivid 
visual hallucinations. 
Laboratory investigations revealed positive serological blood tests for syphilis in serum 
(TPPA 5000,000; VDRL 32) and CSF (TPPA 500,000; VDRL 16) without any hematological, renal, 
hepatic, thyroid, or metabolic dysfunctions. HIV tests were negative. Subsequently, a 
diagnosis of meningovascular neurosyphilis was made and, in accordance with the European 
Guidelines (Janier et al. 2014) treatment was started with intravenous benzylpenicillin (24 
million units daily in six divided doses). Because the patient repeatedly removed his infusion, 
after two days penicillin was replaced with doxycycline in an oral dose of twice daily 200 mg. 
Six days later he refused oral medication, and treatment was therefore continued with 
ceftriaxone 2000 mg 1 dd intramuscularly for 11 days. The comorbid psychotic symptoms 
were treated according to hospital standard. 
In the first month after initiation of antibiotic treatment, there was a slow 
improvement in the patient's functional and cognitive status. He displayed more initiative, his 
gait pattern improved and the incontinence disappeared. Short-term memory and orientation 




This retrospective study, covering a period of 14 years, provides information on the clinical 
presentation and treatment of 34 patients with laboratory confirmed neurosyphilis in a 
geographically defined area in a country with low syphilis incidence. 
 
Patient characteristics 
Age at symptomatic presentation ranged from 31 - 84 years  (median age: 44 years), which is 
in accordance with the data reported by other investigators (Zhang et al. 2013, Daey Ouwens 
et al. 2014, Drago et al. 2016). A lower age at presentation was reported by studies in 
populations with high rates of syphilis and HIV-co-infection from San Francisco (range 22-88 
years; median age 39 years) (Flood et al. 1998) and South Africa (range 17 - 67 years; average 
39 years) (Timmermans and Car 2004). 
In the present study, the proportion of female patients was lower than that of males, 
whereas the reported data on the percentage of female patients varies from 9 to 25% (Flood 
et al. 1998, Mitsonis et al. 2008, Zhang et al. 2013,  Daey Ouwens et al. 2014, Drago et al. 
2016). Male predominance has previously been observed in studies on neurosyphilis, 
especially in studies with a high number of HIV-infected cases (Flood et al. 1998). In the 
present study, HIV-seropositivity was documented for 35% of patients, which is a higher 
percentage as reported in other studies (Daey Ouwens et al. 2014, Drago et al. 2016). The here 
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reported relative absence of female patients may be related to either the high male-to-female 
ratio of syphilis patients in the Netherlands (ECDC 2017) or the low number of patients 
included. 
 
Presenting symptoms and signs 
At admission, in one third of the patients, psychiatric and / or cognitive complaints were 
present which is in concordance with data reported by other investigators (Mitsonis et al. 
2008, Zhang et al. 2013, Lin et al. 2014). Most probably, cognitive function was not extensively 
assessed in all included patients, so that the current number may be an underestimation. In 
the pre-penicillin era, isolated neuropsychiatric symptoms often preceded the full blown 
clinical manifestation of GPI (Kraepelin 1913). The results of our study advocate that 
psychiatrists should consider neurosyphilis in the differential diagnosis of all patients with a 
positive syphilis serology in the blood in the presence of unexplained (progressive) changes in 
cognition and behaviour, especially when focal neurological signs are lacking. 
In the present study, only three patients presented with TD, which is in accordance 
with the general observation that the incidence of TD has decreased since the beginning of 
the pre-antibiotic era (Wolters 1987, Carr 2003). Interestingly, speech and micturition 
disorders, frequently concomitant with late neurosyphilis in the past (Kraepelin 1913, Daey 
Ouwens et al. 2015), were not observed in the present study. 
Although cognitive dysfunction as well as psychotic and depressive symptoms 
classically belong to GPI, these can also result from meningeal involvement (Drago et al. 2016). 




Although the terms “early” and “late” suggest a correlation between duration of syphilitic 
disease and clinical presentation of neurosyphilis, data on the initial syphilitic infection are 
rarely reported. Moreover, precise definitions and consensus of the clinical characteristics 
that accompany these terms are lacking, in that e.g. the reported interval between initial 
syphilitic infection and vascular syphilis as a presenting syndrome of neurosyphilis varies from 
less than one year to 4 - 7 years (Carr 2003). Since detailed information about time of 
occurrence, duration and nature of prior syphilitic symptoms is seldom reported by patients, 
the interval between syphilitic infection and clinical manifest neurosyphilis is often difficult to 
establish. Also in this study, in the majority of patients the first known positive blood test of 
syphilis was performed within 90 days of CSF test of neurosyphilis, suggesting that for most 
patients the diagnosis of syphilis and neurosyphilis were simultaneously established. Possibly, 
prior syphilitic infection is not reported by patients with a low number of (unnoticed) syphilitic 
skin lesions. A low number of skin lesions might be related to a lower concentration of 
treponemas. Exposure to lower concentrations of treponemas could also attenuate the host 
immune response causing impaired ability to clear those that managed to invade the CNS. 
Consequently, this may result in a greater likelihood to develop symptomatic neurosyphilis 
(Zhang et al. 2013). 
 
Treatment 
Since controlled, randomized, prospective studies for optimal dose and duration of therapy 
are lacking no uniform worldwide recommended treatment regimen for neurosyphilis is 
available as yet (Berger and Dean 2014). The European guidelines recommend daily 
administration of benzylpenicillin 18–24 million units intravenously, divided over 3–4 million 
units dosages every 4 hours for 10–14 days as first line therapy (Janier et al. 2014). Second 
line therapy options are ceftriaxone 1–2 g intravenously daily for 10–14 days and, if 
hospitalization and / or intravenously administration of antibiotics is impossible, procaine 
penicillin 1.2–2.4 million units intramuscular daily combined with probenecid 500 mg four 
times daily, both during 10–14 days. 
In the present study, cognitive dysfunction and psychiatric symptoms may have 
hampered intravenous administration of antibiotics which probably explains intravenous 
treatment for less than 14 days in some patients. 
In the literature, the Jarisch-Herxheimer reaction (J-HR), a clinical syndrome composed 
of abrupt onset of fever, chills, myalgias, tachycardia, vasodilatation with flushing, 
exacerbated skin rash, and / or mild hypotension, that can occur in patients after the first 
adequate dose of an antimicrobial drug to treat infectious diseases, is reported in a substantial 
proportion of syphilis patients. In addition, HIV seropositivity (Yang et al. 2010) and several 
clinical manifestations of neurosyphilis, such as syphilitic optic neuritis and involvement of the 
auditory nerve, have been described as a potential risk factor for a dramatic course of J-HR 
(Zifko et al. 1994, Kojan et al. 2000, Fathilah and Choo 2003, Tucker et al. 2011). Therefore, 
the European guidelines recommend inpatient management in cases with cardiovascular or 
neurological involvement and prevention of Jarisch Herxheimer reaction by treatment with 
Prednisolone 20–60 mg daily for 3 days, starting anti-treponemal treatment after 24 h of 
commencing prednisolone (Janier et al. 2014). 
The present case report illustrates that meningovascular neurosyphilis is a severe 
condition but reversible with appropriate therapy and stresses that neurosyphilis should be 
included in the differential diagnosis of a young patient with a cryptogenic stroke and in any 
patient in an acute confusional state. 
In sum, main findings of the present study concerning presentation of neurosyphilis 
are male predominance, regular cognitive, memory and visual complaints and a broad age 
range. In addition, HIV- seropositivity and prior psychiatric disease were frequently reported. 
Since most patients were not able to mention any previous syphilitic infection, the interval 
between first signs and diagnosis was generally long. The results may be biased since only 
those patients were included in whom CSF analysis was performed by a certificated reference 
laboratory. Cognitive and memory complaints were probably not systematically assessed, 
which may have resulted in underestimation of the presence of these symptoms. 
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reported relative absence of female patients may be related to either the high male-to-female 
ratio of syphilis patients in the Netherlands (ECDC 2017) or the low number of patients 
included. 
 
Presenting symptoms and signs 
At admission, in one third of the patients, psychiatric and / or cognitive complaints were 
present which is in concordance with data reported by other investigators (Mitsonis et al. 
2008, Zhang et al. 2013, Lin et al. 2014). Most probably, cognitive function was not extensively 
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psychiatrists should consider neurosyphilis in the differential diagnosis of all patients with a 
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cognition and behaviour, especially when focal neurological signs are lacking. 
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the pre-antibiotic era (Wolters 1987, Carr 2003). Interestingly, speech and micturition 
disorders, frequently concomitant with late neurosyphilis in the past (Kraepelin 1913, Daey 
Ouwens et al. 2015), were not observed in the present study. 
Although cognitive dysfunction as well as psychotic and depressive symptoms 
classically belong to GPI, these can also result from meningeal involvement (Drago et al. 2016). 
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Treatment 
Since controlled, randomized, prospective studies for optimal dose and duration of therapy 
are lacking no uniform worldwide recommended treatment regimen for neurosyphilis is 
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hospitalization and / or intravenously administration of antibiotics is impossible, procaine 
penicillin 1.2–2.4 million units intramuscular daily combined with probenecid 500 mg four 
times daily, both during 10–14 days. 
In the present study, cognitive dysfunction and psychiatric symptoms may have 
hampered intravenous administration of antibiotics which probably explains intravenous 
treatment for less than 14 days in some patients. 
In the literature, the Jarisch-Herxheimer reaction (J-HR), a clinical syndrome composed 
of abrupt onset of fever, chills, myalgias, tachycardia, vasodilatation with flushing, 
exacerbated skin rash, and / or mild hypotension, that can occur in patients after the first 
adequate dose of an antimicrobial drug to treat infectious diseases, is reported in a substantial 
proportion of syphilis patients. In addition, HIV seropositivity (Yang et al. 2010) and several 
clinical manifestations of neurosyphilis, such as syphilitic optic neuritis and involvement of the 
auditory nerve, have been described as a potential risk factor for a dramatic course of J-HR 
(Zifko et al. 1994, Kojan et al. 2000, Fathilah and Choo 2003, Tucker et al. 2011). Therefore, 
the European guidelines recommend inpatient management in cases with cardiovascular or 
neurological involvement and prevention of Jarisch Herxheimer reaction by treatment with 
Prednisolone 20–60 mg daily for 3 days, starting anti-treponemal treatment after 24 h of 
commencing prednisolone (Janier et al. 2014). 
The present case report illustrates that meningovascular neurosyphilis is a severe 
condition but reversible with appropriate therapy and stresses that neurosyphilis should be 
included in the differential diagnosis of a young patient with a cryptogenic stroke and in any 
patient in an acute confusional state. 
In sum, main findings of the present study concerning presentation of neurosyphilis 
are male predominance, regular cognitive, memory and visual complaints and a broad age 
range. In addition, HIV- seropositivity and prior psychiatric disease were frequently reported. 
Since most patients were not able to mention any previous syphilitic infection, the interval 
between first signs and diagnosis was generally long. The results may be biased since only 
those patients were included in whom CSF analysis was performed by a certificated reference 
laboratory. Cognitive and memory complaints were probably not systematically assessed, 
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Appendix 1: Clinico-pathological classification of neurosyphilitic symptoms based on Flood et 
al. 1998. 
 
1. Early neurosyphilis 
1. Syphilitic meningitis: acute syphilitic meningitis, defined by symptoms or 
findings of acute headache, and/or cranial nerve deficits, with or without 
meningeal signs (photophobia or meningismus) 
2. Syphilitic meningovascular disease: defined by findings of stroke or other 
upper motor neuron deficits on exam with characteristic lesions on 
computed tomography or magnetic resonance imaging of the brain and/or 
changes consistent with medium-sized vessel vasculitis on angiogram; and 
3. Uveitis, defined by symptoms of decreased vision, eye pain, or photophobia 
with diagnosis confirmed by slit-lamp examination 
 
1. Late neurosyphilis 
1. General Paralysis of the Insane: defined by a dementia syndrome or 
subacute psychosis not clearly explained by another process 
2. Tabes Dorsalis: defined by posterior column deficits such as sensory ataxia, 
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Neurosyphilis can imitate a wide range of neurological and psychiatric diseases. To illustrate 
that neurosyphilis should be considered in cases suspected of autoimmune encephalitis (AE) 
and vice versa, here, a case of neurosyphilis is reported who presented with new onset focal 
epilepsy, swelling of the left amygdala and temporal slowing of the electro-encephalogram 
(EEG) suggestive of a diagnosis of AE. Early recognition and treatment are crucial to prevent 




A 62-year-old right handed man was referred to a neurology department because of transient 
loss of consciousness for one year. His wife reported that attacks typically started with a 
moaning sound “resembling a baby's crying”, followed by stiffening of the right arm, 
unresponsiveness, stiffening all over and shaking during several minutes. Afterwards he spoke 
in his mother tongue, a language not familiar to his wife. Generally, full recovery took fifteen 
minutes. These episodes were often preceded by anger, followed by a slightly euphoric 
feeling. The patient’s medical history was significant for severe heart failure, a dilated left 
cardiac ventricle, severe mitral and aortic valve insufficiency, current treatment with warfarin, 
approximately 40 packyears of cigarette smoking and therapy for gambling addiction. The 
patient reported  prior antibiotic treatment for syphilis, however he could not provide details  
on these issues. His personal and family history were negative with regard to seizures and 
febrile convulsions. Clinical and neurological examination were unremarkable. 
Interictal EEGs showed intermittent temporal slowing, more on the left than on the 
right side, but no specific epileptic discharges. FLAIR and T2WI cranial MRI sequences 
demonstrated an increased volume of the left amygdala as well as a marked atrophy in the 
parietal regions. A specific focus of temporal lobe epilepsy was not found. Anti-neuronal 
antibodies, including NMDA-R, VGKC-complex, Hu, Yo, Ri, Tr, ampfifysine, CV2, Ma1/2 were 
not detected; syphilis screening test was positive and the Venereal Disease Research 
Laboratory test (VDRL) was 16, demonstrating active syphilis infection. No HIV-test was 
performed. Cerebrospinal fluid (CSF) analysis revealed normal cell count, protein and glucose 
concentration; Treponema blot: positive; Treponema pallidum haemagglutination: positive 
(1:1024) and rapid plasma reagine: positive (< 1.1). 
A diagnosis was made of parenchymatous neurosyphilis presenting with subacute 
mesial encephalitis and focal epilepsy originating in the language dominant hemisphere with 
focal to bilateral tonic-clonic seizures. Treatment with lamotrigine 75 mg bid and intravenous 
penicillin at a dose of 12 million units/d for 10 days was initiated. Two months after initiation 
of antibiotic and anti-epileptic treatment the patient was seizure free and at that time a 
second MRI revealed that the left amygdala was still hyper-voluminous. Two years later the 
patient was still seizure free and lamotrigine was tapered off. 




In our case, a history of new onset focal epilepsy, swelling of the left amygdala and 
intermittent temporal slowing on interictal EEG suggested a diagnosis of AE. Seizures in AE are 
most often associated with Anti-NMDA-R, LGI1, GABAbR, GABAaR and DPPX antibodies, 
whereas LGI1 is particularly associated with faciobrachial dystonic seizures (Van Sonderen et 
al., 2016). However, antibody testing is not always readily accessible, test results can take 
several weeks and cannot serve as a gold standard since absence of antibodies does not 
exclude AE and positive tests do not always imply an accurate diagnosis. Therefore, in the 
initial assessment of suspected AE thorough neurological evaluation and standard diagnostic 
tests (EEG, MRI and CSF studies) should prevail as early initiation of immunotherapy in AE may 
improve prognosis. MRI images with increased FLAIR/T2WI signal with highly selective medial 
temporal lobe involvement, without contrast enhancement, are associated with AE, 
neurosyphilis, Sjögren’s syndrome, Human Herpes Virus 6 infection and rare cases of 
lupus  (Leypoldt et al., 2015). 
Most patients with neurosyphilis mimicking AE are men, with a median age of 54 
years  (Serrano-Cardenas et al., 2018). The most common clinical manifestations at admission 
were cognitive impairment, seizures and psychiatric disorders. Typical findings on EEG are 
focal slow waves and periodic lateralized epileptiform discharges. 
AE and neurosyphilis might partially overlap as illustrated by the report of two patients 
with serological confirmed neurosyphilis accompanied with positive NMDA-R antibody tests 
in serum and CSF (Qin et al., 2017). In these cases, neurosyphilis and anti-NMDAR encephalitis 
may have occurred simultaneously. However, it could be hypothesized that neurosyphilis 
caused a secondary immunological response of anti-NMDAR-Ab production, analogous to AE 
following Herpes Simplex encephalitis (Qin et al., 2017). In our patient no serum NMDA-R 
antibodies were detected and CSF antibody tests were, unfortunately, not performed. 
As illustrated by our case, a diagnosis of neurosyphilis should not be excluded in 
those  with a history of antibiotic treatment for syphilis. Late complications of syphilis and 
progression to neurosyphilis can develop, also in immunocompetent patients, despite 
standard antibiotic therapy for syphilis. It is not known, whether syphilitic infection 




Neurosyphilis presenting with focal seizures and MRI abnormalities of the amygdala can mimic 
AE and neurosyphilis should be excluded prior to initiation of immunotherapy in patients 
suspected of AE, even in those who were considered adequately treated for syphilis in the 
past. Further studies are required to determine whether immunologic mechanisms contribute 
to this atypical presentation of neurosyphilis. 
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INTRODUCTION 
Neurosyphilis can imitate a wide range of neurological and psychiatric diseases. To illustrate 
that neurosyphilis should be considered in cases suspected of autoimmune encephalitis (AE) 
and vice versa, here, a case of neurosyphilis is reported who presented with new onset focal 
epilepsy, swelling of the left amygdala and temporal slowing of the electro-encephalogram 
(EEG) suggestive of a diagnosis of AE. Early recognition and treatment are crucial to prevent 




A 62-year-old right handed man was referred to a neurology department because of transient 
loss of consciousness for one year. His wife reported that attacks typically started with a 
moaning sound “resembling a baby's crying”, followed by stiffening of the right arm, 
unresponsiveness, stiffening all over and shaking during several minutes. Afterwards he spoke 
in his mother tongue, a language not familiar to his wife. Generally, full recovery took fifteen 
minutes. These episodes were often preceded by anger, followed by a slightly euphoric 
feeling. The patient’s medical history was significant for severe heart failure, a dilated left 
cardiac ventricle, severe mitral and aortic valve insufficiency, current treatment with warfarin, 
approximately 40 packyears of cigarette smoking and therapy for gambling addiction. The 
patient reported  prior antibiotic treatment for syphilis, however he could not provide details  
on these issues. His personal and family history were negative with regard to seizures and 
febrile convulsions. Clinical and neurological examination were unremarkable. 
Interictal EEGs showed intermittent temporal slowing, more on the left than on the 
right side, but no specific epileptic discharges. FLAIR and T2WI cranial MRI sequences 
demonstrated an increased volume of the left amygdala as well as a marked atrophy in the 
parietal regions. A specific focus of temporal lobe epilepsy was not found. Anti-neuronal 
antibodies, including NMDA-R, VGKC-complex, Hu, Yo, Ri, Tr, ampfifysine, CV2, Ma1/2 were 
not detected; syphilis screening test was positive and the Venereal Disease Research 
Laboratory test (VDRL) was 16, demonstrating active syphilis infection. No HIV-test was 
performed. Cerebrospinal fluid (CSF) analysis revealed normal cell count, protein and glucose 
concentration; Treponema blot: positive; Treponema pallidum haemagglutination: positive 
(1:1024) and rapid plasma reagine: positive (< 1.1). 
A diagnosis was made of parenchymatous neurosyphilis presenting with subacute 
mesial encephalitis and focal epilepsy originating in the language dominant hemisphere with 
focal to bilateral tonic-clonic seizures. Treatment with lamotrigine 75 mg bid and intravenous 
penicillin at a dose of 12 million units/d for 10 days was initiated. Two months after initiation 
of antibiotic and anti-epileptic treatment the patient was seizure free and at that time a 
second MRI revealed that the left amygdala was still hyper-voluminous. Two years later the 
patient was still seizure free and lamotrigine was tapered off. 




In our case, a history of new onset focal epilepsy, swelling of the left amygdala and 
intermittent temporal slowing on interictal EEG suggested a diagnosis of AE. Seizures in AE are 
most often associated with Anti-NMDA-R, LGI1, GABAbR, GABAaR and DPPX antibodies, 
whereas LGI1 is particularly associated with faciobrachial dystonic seizures (Van Sonderen et 
al., 2016). However, antibody testing is not always readily accessible, test results can take 
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Neurosyphilis presenting with focal seizures and MRI abnormalities of the amygdala can mimic 
AE and neurosyphilis should be excluded prior to initiation of immunotherapy in patients 
suspected of AE, even in those who were considered adequately treated for syphilis in the 
past. Further studies are required to determine whether immunologic mechanisms contribute 
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In this section the work of this thesis will be reviewed from a broader perspective. Specific 
attention will be given to General Paralysis of the Insane (GPI) and the treatment of 
neurosyphilis. 
 
EPIDEMIOLOGICAL ASPECTS OF NEUROSYPHILIS 
 
Syphilology, a medical discipline studying the diagnosis and treatment of syphilis, arose as a 
new medical speciality at the end of the 19th century due to the high prevalence of syphilitic 
disease and other venereal diseases (Albert, 1999). Nowadays, in higher-income parts of the 
world, physicians often classify syphilis among the extraordinary diseases. However, despite 
considerable advances in diagnosis, knowledge of pathophysiological aspects and treatment 
as well as the high rates of cure since the widespread use of antibiotic therapy for syphilis 
after the Second World War and extension of screening, treatment and prevention programs, 
syphilis persisted as a worldwide challenge in health care (Tuddenham and Ghanem, 2018). 
Estimates suggest a global prevalence of 12 million people in 1995 (Gerbase et al., 1998). The 
rates of primary and secondary syphilis have increased in the past decade both in the 
developing and developed countries (Tuddenham and Ghanem, 2015). In Russia and the now 
independent states of the former Union of Soviet Socialist Republics, after achieving a 
notification rate of 4.2 cases per 100,000 in 1988, the rate of syphilis cases rose to 263 per 
100,000 in 1996 (Kent and Romanelli, 2008). In the United States, higher rates of sexually 
transmitted infections, particularly syphilis, are reported more often in men who have sex 
with men (MSM) than in other risk groups (Gianella et al., 2015) and a similar trend was  
noticed in the Netherlands (Visser et al., 2018) and other developed countries (Ho and 
Spudich, 2015). In MSM, immunomodulatory mechanisms secondary to the presence of other 
infections might be involved. Particularly Human Immunodeficiency Virus (HIV)-infected 
individuals seem susceptible to acquisition of syphilis (Gianella et al., 2015). Use of 
methamphetamine and other drugs, participation in specific sexual networks and a higher 
number of sexual partners appear to be associated with this increased susceptibility (Gianella 
et al., 2015). 
In the Netherlands, syphilis is not a notifiable disease and therefore exact data on the 
incidence of syphilis are lacking. Instead, data derived from Sexual Health Clinics and General 
Practitioners is used for surveillance. In 2017, 1,228 clients (95.3% MSM, 2.4% heterosexual 
men, 2.3% women) received a new diagnosis of syphilis at Sexual Health Clinics (Visser et al., 
2018). The estimated disease burden of syphilis in the Netherlands in 2015 was 15 DALY 
(disability adjusted life years), with a 95% uncertainty interval of 12-17 (Gier de et al., 2017). 
However, the typically painless chancre of primary syphilis often develops unnoticed by 
patients, especially when located in a less visible body area (e.g., vagina, cervix, anus, rectum) 
and therefore many patients present only after this first stage of syphilis has passed. 
Presently, robust estimates of the prevalence of neurosyphilis worldwide are lacking 
and much of the knowledge comes from the pre-antibiotic era (Tuddenham and Ghanem, 
2018). In Europe, a yearly neurosyphilis incidence varying from 0.16 to 2.1 per 100,000 
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inhabitants is estimated (Nordenbo and Sorensen, 1981; Alani and Millac, 1982; Conde-Sendin 
et al., 2004). In line with this finding, an incidence of 0.47 per 100,000 adults was calculated 
in the study in the Netherlands, presented in Chapter 4, which examined countrywide hospital 
discharge diagnoses of neurosyphilis between 1999 and 2010 from a national registry. 
However, comparison of incidence rates of neurosyphilis in the various European countries is 
difficult, because of considerable differences in case definitions. 
As for the sex ratio, the higher neurosyphilis rate in men as documented in the 
Netherlands (Chapter 4), is comparable to that reported in other European countries. It is 
unknown whether male predominance in syphilis and neurosyphilis patients is related to 
social-cultural and behavioural factors, or underlying biological characteristics that influence 
the susceptibility to protract syphilis or to develop neurosyphilis after syphilitic infection. 
Nevertheless, MSM constitute an important subpopulation in syphilis epidemiology, with the 
use of sex enhancing and other recreational drugs (e.g., the combined use of sildenafil and 
methamphetamines) promoting concurrent sexual partnerships, increased rates of new 
partner acquisition, and short intervals between new sex partners, all of which enhance sexual 
spread of infections (Fenton et al., 2008). 
HIV seropositivity was reported in 15% of neurosyphilis patients hospitalized in the 
Netherlands (Chapter 4). However, this percentage was based on hospital discharge diagnoses 
rather than documented clinical examination or laboratory criteria and, therefore, HIV 
seropositivity might have been underreported. In the study on the clinical presentation of 
neurosyphilis patients (Chapter 4) laboratory data demonstrated that 12 out of 34 
neurosyphilis patients were known to have positive HIV tests at the time neurosyphilis was 
diagnosed. In this study, most HIV seropositive patients presented with early neurosyphilis. 
The natural history of neurosyphilis may be significantly altered by concomitant HIV infection 
(Berger and Dean, 2014). Whether increasing numbers of reported neurosyphilis - particularly 
early neurosyphilis - cases in HIV infected persons is a result of biological susceptibility, as a 
consequence of immunosuppression or increased detection as a result of enhanced follow-up 
is not known as yet (Tuddenham and Ghanem, 2018). 
 
CLINICAL PRESENTATION OF NEUROSYPHILIS 
 
General Paralysis of the Insane (GPI) was a common cause of psychosis and psychiatric 
hospitalization in the nineteenth century (Frankenburg and Baldessarini, 2008). Even as 
recently as in the mid-twentieth century, GPI accounted for 10% of all first admissions to 
psychiatric hospitals and for more than 20% of all patients residing in psychiatric hospitals in 
the United States (Frankenburg and Baldessarini, 2008). Like most research into the historical 
aspects of GPI (Thompson, 1984; Braslow, 1997; Hurn, 1998; Davis, 2008; Slijkhuis and 
Oosterhuis, 2012), the studies presented in Chapter 2 and Chapter 3 focus on patients with 
this condition in a psychiatric hospital in the first half of the 20th century. At that time, GPI 
patients without serious behavioural problems were probably mostly treated in general 
hospitals, as is indicated by the referral of several patients to Vincent van Gogh Institute for 
psychiatry (VvGI) due to challenging behaviours that first appeared during their stay on a 
general hospital ward and the high number of patients with a history of anti-syphilitic therapy 
elsewhere prior to admission to VvGI. Therefore, the findings presented in Chapter 2 and 
Chapter 3 are probably mainly representative of patients in a late stage of neurosyphilis. In 
agreement with the findings of other investigators, the majority of GPI patients hospitalized 
in VvGI were middle-aged. This results from the sexual transmissibility of syphilis and the fact 
that GPI manifests at a late stage of syphilis, usually at least 10 years after infection. Since the 
beginning of the 19th century, GPI is predominantly reported in men (Hare, 1959). The 
underlying biological, cultural and individual behavioural mechanisms are unknown. Torres 
suggests that the greater sexual freedom allowed to men as compared to women in the 20th 
century could explain that GPI was found much more often in men than in women (Torres, 
2014). However, sexual freedom for women has increased in the western world in the 21st 
century and GPI is still more often diagnosed in men than in women (see Chapter 4 and 
Chapter 5), therefore this sociological explanation is probably not sufficient to explain the 
differences in incidence of GPI. 
The total group of GPI patients in VvGI as described in Chapter 2 presented at 
admission with a broad array of neuropsychiatric and neurological manifestations, which is in 
accordance with Kraepelins description of a wide range of initial symptoms and a large variety 
in the course of GPI (Kraepelin, 1903). Lack of insight and judgement, “dementia” and 
hyperactivity were most often reported. This lack of insight and judgment in combination with 
delusions, especially when persecutory in nature, probably contributed to the frequently 
reported challenging behaviours of patients prior to admission to VvGI. About half of the 
patients with GPI were referred to VvGI, because of provocative behaviour in a general 
hospital ward, while in about 20% of those living at home, prior to admission, severe 
behavioural problems had resulted in judicial contacts. These findings suggest that GPI 
patients were referred to a psychiatric hospital only when their behaviour caused serious 
problems for their environment and justified forced hospitalization. 
Delusion of grandeur or "megalomania" was reported in almost half of the patients 
presented in Chapter 2. Patients suffering from such "delusions of grandeur" demonstrated a 
grossly exaggerated belief of self-worth, power, knowledge or identity or of an exceptional 
relationship with a divinity or famous person (Wing et al., 1980). This type of delusion is not 
pathognomonic for neurosyphilis, as megalomania may also occur in other diseases, including 
bipolar disorder and schizophrenia. In patients with GPI, delusions of grandeur may have 
particularly impressed physicians due to the contrast between the content of the delusions 
and the often deplorable conditions of the patients. Megalomia probably reflected the lack of 
insight of these patients into their condition (Davis, 2012 p.87). A recent survey of the 
literature of the period 2010-2015 demonstrated that GPI was the commonest reported form 
of neurosyphilis (49%), often manifesting with cognitive impairment and psychiatric 
symptoms (Drago et al., 2016b). Many of the patients of this review were admitted to a 
psychiatric unit rather than to a medical or neurological one (Drago et al, 2016b). The results 
of a study on the current clinical presentation of neurosyphilis presented in Chapter 5 are in 
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accordance with these findings. In this study, syphilitic disease was first diagnosed during 
routine serological screening for syphilis in a psychiatric hospital in several patients. These 
data suggest that, given the increasing incidence of syphilis and the decreasing familiarity of 
clinicians with the multisystemic and multiphasic nature of syphilis, reintroduction of 
screening for syphilis at psychiatric, neurological and geriatric departments should seriously 
be considered. 
At admission to VvGI cardiovascular disease was reported in 14 (7,5%) GPI patients, as 
described in Chapter 2. In six patients an aortic aneurysm was described and 8 patients had a 
history of cerebrovascular accident. Heart failure and cerebrovascular accident were 
documented as cause of death in 7 and 2 patients respectively. Cardiovascular syphilis was a 
common late manifestation of syphilis prior to the introduction of penicillin as the standard 
therapy for syphilis. In 1956, Macfarlane and colleagues reported a diagnosis of cardiovascular 
syphilis in 15% (202 patients) of 1,330 syphilitic patients referred for cardiovascular 
investigation in the period 1945-1951 (Macfarlane et al., 1956). Although cardiovascular 
syphilis is still present today (Roberts et al., 2009), no cardiovascular disease was noted in the 
records of the cases described in Chapter 5. 
In the pre-antibiotic era, Tabes Dorsalis (TD) affected 3-9% of persons infected with 
syphilis (Merritt at al., 1946) and TD was the most frequently reported manifestation of 
neurosyphilis in the study presented in Chapter 2. However, in the antibiotic era, a shift in 
clinical patterns of patients diagnosed with neurosyphilis is noted, with a decreasing rate of 
late neurosyphilis, in particular of TD (Hooshmand et al., 1972; Wolters, 1987) and TD is rarely 
diagnosed today (Kulkarni and Serpa, 2018). The cause of this change in clinical presentation 
is unknown as yet (Zhang et al., 2015). However, as mentioned before, exact data of the 
incidence of TD and precise diagnostic criteria are lacking. A possible explanation for this 
phenomenon might include changes in diagnostic methods. Currently, examination of the 
cerebrospinal fluid (CSF), including syphilis serology, in patients with pain in the distal 
extremities with or without bladder dysfunction, is less often performed than in the pre-
antibiotic era, due to the increased availability and accuracy of imaging techniques and a 
decreased a priori probability of syphilis. Micturition disturbances related to neurosyphilis had 
a high prevalence in the pre-penicillin era, as demonstrated in patients with GPI in Chapter 2. 
Neurogenic bladder dysfunctions due to syphilis still occurs, particularly in immunodeficient 
patients (Prydacz et al., 2018). These patients most often present with urine retention 
resulting from neurogenic detrusor underactivity (Prydacz et al., 2018). 
The clinical importance of diagnosing asymptomatic neurosyphilis (ANS) was evident 
in the pre-antibiotic era. Syphilis patients with demonstrated ANS had a significantly higher 
chance of developing late neurological complications than syphilis patients, whose CSF tests 
were normal (Ghanem, 2010). Diagnosing ANS lost relevance after the introduction of 
penicillin in the 1940s and the subsequent decrease in the incidence of neurosyphilis. The 
clinical significance of detecting ANS in the penicillin era is unknown, because no studies have 
been reported comparing the long-term results of treatment with one of the recommended 
antibiotic regimens in patients with and without asymptomatic CSF abnormalities (Ghanem, 
2010). The increasing number of patients suffering from neurological complications in HIV-
infected patients (Ghanem, 2010) and case reports on the unmasking of syphilitic infection 
and rapid development of neurosyphilis in patients treated with immunomodulating therapy 
(Bories-Haffner et al., 2010; Bettenworth et al., 2012; Kase et al., 2015) have updated this 
dilemma. These findings stress the importance of screening for syphilis also in these patients 
prior to initiate immunomodulating therapy. 
 
THOUGHTS ABOUT THE PATHOGENESIS OF NEUROSYPHILIS 
 
The pathology of neurosyphilis results from the invasion of the central nervous system by T. 
pallidum and the associated immunological response (Berger and Dean, 2014). In the pre-
antibiotic era, early neurosyphilis was rarely diagnosed among persons who were not treated 
for syphilis (0.3%), but the incidence increased nearly ten-fold in those, who were 
inadequately treated (2–3%). The latter suggests that inadequate or incomplete treatment 
may alter the immune response, resulting in an increased risk to develop early neurosyphilis 
(termed “neurorecurrence”) (Tuddenham and Ghanem, 2018). A similar alteration of the 
host’s immune response may be involved in the pathogenesis of neurosyphilis in human 
immunodeficiency virus (HIV) infected patients. In syphilis patients with concomitant HIV 
infection, symptomatic neurosyphilitic meningitis during secondary syphilis is not uncommon 
and suggests a more aggressive course of disease (Berger and Dean, 2014). However, a 
randomized controlled trial of enhanced therapy for early syphilis in patients with and without 
HIV infection in the 1990s could not substantiate this hypothesis (Rolfs et al., 1997). 
Several studies have demonstrated that long-term complications of syphilis such as 
neurosyphilis can develop, also in immunocompetent patients, despite adequate penicillin 
treatment for early manifestations of syphilis (Zhou et al., 2012; Drago et al., 2016b; Rebora 
et al., 2018). This finding may refer to particularly neuroinvasive T. pallidum strains or to the 
incapacity of penicillin to pass effectively through the hemato-encephalic barrier, achieve 
treponemicidal concentrations in the central nervous system (CNS) and/or destroy T. pallidum 
present in the CNS (Drago et al., 2016a). However, other hypotheses that involve autoimmune 
or autoinflammatory mechanisms, can be put forward. Recent findings suggest that in 
neurosyphilis patients down regulation of the systemic immune response may promote 
disease progression towards neurological involvement and, conversely, the CNS damage may 
be due to an uncontrolled local host immune response (Drago et al., 2016a). The development 
of chronic neurosyphilis may be the result of an uncontrolled local production of antibodies 
by persistent antigenic stimulation due to survival of spirochetes or, most likely, from residues 
of bacteria in the form of protein (Drago et al., 2016a). 
Production of auto-immune antibodies may also play a role in the rare neurosyphilis 
cases that mimic autoimmune encephalitis (AE), as in the patient described in Chapter 6. In 
these cases, neurosyphilis presents with progressive cognitive impairment, new onset 
epilepsy and psychiatric disorder in combination with predominant mesiotemporal or 
frontobasal hyperintensities hyperintense on Fluid Attenuation Inversion Recovery (FLAIR) 
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in the pre-antibiotic era. Syphilis patients with demonstrated ANS had a significantly higher 
chance of developing late neurological complications than syphilis patients, whose CSF tests 
were normal (Ghanem, 2010). Diagnosing ANS lost relevance after the introduction of 
penicillin in the 1940s and the subsequent decrease in the incidence of neurosyphilis. The 
clinical significance of detecting ANS in the penicillin era is unknown, because no studies have 
been reported comparing the long-term results of treatment with one of the recommended 
antibiotic regimens in patients with and without asymptomatic CSF abnormalities (Ghanem, 
2010). The increasing number of patients suffering from neurological complications in HIV-
infected patients (Ghanem, 2010) and case reports on the unmasking of syphilitic infection 
and rapid development of neurosyphilis in patients treated with immunomodulating therapy 
(Bories-Haffner et al., 2010; Bettenworth et al., 2012; Kase et al., 2015) have updated this 
dilemma. These findings stress the importance of screening for syphilis also in these patients 
prior to initiate immunomodulating therapy. 
 
THOUGHTS ABOUT THE PATHOGENESIS OF NEUROSYPHILIS 
 
The pathology of neurosyphilis results from the invasion of the central nervous system by T. 
pallidum and the associated immunological response (Berger and Dean, 2014). In the pre-
antibiotic era, early neurosyphilis was rarely diagnosed among persons who were not treated 
for syphilis (0.3%), but the incidence increased nearly ten-fold in those, who were 
inadequately treated (2–3%). The latter suggests that inadequate or incomplete treatment 
may alter the immune response, resulting in an increased risk to develop early neurosyphilis 
(termed “neurorecurrence”) (Tuddenham and Ghanem, 2018). A similar alteration of the 
host’s immune response may be involved in the pathogenesis of neurosyphilis in human 
immunodeficiency virus (HIV) infected patients. In syphilis patients with concomitant HIV 
infection, symptomatic neurosyphilitic meningitis during secondary syphilis is not uncommon 
and suggests a more aggressive course of disease (Berger and Dean, 2014). However, a 
randomized controlled trial of enhanced therapy for early syphilis in patients with and without 
HIV infection in the 1990s could not substantiate this hypothesis (Rolfs et al., 1997). 
Several studies have demonstrated that long-term complications of syphilis such as 
neurosyphilis can develop, also in immunocompetent patients, despite adequate penicillin 
treatment for early manifestations of syphilis (Zhou et al., 2012; Drago et al., 2016b; Rebora 
et al., 2018). This finding may refer to particularly neuroinvasive T. pallidum strains or to the 
incapacity of penicillin to pass effectively through the hemato-encephalic barrier, achieve 
treponemicidal concentrations in the central nervous system (CNS) and/or destroy T. pallidum 
present in the CNS (Drago et al., 2016a). However, other hypotheses that involve autoimmune 
or autoinflammatory mechanisms, can be put forward. Recent findings suggest that in 
neurosyphilis patients down regulation of the systemic immune response may promote 
disease progression towards neurological involvement and, conversely, the CNS damage may 
be due to an uncontrolled local host immune response (Drago et al., 2016a). The development 
of chronic neurosyphilis may be the result of an uncontrolled local production of antibodies 
by persistent antigenic stimulation due to survival of spirochetes or, most likely, from residues 
of bacteria in the form of protein (Drago et al., 2016a). 
Production of auto-immune antibodies may also play a role in the rare neurosyphilis 
cases that mimic autoimmune encephalitis (AE), as in the patient described in Chapter 6. In 
these cases, neurosyphilis presents with progressive cognitive impairment, new onset 
epilepsy and psychiatric disorder in combination with predominant mesiotemporal or 
frontobasal hyperintensities hyperintense on Fluid Attenuation Inversion Recovery (FLAIR) 
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and T2 weighted (T2WI) sequences on magnetic resonance imaging (MRI) and intermittent 
temporal slowing on electroencephalogram (EEG) (Hama et al., 2008; Budhram, 2017; 
Serrano-Cardenas et al., 2018). Recently, Qin and colleagues reported two patients with 
serological confirmed neurosyphilis accompanied with positive anti-N-methyl-d-aspartate 
Receptor (NMDAR) antibody tests in serum and CSF (Qin et al., 2017). Neurosyphilis and anti-
NMDAR encephalitis might have occurred simultaneously, however, neurosyphilis may have 
caused a secondary immunological response of anti-NMDAR-antibody production (Qin et al., 
2017). It could be hypothesized that not only both bacterial and autoimmune 
pathophysiological mechanism are involved in neurosyphilis, but also that different clinical 
presentations of neurosyphilis are linked with different autoimmune antibodies and different 
neuroinflammatory profiles. 
 
TREATMENT OF NEUROSYPHILIS 
 
Fever therapy 
The notion that fever can have a healing effect in patients with a brain disease has been 
described since ancient times (Bierman, 1942). Samuel Alexander Kinnier Wilson (1878-1937) 
suggested involvement of the immune system in the effect of fever in epilepsy patients 
(Wilson, 1935). He mentioned the observation ascribed to Hippocrates that “intermittent 
fever”, a disease known today as malaria, replaced or mitigated epilepsy (“quartana epilepsia 
vindex appellatur”) and the beneficial effects of “exanthems and other fevers of childhood, 
especially perhaps measles, chicken-pox, typhoid and scarlatina” (Wilson, 1935). Galenus 
(129-199) reported a healing effect of fever in a patient suffering from melancholy (Whitrow, 
1990; Albert, 1999). Reports from the Middle ages describe improvement of psychiatric 
symptoms in patients in asylums suffering from cholera (Albert, 1999). A 17th century 
engraving by Jacques Lainet (Paris, 1659) represented treatment of syphilis through 
fumigation with mercury, carried out in an oven. The resulting intense sweating along with 
salivation was thought to rid the body of disease poisons (Bierman, 1942). Herman Boerhaave 
(1668-1738), who was the first physician to introduce thermometer measurements in clinical 
practice, wished that he could produce the febrile curing action by artificial means and is 
quoted to have remarked "I would be the greatest physician if I could produce intermittent 
fever as easily as suppress it" (Bierman, 1942). 
In the late 19th century many investigators reported on the effect of spontaneous 
fever on mental disease and in 1887 Julius Wagner-Jauregg (1857-1940), an Austrian 
psychiatrist, published an extensive review on this topic, including descriptions of his own 
cases (Wagner-Jauregg, 1887). In the same period the “germ theory”, the hypothesis that 
some infectious diseases, such as malaria and typhoid, were caused by microorganisms 
evolved. These developments merged into the idea to induce fever to alleviate psychiatric 
symptoms rather than to wait for an outbreak or epidemic to occur (De Young, 2015 p.120). 
Wagner-Jauregg’s first attempts to apply pyrotherapy involved inoculating several psychiatric 
patients with streptococci derived from wounds of patients with erysipelas, injections of 
tuberculin and typhus vaccine, all intended to produce fever in patients with psychoses (Tsay, 
2013). The results of these treatments, however, were not satisfying. In 1917, he continued 
this line of research by inoculating GPI patients with blood from patients, who were suffering 
from tertian malaria. Soon thereafter he reported favourable results of this treatment 
(Whitrow, 1990; Gartlehner and Stepper, 2012). The availability of quinine as an effective cure 
of malaria and the absence, at the time, of an effective treatment for GPI, probably 
contributed to the rapid international adoption of this technique, known as malariotherapy or 
malaria fever therapy (MFT) (Whitrow, 1990; Albert, 1999; Gartlehner and Stepper, 2012; 
Tsay, 2013), as described in Chapter 3. 
In 1927, Wagner-Jauregg was awarded the Nobel Prize of Medicine or Physiology "for 
his discovery of the therapeutic value of malaria inoculation in the treatment of dementia 
paralytica''. It should be noted, however, that the idea that fever was beneficial in syphilis was 
first noted more than three centuries previously by Spanish physician Ruy Diaz de Isla (1462-
1542) (Albert, 1999). Moreover, not Wagner-Jauregg, but the Ukrainian psychiatrist Alexander 
Samoilovich Rosenblum (1826-1903) was the first to report a therapeutic effect of 
intentionally induced malaria in patients with GPI in 1876 (Tsay, 2013). The controversial 
nature of inducing fever in patients, especially with the rise of conservatism in Russia, might 
have prompted Rosenblum to omit this fact in his article (Tsay, 2013). 
In 1924, when Wagner-Jauregg was first nominated for the Nobel Prize in Physiology 
or Medicine, B. Gadelius, a Swedish professor of psychiatry, was the referee for awarding the 
Nobel Prize. Gadelius did not agree with the nomination, because, in his eyes, a doctor who 
administered malaria to a patient with GPI was a criminal (Whitrow, 1990). MFT raised a large 
number of ethical questions, all the more complicated by attempts to understand them in the 
context of the early 20th century, when neurosyphilis was a devastating and almost invariable 
mortal disease with little help from conventional medical therapy (including mercury, arsenic 
and bismuth compounds) (Gambino, 2015). What should be considered as “acceptable risks” 
in the treatment of this devastating disease? “Consent” was an evolving concept at the time 
and the interpretation, especially with regard to patients with a disease that impaired their 
ability for effective reasoning was another matter of debate (Gambino, 2015). Since most 
hospitals did not have a research centre that cultivated colonies of mosquitoes to preserve a 
malarial strain, treatment of GPI patients with MFT needed to be suspended if physicians 
could not locate a patient with malaria willing to serve as a donor. As early as 1923 an editorial 
in the American Journal of Psychiatry urged that “... every large hospital for mental disorders 
may have to maintain one or more malarial patients as source of infectious material" 
(Whitrow, 1990). Therefore, often a psychiatric patient with (induced) malaria served as a 
reservoir and this might have caused suspension of his or her own treatment of malaria with 
quinine. 
Since the end of the Second World War the important medical achievements of 
Wagner-Jauregg were overshadowed by his antisemitism, his close tie with the Nazi Party and 
his support for the concept of “racial hygiene” (Whitrow, 1990; Tsay, 2013). In the interbellum, 
“racial hygiene” was a popular ideology throughout Europe and Wagner-Jauregg argued for 
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fever on mental disease and in 1887 Julius Wagner-Jauregg (1857-1940), an Austrian 
psychiatrist, published an extensive review on this topic, including descriptions of his own 
cases (Wagner-Jauregg, 1887). In the same period the “germ theory”, the hypothesis that 
some infectious diseases, such as malaria and typhoid, were caused by microorganisms 
evolved. These developments merged into the idea to induce fever to alleviate psychiatric 
symptoms rather than to wait for an outbreak or epidemic to occur (De Young, 2015 p.120). 
Wagner-Jauregg’s first attempts to apply pyrotherapy involved inoculating several psychiatric 
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Samoilovich Rosenblum (1826-1903) was the first to report a therapeutic effect of 
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nature of inducing fever in patients, especially with the rise of conservatism in Russia, might 
have prompted Rosenblum to omit this fact in his article (Tsay, 2013). 
In 1924, when Wagner-Jauregg was first nominated for the Nobel Prize in Physiology 
or Medicine, B. Gadelius, a Swedish professor of psychiatry, was the referee for awarding the 
Nobel Prize. Gadelius did not agree with the nomination, because, in his eyes, a doctor who 
administered malaria to a patient with GPI was a criminal (Whitrow, 1990). MFT raised a large 
number of ethical questions, all the more complicated by attempts to understand them in the 
context of the early 20th century, when neurosyphilis was a devastating and almost invariable 
mortal disease with little help from conventional medical therapy (including mercury, arsenic 
and bismuth compounds) (Gambino, 2015). What should be considered as “acceptable risks” 
in the treatment of this devastating disease? “Consent” was an evolving concept at the time 
and the interpretation, especially with regard to patients with a disease that impaired their 
ability for effective reasoning was another matter of debate (Gambino, 2015). Since most 
hospitals did not have a research centre that cultivated colonies of mosquitoes to preserve a 
malarial strain, treatment of GPI patients with MFT needed to be suspended if physicians 
could not locate a patient with malaria willing to serve as a donor. As early as 1923 an editorial 
in the American Journal of Psychiatry urged that “... every large hospital for mental disorders 
may have to maintain one or more malarial patients as source of infectious material" 
(Whitrow, 1990). Therefore, often a psychiatric patient with (induced) malaria served as a 
reservoir and this might have caused suspension of his or her own treatment of malaria with 
quinine. 
Since the end of the Second World War the important medical achievements of 
Wagner-Jauregg were overshadowed by his antisemitism, his close tie with the Nazi Party and 
his support for the concept of “racial hygiene” (Whitrow, 1990; Tsay, 2013). In the interbellum, 
“racial hygiene” was a popular ideology throughout Europe and Wagner-Jauregg argued for 
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the forced sterilization of people who were mentally ill, criminal or considered genetically 
inferior (Gartlehner and Stepper, 2012). 
For a number of years, MFT was accepted as a truly specific treatment of neurosyphilis. 
The data from clinical and experimental evidence suggested that increased body heat was the 
effective therapeutic agent, which stopped active neurosyphilis (Bennett et al., 1941). A 
variety of biologic, infectious and physical agents (e.g. hot baths and diathermy) were 




In the 1940s, syphilis still presented an important problem for health care worldwide as a 
considerable cause of neurological, cardiovascular and perinatal morbidity and mortality. The 
estimated prevalence rate of syphilis in the United States was 5% - 10%, with rates as high as 
25% in lower socioeconomic classes (Douglas, 2009). A major therapeutic breakthrough 
followed in 1943 when Mahoney and colleagues (Mahoney et al., 1943) reported a favourable 
effect of penicillin for the treatment of syphilis and soon penicillin treatment became the 
standard of care for all syphilitic infections. Penicillin treatment for syphilitic infections was 
further optimized with regard to dose, duration and serological follow-up based on case series 
and expert opinion, rather than on large, well-controlled clinical trials. Within a year, 
widespread use of penicillin for the treatment of all stages of syphilis (primary, secondary, 
tertiary, latent) resulted in dramatic decreases in the incidence of syphilis and related 
mortality (Douglas, 2009). 
Current European guidelines for the management of syphilis recommend treatment of 
early syphilis (primary, secondary and early latent, i.e. acquired ≤1 year previously) as first line 
therapy option with benzathine penicillin G (BPG) 2.4 million units intramuscularly (IM) (one 
injection of 2.4 million units or 1.2 million units in each buttock) on day 1 (Janier et al., 2014). 
Since cardiovascular syphilis and neurosyphilis still exist and are reported to occur also 
after treatment of early syphilis according to the current guidelines, enhanced treatment for 
early syphilis might be considered (Zhou et al., 2012). In a recent study, addition of doxycycline 
and ceftriaxone to the conventional BPG treatment was found to result in a higher and faster 
cure rate of early syphilis (Drago et al., 2016c). Moreover, this enhanced treatment provided 
treponemicidal antibiotic levels in the cerebrospinal fluid, and therefore it might prevent late 
complications (Drago et al., 2016c). For late latent (i.e. acquired >1 year previously or of 
unknown duration), cardiovascular and gummatous syphilis BPG 2.4 million units IM (one 
injection 2.4 million units single dose or 1.2 million units in each buttock) weekly on day 1, 8 
and 15 is recommended as first line therapy option (Janier et al., 2014). 
The optimal management of neurosyphilis, ocular and auricular syphilis continues to 
be inpatient treatment with benzylpenicillin 18–24 million units intravenous daily, as 3–4 
million units every 4 h during 10–14 days. Follow-up examination of cerebrospinal fluid should 
be performed 6 weeks–6 months after treatment of neurosyphilis (Janier et al., 2014). 
Within 24 hours after antibiotic treatment patients might experience an array of 
symptoms like fever, chills, headache, myalgias, and exacerbation of existing cutaneous 
lesions with symptoms resolving a few hours later, known as the Jarisch–Herxheimer reaction 
(JHR) (Read and Donovan, 2012; Buitrago et al., 2014; Butler, 2017). JHR was named after two 
dermatologist-syphilologists, the Austrian Adolf Jarisch (1850-1902) (Jarisch, 1895) and the 
German Karl Herxheimer (1861 –1942) (Herxheimer and Martin, 1902), who independently 
reported the phenomenon in patients with syphilis who developed exacerbations of their skin 
lesions after treatment with mercurial compounds, in 1895 and 1902 respectively (Belum et 
al., 2013; Butler, 2017). 
Although classically, JHR was observed during treatment of syphilis, it is now well 
documented in louse-borne relapsing fever, leptospirosis, tick-borne relapsing fever and lyme 
disease, while case reports mention JHR in a range of other infectious diseases including 
meningococcal meningitis (Belum et al., 2013; Butler, 2017). Clinical observations of patients 
with the JHR suggest a role for endotoxin, while experimental evidence indicates involvement 
of non-endotoxin pyrogen and spirochetal lipoproteins (Butler, 2017). However, the exact 
pathogenesis remains to be elucidated (Butler, 2017). In prospective studies, randomized 
trials of antimicrobial drugs, surveys and meta-analysis, JHR is reported not only in primary 
and secondary syphilis (40% of the cases), but also in neurosyphilis (Butler, 2017). The 
reported frequency rate in neurosyphilis varies from 8-75%, indicating large variations in 
patients’ susceptibilities as well as varying criteria used by observers of the reaction (Butler, 
2017). 
The transient worsening of syphilitic lesions may have serious consequences in 
important small arteries, such as those surrounding the coronary ostium or the optic nerve, 
as reported in several cases (Marra, 2009). Many experts recommend a combined treatment 
of antibiotics and topical, periocular and systemic (oral or intravenous) corticosteroids in 
patients with ocular syphilis (Marra, 2009). The British guidelines of 2008 (Kingston et al., 
2008; Kinston et al., 2016) and the 2014 European guidelines on the management of syphilis 
(Janier et al., 2014) state that prednisolone can prevent the febrile episode and that, although 
steroids are not proven to ameliorate local infection, biological plausibility suggests that 
steroids may help preventing JHR in early syphilis with optic neuritis and uveitis. Therefore, in 
these cases, administration of prednisolone 20–60 mg daily for 3 days is recommended, 
starting antitreponemal treatment after 24 h of commencing prednisolone. Since the efficacy 
of this strategy is not proven (Read and Donovan, 2012), this advice is not included in the US 
guidelines (Workowski and Bolan, 2015). 
 
Other therapeutic options 
Neurosyphilis commonly presents with neuropsychiatric symptoms (see also Chapter 5). Early 
cohort studies demonstrated that cognitive deficits in neurosyphilis patients were least likely 
to respond to treatment, while re-emergence of gross neurological signs after treatment was 
common over prolonged time. It is not known whether this was paralleled by a decline in 
cognitive function (Chen et al., 2017). However, epidemiological studies with long-term 
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cognitive function (Chen et al., 2017). However, epidemiological studies with long-term 
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follow-up conducted in the pre-penicillin era included patients who were treated with 
regimens of varying effectiveness and their outcomes may not necessarily apply to patients 
treated with penicillin (Ghanem, 2010). Despite evidence of short-term improvement, there 
are insufficient data to support long-term benefit of penicillin therapy on cognitive function 
(Moulton and Koychev, 2015) and psychiatric disease in neurosyphilis. Case reports mention 
persisting psychiatric symptoms after penicillin therapy for neurosyphilis (Ni et al., 2016), even 
years after antibiotic treatment (Roy et al., 2016), also after remittance of neurologic 
symptoms (Allen et al., 2014; Othman and Nordin, 2018). Refractory psychiatric symptoms 
may result from nonadherence to psychotropic medication as well as from an ongoing 
infectious or inflammatory irreversible brain damage, as evidenced by cerebral atrophy  (Allen 
at al., 2014). Recently, augmentation of clozapine with electroconvulsive therapy has been 
suggested as a possible strategy in pharmacotherapy resistant psychiatric conditions, such as 
depression and psychosis, in neurosyphilis patients (Othman and Nordin, 2018). Future 
studies should address the hypothesis of local production of antibodies in the CNS resulting in 
ongoing neuroinflammation and associated therapeutic implications that may include 
immunomodulatory therapy in (a subsection of) patients with neurosyphilis. 
 
Outcome measures 
Objective outcome measures of therapy for neurosyphilis are confined to normalization of CSF 
abnormalities. Success of antimicrobial therapy is marked by decline in CSF leukocyte count 
at six months and resolution of all CSF abnormalities at two years and clinical improvement or 
stabilization (Marra, 2017). CSF abnormalities may resolve more slowly in HIV-infected 
persons than in those not infected with HIV and clinical abnormalities may persist after 
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Vincent van Gogh (1880) “De zaaier” 
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This chapter offers some concluding remarks and identifies future directions to expand our 
conceptualization and treatment of neurosyphilis. 
This study reminds clinicians that syphilis is a multisystemic and multiphasic disease. 
Since the beginning of the 20th century, significant progress has been made in the diagnosis 
and treatment of the various manifestations of syphilis. However, despite the efficacy of 
penicillin in most cases of syphilis, neurosyphilis is still present and should be considered in 
the diagnostic workup of various neurological and psychiatric disorders. Moreover, in 
developed countries, many clinicians are unfamiliar with syphilis, due to the low incidence of 
syphilis over the last two decades of the 20th century, while early recognition of neurosyphilis 
is imperative since early institution of antibiotic treatment is associated with better outcome. 
In the absence of reliable data, it is difficult to know the extent to which neurosyphilis 
is overlooked in clinical practice. Given the results of the investigations presented in this 
thesis, further large-scale studies are warranted to elucidate the more exact prevalence of 
(neuro)syphilis especially in patients with psychiatric diseases. It is therefore recommended 
to re-introduce the obligatory screening for syphilis in order to initiate appropriate treatment 
as soon as possible. Patients with late neurosyphilis may have non-reactive serum 
nontreponemal tests (such as the Venereal Disease Research Laboratory (VDRL) and the Rapid 
Plasma Reagin (RPR)). Therefore, serum treponemal tests should be used for screening for 
neurosyphilis, for example, in the Netherlands, the Treponemal pallidum hemagglutination 
(TPHA) test, Treponemal pallidum particle agglutination (TPPA) test or enzyme-linked 
immunosorbent assays (ELISA). If serologic testing for syphilis is positive, lumbar puncture is 
essential to assess for cerebrospinal fluid abnormalities that demonstrate neuro-invasive 
disease (leukocyte count ≥ 5 × 106 /L, positive VDRL). 
Unfortunately, many questions about the pathogenesis, diagnosis and management of 
neurosyphilis still persist. Recent findings suggest that down regulation of the systemic 
immune response may promote disease progression towards neurological involvement and, 
conversely, the damage in the central nervous system may be due to an uncontrolled local 
host immune response. T. pallidum may initiate and maintain chronic inflammation and tissue 
damage in neurosyphilis, independent of active infection. It could be hypothesized that not 
only both infectious and (auto)immune pathophysiological mechanism are involved in the 
pathogenesis of neurosyphilis, but also that different clinical presentations of neurosyphilis 
are linked with specific (as yet undiscovered) autoimmune antibodies and distinct 
neuroinflammatory profiles. 
Future research into the pathogenesis of neurosyphilis may address these hypotheses 
and, if correct, investigate related therapeutic implications: is there a role for immunotherapy 
in (a subsection of) patients with neurosyphilis? 
The diagnosis of neurosyphilis is a challenging medical issue as neurosyphilis presents 
in many guises, Human Immunodeficiency Virus infection can change the course of syphilis 
and, due to the inability to culture T. pallidum, only indirect measurement of syphilitic disease 
activity is possible. Since syphilis screening in neurological, psychiatric and geriatric patients is 
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no longer standard practice in the Netherlands, a high à priori index of suspicion is needed to 
consider a diagnosis of neurosyphilis. Therefore, a detailed history of sexually transmitted 
disease and subsequent treatment is required and a diagnosis of neurosyphilis should not be 
excluded based on a history of currently considered “adequate” antibiotic treatment for 
primary of secondary syphilis. 
Careful description of neurological and psychiatric symptomatology and validated 
bedside cognitive tests should be performed in neurosyphilis patients and are valuable tools 
for the clinical assessment of illness severity and can be used to evaluate clinical response to 
treatment. 
Hopefully, in the near future, we will reconceptualise neurosyphilis as a syndrome that 
constitutes of specific neurological and psychiatric manifestations following infection with a 
specific strain of T. pallidum (resistant or not resistant to penicillin), due or not due to 
maternal, sexual or other mode of transmission, in a person with a specific genetic profile, 
with or without a competent immune system, and with or without specific (active) 
(autoimmune) antibodies in serum and/or cerebrospinal fluid. Such a descriptive diagnosis 
might eventually substantiate a personalized prognosis and an individualized treatment 
proposal, including, if indicated, vascular preventive measures, anti-epileptic drugs, 
immunotherapy, psychoactive medication, cognitive rehabilitation therapy and psychosocial 
interventions. 
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Syphilis is a mainly sexually transmitted multistage infectious disease with a long and variable 
course. Neurosyphilis may present with meningitis, meningovascular or parenchymatous 
disease. The clinical syndromes of parenchymatous neurosyphilis comprise General Paresis of 
the Insane (GPI, also known as syphilitic dementia or dementia paralytica) and Tabes dorsalis. 
In the beginning of the 20th century, patients with neurosyphilis were treated with heavy 
metals and malaria fever therapy (MFT). At that time, GPI was a major reason for psychiatric 
hospitalisation. Most patients with GPI died within three years of admission, irrespective of 
treatment. The incidence of syphilis and neurosyphilis declined after the introduction of 
antibiotic therapy. Nevertheless, in the last decades, the incidence of syphilis has worldwide 
sharply increased, and, therefore, a revival of GPI can be expected. Research on the current 
clinical presentation of neurosyphilis is warranted since early recognition and treatment 
improve outcome. 
In the first part of this thesis, the clinical presentation of patients with GPI and 
treatment of GPI with MFT are examined. In the second part of the present thesis the 
epidemiology and clinical presentation of neurosyphilis in the 21st century are investigated. 
In Chapter 2, the clinical presentation of 105 patients with GPI admitted to a Dutch 
psychiatric hospital in the period 1924-1954 is described. At admittance, patients presented 
with a wide range of psychotic and mood disorders accompanied by impaired judgment. 
Prevailing neurological symptoms comprised impaired speech, pupillary abnormalities and 
cranial nerve dysfunction. The result of MFT was investigated in the same cohort of patients 
and described in Chapter 3. MFT was practiced in a wide range of patients with GPI up to 70 
years of age, including those with a disease duration of more than 1 year and those with a 
broad array of symptoms and co-morbidities, such as (syphilitic) cardiac disease. 
Notwithstanding these broad inclusion criteria, practice and mortality rates in MFT-treated 
patients corresponded to findings worldwide. MFT was well tolerated and MFT-treated 
patients had a significantly longer survival. It should be kept in mind that on admission, the 
group of MFT-treated patients was possibly in a better medical condition than the group of 
non-treated patients and it is likely that this has affected the survival time. However, this is 
not reflected by differences in baseline conditions that may be associated with higher risk of 
death. Main causes of death in patients with GPI were epileptic seizures and infectious 
diseases, irrespective of MFT. 
In Chapter 4 the epidemiology of neurosyphilis in Dutch general hospitals in the period 
1999-2010 is investigated in a nationwide study. In this study neurosyphilis was diagnosed in 
about 60 Dutch hospitalised adult patients per year, indicating that neurosyphilis is yet to be 
considered in the differential diagnosis. The incidence of neurosyphilis was highest in young, 
urban men, although Tabes dorsalis was the most frequently reported clinical manifestation. 
The low incidence of diagnosis of neurosyphilis co-occurs with less familiarity of clinicians with 
the asymptomatic and atypical manifestations of the disease. Since further research on the 
frequent atypical clinical symptomatology is needed to improve both diagnosis and 
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patients with laboratory confirmed neurosyphilis are analysed. Main findings are male 
predominance, regular cognitive, memory and visual complaints as well as a broad age range. 
In addition, HIV- seropositivity and previous psychiatric disease were frequently reported. 
Since most patients were not able to mention any earlier syphilitic infection, the interval 
between first signs and diagnosis was generally long. The results of this study may be biased 
since only those patients were included in whom CSF analysis was performed by a certificated 
reference laboratory. Cognitive and memory complaints were probably not systematically 
assessed in all patients, which may have resulted in underestimation of the presence of these 
symptoms. The number of patients diagnosed with GPI was too low to enable comparison 
with the clinical presentation of GPI in the study as described in Chapter 2. In Chapter 6 a case 
of neurosyphilis mimicking autoimmune encephalitis is presented, indicating that exclusion of 
neurosyphilis should be considered in patients presenting with focal seizures and MRI 
abnormalities of the amygdala. 
A general discussion and conclusions, including future perspectives, are presented in 
Chapter 7 and Chapter 8 respectively. Finally, in Chapter 9 and Chapter 10 the findings of this 




Syphilis ist eine Infektionskrankheit die überwiegend sexuell übertragen wird und einen 
langen und variablen Krankheitsverlauf hat. Die klinischen Manifestionen der Neurosyphilis 
können in eine meningeale, meningovaskuläre und ein parenchymatöse Subform unterteilt 
werden. Ein Befall des Zentralnervensystems mit Gummen ist ebenfalls möglich, aber selten. 
Bei der Neurosyphilis ist das Parenchym von Gehirn und Rückenmark betroffen. Die 
klinischen Syndrome der parenchymatösen Neurosyphilis umfassen die progressive Paralyse 
(auch bekannt als Dementia Paralytica) und die Tabes dorsalis. Zu Beginn des 20. Jahrhunderts 
wurden Patienten mit Neurosyphilis mit Schwermetallen und Malaria-Fieber-Therapie (MFT) 
behandelt. Zu dieser Zeit war die progressive Paralyse ein Hauptgrund für psychiatrische 
Krankenhausaufenthalte. Die meisten Patienten mit progressiver Paralyse starben innerhalb 
von drei Jahren nach der Aufnahme, unabhängig von der Behandlung. Die Inzidenz von Syphilis 
und Neurosyphilis nahm nach Einführung der Antibiotikatherapie ab. Dennoch hat in den 
letzten Jahrzehnten die Inzidenz von Syphilis weltweit stark zugenommen, und daher ist mit 
einer Wiederbelebung des progressive Paralyse zu rechnen. Die Erforschung des 
gegenwärtigen klinischen Erscheinungsbilds der Neurosyphilis ist gerechtfertigt, da die 
Früherkennung und Behandlung das Ergebnis verbessern kann. 
In der vorliegenden Dissertation werden die Epidemiologie und das klinische 
Erscheinungsbild der Neurosyphilis im 21. Jahrhundert untersucht. Im historischen Teil dieser 
Arbeit, der sich auf die erste Hälfte des 20. Jahrhunderts bezieht, werden die klinische 
Präsentation und Behandlung von MFT bei Patienten mit progressive Paralyse untersucht. 
In Kapitel 2 wird die klinische Darstellung von 105 Patienten mit progressiver Paralyse 
beschrieben, die zwischen 1924 und 1954 in eine niederländische psychiatrische Klinik 
eingewiesen wurden. Bei der Aufnahme hatten die Patienten ein breites Spektrum an 
psychotischen Symptomen und Stimmungsstörungen, die mit einer Beeinträchtigung des 
Urteilsvermögens einhergingen. Vorherrschende neurologische Symptome umfassen 
Sprachstörungen, Pupillenanomalien und Hirnnervenstörungen. Das Ergebnis der MFT wurde 
in der gleichen Kohorte von Patienten untersucht und in Kapitel 3 beschrieben. Die MFT 
wurde bei einer Vielzahl von Patienten mit progressive Paralyse durchgeführt, auch bei 
Patienten mit einer Krankheitsdauer von mehr als 1 Jahr, sogar bis zu einem Alter von 70 
Jahren sowie bei Patienten mit einer breiten Palette von Symptomen und 
Begleiterkrankungen, wie (syphilitische) Herzerkrankungen. Ungeachtet dieser umfassenden 
Einschlusskriterien entsprachen die Praxis- und Sterblichkeitsraten bei MFT-behandelten 
Patienten den weltweiten Ergebnissen. MFT wurde gut vertragen und mit MFT behandelte 
Patienten hatten ein signifikant längeres Überleben. Haupttodesursachen bei Patienten mit 
progressive Paralyse waren epileptische Anfälle und Infektionskrankheiten, unabhängig ob 
eine Behandlung mit MFT stattgefunden hat oder nicht. 
         In Kapitel 4 wird die Epidemiologie der Neurosyphilis in niederländischen 
Allgemeinkrankenhäusern im Zeitraum 1999-2010 in einer nationalen Studie untersucht. In 
dieser Studie wurde Neurosyphilis bei etwa 60 Erwachsenen pro Jahr diagnostiziert, was 
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darauf hinweist, dass Neurosyphilis in der Differentialdiagnose noch zu berücksichtigen ist. 
Die Inzidenz von Neurosyphilis war bei jungen Männern in der Stadt am höchsten, obwohl 
Tabes dorsalis die am häufigsten berichtete klinische Manifestation war. Die geringste 
Inzidenz der Diagnose von Neurosyphilis tritt bei Ärzten auf, die wenig vertraut mit den 
asymptomatischen und atypischen Manifestationen der Krankheit sind. 
Da weitere Untersuchungen zur häufigen atypischen klinischen Symptomatik 
erforderlich sind, um sowohl Diagnose und Behandlung von Patienten mit Neurosyphilis zu 
verbessern, werden in Kapitel 5 die klinischen Daten einer Reihe von Patienten mit vom 
Liquordiagnostik bestätigter Neurosyphilis analysiert. Hauptbefunde sind männliche 
Prädominanz, regelmäßige Beschwerden kognitiver, mnestischer und visueller Art sowie ein 
breites Altersspektrum. Darüber hinaus wurde häufig über HIV-Seropositivität und frühere 
psychiatrische Erkrankungen berichtet. Da die meisten Patienten keine frühere syphilitische 
Infektion erwähnen konnten, war die Zeitspanne zwischen den ersten Anzeichen und der 
Diagnose im Allgemeinen lang. 
Die Ergebnisse dieser Studie könnten verzerrt sein, da nur Patienten eingeschlossen 
wurden, bei denen die CSF-Analyse von einem zertifizierten Referenzlabor durchgeführt 
wurde. Kognitive und Gedächtnisbeschwerden wurden wahrscheinlich nicht bei allen 
Patienten systematisch bewertet, was möglicherweise zu einer Unterschätzung des 
Auftretens dieser Symptome geführt hat. Die Anzahl der mit progressiver Paralyse 
diagnostizierten Patienten war zu gering, um einen Vergleich mit der klinischen Darstellung 
von progressiver Paralyse  in der Studie gemäß Kapitel 2 zu ermöglichen. In Kapitel 6 wird ein 
Fall von Neurosyphilis vorgestellt, der eine Autoimmunenzephalitis imitiert, was darauf 
hinweist, dass der Ausschluss von Neurosyphilis bei Patienten mit fokalen epileptischen 
Anfällen und magnetresonanztomographischen Anomalien der Amygdala 
differentialdiagnostisch in Betracht gezogen werden sollte. 
Eine allgemeine Diskussion und Schlussfolgerungen einschließlich zukünftiger 
Perspektiven werden in Kapitel 7 und Kapitel 8 vorgestellt. Abschließend werden in Kapitel 9 




La syphilis est une maladie infectieuse à transmission sexuelle prédominante qui connaît une 
évolution longue et variable de la maladie. La neurosyphilis peut être associée à une 
méningite, une maladie méningovasculaire ou parenchymateuse. L'infestation du système 
nerveux central par des gencives est également possible, mais rare. Dans la neurosyphilis 
parenchymateux le parenchyme est affecté par le cerveau et la moelle épinière. Les 
syndromes cliniques de  neurosyphilis parenchymateux incluent la paralysie générale et la 
tabès (dorsale). Au début du 20ème siècle, les patients atteints de neurosyphilis étaient traités 
avec un traitement aux  métaux lourds et avec la malaria-thérapie. A cette époque, la paralysie 
générale était une cause majeure d'hospitalisation psychiatrique. La plupart des patients 
atteints de cette maladie sont décédés dans les trois ans suivant leur admission, quel que soit 
le traitement. L'incidence de la syphilis et de la neurosyphilis a diminué après l'introduction 
de la thérapie antibiotique. Néanmoins, au cours des dernières décennies, l’incidence de la 
syphilis a considérablement augmenté dans le monde et on peut donc s’attendre à une 
recrudescence de la neurosyphilis. La recherche sur la présentation clinique actuelle de la 
neurosyphilis est justifiée dans la mesure où la reconnaissance précoce et le traitement 
améliorent les résultats. 
Dans la première partie de cette thèse, concernant la première moitié du 20e siècle, la 
présentation clinique et la malaria-thérapie chez les patients atteints de la paralysie générale 
sont examinés. Dans la deuxième partie de ce travail l’épidémiologie et l’apparence clinique 
de la neurosyphilis au XXIe siècle sont examinées. 
Le Chapitre 2 décrit la présentation clinique de 105 patients atteints de paralysie 
générale admis dans un hôpital psychiatrique néerlandais au cours de la période 1924-1954. 
À l'admission, les patients présentaient un large éventail de troubles psychotiques et 
d'humeur accompagnés d'une altération du jugement et du raisonnement. Les principaux 
symptômes neurologiques comprenaient une altération de la parole, des anomalies 
(l’anisocorie) de la pupille et un dysfonctionnement des nerfs crâniens. Le résultat de la 
malaria-thérapie a été étudié dans la même cohorte de patients et décrit au Chapitre 3. La 
malaria-thérapie a été pratiquée sur un large éventail de patients atteints de la paralysie 
générale, y compris ceux présentant la maladie d’une durée de plus d'un an, même jusqu'à 70 
ans et ceux qui présentent un large éventail de symptômes et de comorbidités, tels que la 
maladie cardiaque (syphilitique). Malgré ces critères d'inclusion généraux, les taux de pratique 
et de mortalité chez les patients traités avec malaria-thérapie correspondaient aux résultats 
obtenus dans le monde entier. La malaria-thérapie était bien toléré et les patients traités ainsi 
avaient une survie significativement plus longue. Les principales causes de décès chez les 
patients atteints de la paralysie générale étaient les crises d'épilepsie et les maladies 
infectieuses, indépendamment de la malaria-thérapie. 
Le Chapitre 4 examine l’épidémiologie de la neurosyphilis dans les hôpitaux généraux 
néerlandais de 1999 à 2010 dans le cadre d’une étude nationale. Dans cette étude, la 
neurosyphilis a été diagnostiquée chez environ 60 patients adultes hollandais hospitalisés 
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chaque année, ce qui indique que la neurosyphilis doit encore être prise en compte dans le 
diagnostic différentiel. 
L'incidence de la neurosyphilis était la plus élevée chez les hommes jeunes et urbains, bien 
que la manifestation clinique la plus fréquemment rapportée ait été tabès. La faible incidence 
du diagnostic de neurosyphilis est concomitante de la familiarité des cliniciens avec les 
manifestations asymptomatiques et atypiques de la maladie. 
Etant donné que des recherches complémentaires sur la symptomatologie clinique atypique 
fréquente sont nécessaires pour améliorer à la fois le diagnostic et la gestion des patients 
atteints de neurosyphilis, le Chapitre 5 analyse les données cliniques d'une série de patients 
présentant une neurosyphilis confirmée en laboratoire. Les principales conclusions sont la 
prédominance masculine, des plaintes régulières sur le plan cognitif, de la mémoire et de la 
vue, et cela sur une vaste tranche d'âge. De plus, une séropositivité au Virus de 
l'immunodéficience humaine et une maladie psychiatrique antérieure ont été fréquemment 
rapportées. La plupart des patients n'ayant pu mentionner aucune infection syphilitique 
antérieure. Cela peut avoir entraîné un intervalle prolongé entre les premiers signes et le 
diagnostic. Les résultats de cette étude peuvent être biaisés, car seuls les patients pour 
lesquels une analyse du Liquide Cephalo-Rachidien a été réalisée par un laboratoire de 
référence certifié ont été inclus. Les problèmes de mémoire et de vue n'ont probablement pas 
été systématiquement évalués chez tous les patients, ce qui peut avoir entraîné une sous-
estimation de la présence de ces symptômes. Le nombre de patients diagnostiqués avec 
paralysie générales était trop faible pour permettre une comparaison avec le tableau clinique 
de cette maladie dans l'étude décrite au Chapitre 2. Au Chapitre 6, un cas de neurosyphilis 
imitant l'encéphalite auto-immune est présenté, ce qui indique qu'une exclusion de la 
neurosyphilis doit être envisagée, chez des  patients présentant des convulsions focales et des 
anomalies d‘imagerie par résonance magnétique du corps amygdaloïde. 
 
La discussion générale et des conclusions, y compris les perspectives futures, sont 
respectivement présentées aux Chapitres 7 et 8. 
Enfin, les Chapitres 9 et 10 résument les résultats de cette thèse. 
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'Ick vont lest eenen vrient, die in syn groene jaren 
Met ons was uytgereyst, en over zee gevaren; 
hy scheen in geenen deel gelyck hij eertijts plagh; 
Nadien hy byster vreemt,en wonder deerlick sagh 
Syn hooft meest sonder hair syn neuse was gesoncken, 
Syn lippen sonder verf, syn holle tanden stonken, 
Syn handen blaeu gepleckt, syn beenen sonder kuyt, 
En dan een lelick vocht, quam hem ten oogen uyt'. 
 
 
'Me gaet by Meester Jan, die tijdt gezwind aen 't stoven; 
Die douwt den vuylen Romp in een berookten Oven; 
Een schadelijken domp om-vangt zijn naekte le'en, 
Die, machteloos door 't zweet, nu tuymelen daer he’en; 
Die gaet in 't stinckend Rift bereydt Quik-zilver gietten; 
Dat doet een vuylen vloed na zijne lippen vlietten; 
Me quijlt er nacht, en dag; tot dat het tanden-rek, 
Door 't giftig zever-zap, hem rammelt in den bek. 
't Viel licht, indien hierme'e het guijlen op wou kouwen, 
Maer neen, hij moet van nieus aan Deel Ducaten spouwen; 
Het lijf moet van 't Vergif, voor 't lest, gezuyvert zijn: 
Daartoe houd Jan het Goud de beste medicijn. 
 
 
Na lange tijd-verloop zie ik den Gast verrijzen: 
Zijn dood-gelijk Gelaet doet zijn Aenschouwers yzen: 
't Geheuvelt kakebeen dat wijzt genogzaem uyt 













































Bron: Gedicht van Jacob Cats (1577-1660) uit: “Spiegel van den ouden en nieuwen tyt” (1657). Cats beschrijft 
hoe de “oude varensgezel”, lijdend aan syfilis, is overgeleverd aan (pock-)Meester Jan, die hem behandelt met 
kwikzilver in een soort oven. 
 
pockig = aangetast door “pokken” oftewel “syfilis” 
rift = tot op het vermagerd, uitgeteerd lichaam 
 
Uit:  
Meininger JV. 'Een pockig rif: het ziektebeeld van syfilis in vroeger dagen. Bulletin Seksueel Overdraagbare 
Aandoeningen, 1980;2:10-11. 
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General Paralysis of the Insane (GPI), in Nederland ook wel “dementia paralytica” genoemd, 
was in het verleden een fatale vorm van neurosyfilis die zeer frequent een, al dan niet 
gedwongen, opname in een psychiatrische ziekenhuis noodzakelijk maakte. Tegenwoordig 
veronderstellen artsen vaak dat syfilis en neurosyfilis zeldzame aandoeningen zijn. Maar sinds 
het begin van de 21ste eeuw is de incidentie van syfilis wereldwijd gestegen en een toename 
van het aantal gevallen van neurosyfilis is te verwachten. Vroege diagnose en snelle start van 
behandeling zijn van groot belang bij neurosyfilis om te voorkomen dat schade aan 
zenuwcellen tot onherstelbaar verlies van functie leidt. Derhalve is een hernieuwde 
bewustwording van het brede spectrum van psychiatrische en neurologische verschijnselen 




Het doel van dit onderzoek is ten eerste het beschrijven van de epidemiologie en klinische 
presentatie van neurosyfilis in de 21e eeuw en ten tweede het vergelijken van de klinische 




In hoofdstuk 2 wordt de klinische presentatie van GPI bij opname in het psychiatrisch 
ziekenhuis in Venray in de eerste helft van de 20e eeuw beschreven aan de hand van de 
oorspronkelijke patiëntendossiers van 105 patiënten (91 mannen en 14 vrouwen). De meest 
gerapporteerde psychiatrische verschijnselen waren oordeels– en kritiekstoornissen, 
psychotische stoornissen en stemmingsstoornissen. Grootheidswanen werden bij bijna de 
helft van de patiënten gerapporteerd. Opvallend was dat veel patiënten zeer snelle 
stemmingswisselingen doormaakten. Spraakstoornissen in de zin van “Sylbenstolpern” (het 
weglaten of verplaatsen van lettergrepen in een woord), uitspraakstoornissen en onvermogen 
om te spreken vormden de meest frequent vermelde neurologische symptomen, gevolgd 
door pupilafwijkingen (zoals de Argyll-Robertson pupil: een nauwe pupil met afgenomen 
reactie op licht bij behouden reactie op convergentie) en problemen bij plassen. 
In 1921 vond in Nederland de introductie van malariakoortstherapie bij patiënten met 
GPI plaats en al snel werd deze behandeling toegepast in het psychiatrisch ziekenhuis in 
Venray. Men injecteerde met malaria geïnfecteerd bloed onder de huid tussen de 
schouderbladen. Ongeveer 10 dagen later trad een eerste koortspiek op en na circa 10 
episodes van hoge koorts volgde eerst behandeling van de malaria met kinine, gevolgd door 
behandeling met een combinatie van arsenicum, bismut en kwik gericht tegen de Treponema 
pallidum, de bacterie die syfilis veroorzaakt. Uit onderzoek naar het effect van 
malariakoortstherapie bij de patiënten met GPI beschreven in hoofdstuk 2, bleek dat met 
malariakoortstherapie behandelde patiënten (n = 43) een langere overlevingsduur na opname 
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hadden dan niet met malariakoortstherapie behandelde patiënten (n = 62), zie hoofdstuk 3. 
Het is echter niet duidelijk of de langere overlevingsduur (geheel) is toe te schrijven aan de 
effectiviteit van malariakoortstherapie of dat selectiecriteria voorafgaand aan de therapie een 
rol speelden. Want malariakoortstherapie vormde een zeer sterke fysieke belasting en 
patiënten met een matige tot slechte lichamelijke conditie (bijvoorbeeld met ernstig hartfalen 
door syfilitische infectie van het hart) kwamen niet voor malariakoortstherapie in aanmerking. 
Desalniettemin werd malariakoortstherapie toegepast bij patiënten tot de leeftijd van 71 jaar 
en bij patiënten met een breed scala aan klinische verschijnselen, ook bij een ziekteduur 
langer dan één jaar. De wijze van uitvoering van de malariakoortstherapie behandeling en de 
mortaliteitscijfers bij met malariakoortstherapie behandelde patiënten stemden overeen met 
de bevindingen in de rest van de Europa en de Verenigde Staten. Epileptische aanvallen en 
infectieziekten waren de meest voorkomende doodsoorzaken, zowel bij patiënten mét als bij 




Na de tweede wereldoorlog kwam penicilline beschikbaar voor de behandeling van syfilis. 
Uitbreiding van programma’s gericht op screening, behandeling en preventie leidden tot een 
sterke daling van de incidentie van syfilis in Nederland en andere economisch welvarende 
landen. In Nederland werd de meldplicht voor syfilis opgeheven en later ook de standaard 
screening op syfilis bij neurologische patiënten. Hoewel syfilis vrijwel verdween uit het 
gezichtsveld van de neuroloog, hield de ziekte niet op te bestaan. De epidemiologische studie 
beschreven in hoofdstuk 4 maakte gebruik van data van SOA-poliklinieken en 
ontslagdiagnoses, zoals vermeld in de Landelijke Medische Registratie, in de periode 1999-
2010. In deze periode werd in totaal bij 60 patiënten per jaar voor de eerste keer de diagnose 
neurosyfilis gesteld. Deze studie toonde aan dat de incidentie van neurosyfilis in Nederland 
significant hoger was in het meer verstedelijkte deel van Nederland (0.6) dan in de rest van 
Nederland (0.4). Zowel de diagnose syfilis als neurosyfilis werd vaker bij mannen gesteld dan 
bij vrouwen, namelijk in 90% van de gevallen van syfilis en 75% van de gevallen van 
neurosyfilis. Bij mannen werd de hoogste incidentie van neurosyfilis vastgesteld in de 
leeftijdscategorie 35-65 jaar, bij vrouwen in de leeftijdscategorie van 75 jaar en ouder. 
Opvallend is dat tabes dorsalis de meest gerapporteerde klinische verschijningsvorm van 
neurosyfilis was. 
De retrospectieve studie beschreven in hoofdstuk 5 was gericht op een gedetailleerde 
inventarisatie van de klinische presentatie van neurosyfilis bij patiënten met een positieve 
syfilisserologie in het hersenvocht, vastgesteld in Certe, in de periode 2004-2018. Certe is een 
organisatie voor integrale medische diagnostiek en advies voor de eerste- en 
tweedelijnsgezondheidszorg en fungeert als referentielaboratorium voor syfilisserologie. In 
deze periode werd de diagnose neurosyfilis vastgesteld bij 34 patiënten (1 vrouw en 33 
mannen), met een leeftijdsspreiding van 31 tot 84 jaar (mediane leeftijd: 44 jaar). Ten tijde 
van het stellen van de diagnose neurosyfilis was bij 12 (35%) patiënten bekend dat zij besmet 
waren met het Human immunodeficiency virus (HIV). Cognitieve dysfunctie en psychiatrische 
verschijnselen werden bij een derde van de patiënten gerapporteerd. Aangezien 
gestandaardiseerd psychiatrisch en neuropsychologisch onderzoek geen onderdeel van de 
diagnostische work-up vormden, kan hier sprake zijn van onderraportage. De verdeling van 
de klinische syndromen was als volgt: 16 patiënten met vroege neurosyfilis (acute meningitis, 
meningovasculitis en/of uveitis), 9 patiënten met late neurosyfilis (GPI of tabes dorsalis), 2 
patiënten met zowel symptomen passend bij vroege als bij late neurosyfilis, en 6 patiënten 
met asymptomatische neurosyfilis. Bij één patiënt waren onvoldoende gegevens beschikbaar 
om het klinische syndroom te kunnen vaststellen. Vroege neurosyfilis trad in alle 
leeftijdscategorieën op, late neurosyfilis werd alleen gezien bij patiënten ouder dan 40 jaar. 
 In hoofdstuk 6 wordt een 62 jarige man beschreven met sinds 1 jaar bestaande focale 
epilepsie. De Magnetic Resonance Imaging (MRI) scan van de hersenen liet aanwijzingen zien 
voor een zwelling van de amygdala, een amandelvormige structuur diep in de slaapkwab. Het 
EEG toonde intermitterende trage activiteit ter plaatse van de slaapkwabben, links meer dan 
rechts Op grond van deze combinatie van gegevens werd aanvankelijk de diagnose 
autoimmuun ontsteking van de hersenen overwogen. In het bloed werden geen anti-
neuronale antistoffen aangetoond en derhalve kon de diagnose autoimmuun 
hersenontsteking niet worden bevestigd. Maar er werden wel antistoffen tegen Treponema 
pallidum, de veroorzaker van syfilis, in het bloed en in het hersenvocht van deze patiënt 
gevonden en daarmee was de diagnose neurosyfilis bewezen. Zowel bij neurosyfilis als bij 
autoimmuun hersenontsteking is het tijdig stellen van de diagnose en starten van adequate 
behandeling van groot belang om een optimaal behandelresultaat te kunnen bereiken. Deze 
patientenbeschrijving illustreert dat het spectrum aan uitingsvormen van neurosyfilis zeer 
breed is en onderstreept het belang van het uitsluiten van neurosyfilis alvorens 
immunotherapie te starten bij patiënten met een klinische verdenking op autoimmuun 
hersenontsteking. 
 
Het aantal patiënten met GPI in de 21ste eeuw beschreven in hoofdstuk 5 is te gering om het 
klinische beeld van deze aandoening betrouwbaar te vergelijken met dat van GPI patiënten in 
het begin van de 20ste eeuw. Desalniettemin is het opvallend dat bij 4 patiënten beschreven 
in hoofdstuk 5 de diagnose neurosyfilis door routinematige screening op syfilis bij opname in 





Deze studie helpt eraan herinneren dat syfilis een multisysteem aandoening is met een 
multifasisch beloop. Ondanks alle verbeteringen in diagnostiek en de effectiviteit van 
penicilline, met name voor de behandeling van de huidmanifestaties van syfilis, komt 
neurosyfilis nog steeds voor, ook na thans adequaat geachte behandeling van de vroege stadia 
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van syfilis. Derhalve hoort neurosyfilis thuis in de differentiaaldiagnose van uiteenlopende 
psychiatrische en neurologische ziektebeelden. 
 Als gevolg van de lage incidentie van syfilis in de laatste decades van de 20ste eeuw, 
zijn veel hedendaagse clinici niet vertrouwd met de uiteenlopende verschijningsvormen van 
neurosyfilis. Bij afwezigheid van betrouwbare cijfers aangaande de incidentie van deze 
aandoening is het niet vast te stellen hoe vaak en bij welke patiënten deze diagnose wordt 
“gemist”. De resultaten van dit onderzoek ondersteunen de noodzaak om screening op syfilis 
opnieuw in te voeren bij psychiatrische en neurologische patiënten. Ten eerste kan zo tijdig 
adequate therapie kan worden gestart en ten tweede kan zo in de toekomst de incidentie en 
presentatie van neurosyfilis volledig in kaart worden gebracht. Alleen treponemale testen 
(zoals de Treponema pallidum hemagglutinatie test, Treponema pallidum particle 
agglutinatietest of de Enzyme Linked Immunosorbent Assays test) zijn geschikt voor screening, 
aangezien met name bij late neurosyfilis non-treponemale testen (zoals de Venereal Disease 
Research Laboratory test en de Rapid Plasma Reagin test) vals negatief kunnen zijn. Bij 
positieve syfilisserologie in bloed dient altijd onderzoek van hersenvocht te volgen. 
Nog veel vragen aangaande de ontstaanswijze, diagnostiek en behandeling van 
neurosyfilis zijn onbeantwoord. Zo is nog altijd niet duidelijk hoe de Treponema pallidum, die 
al korte tijd na infectie in het centraal zenuwstelsel kunnen bevinden, jarenlang 
asymptomatisch aanwezig kunnen blijven, schijnbaar onopgemerkt door het afweersysteem. 
Evenmin is bekend welke factoren de omslag van asymptomatische  naar symptomatische 
neurosyfilis veroorzaken. Recent onderzoek suggereert dat zowel infectie als (auto)immuun 
gerelateerde mechanismen hierbij betrokken zijn. Mogelijk kunnen de verschillende klinische 
verschijningsvormen van neurosyfilis in de toekomst gerelateerd worden aan een specifiek 
“ontstekingsprofiel” en (nu nog onontdekte) auto-immuun-antistoffen. Toekomstig 
onderzoek kan hopelijk duidelijkheid verschaffen ten aanzien van de rol van auto-immuun-
antistoffen bij het ziekteproces en de eventueel hieraan gekoppelde therapeutische 
consequenties. 
Zowel gedetailleerde beschrijving van neuropsychiatrische klachten en verschijnselen 
als gestandaardiseerd en gevalideerd neuropsychologisch onderzoek van patiënten met 
neurosyfilis zijn waardevolle methoden om de ernst van deze manifestaties in kaart te 
brengen en de effectiviteit van ingestelde behandeling te evalueren. 
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In de allereerste plaats dank ik mijn promotoren, Professor Verhoeven en Professor 
Hoogendijk: hartelijke dank voor de mogelijkheid om mijn promotieonderzoek aan de 
Erasmus Universiteit te kunnen uitvoeren. 
In de allereerste plaats dank ik mijn promotoren, Professor Verhoeven en Professor 
Hoogendijk: hartelijke dank voor de mogelijkheid om mijn promotieonderzoek aan de 
Erasmus Universiteit te kunnen uitvoeren. 
Professor Verhoeven, beste Willem, aan jou in het bijzonder mijn dank voor het 
vertrouwen dat je steeds in mij hebt gesteld. Ons samenwerkingsverband paste in het begin 
in de medische traditie van leermeester en gezel. Je hebt mij de op het juiste spoor gezet in 
de wereld van de wetenschap, aangemoedigd als ik dat nodig had en mij van het begin af aan 
het gevoel gegeven dat jij in elk geval wist wat het eindstation moest zijn. Geduldig luisterde 
je naar mijn al mijn ideeën en gaf me de ruimte om zelf de mogelijkheden te verkennen. Soms 
dwaalde ik af……, maar als ik aan jouw deur klopte, stond je altijd klaar om mij te herinneren 
aan het juiste vertrek- en eindpunt van de rit.  Ik waardeer het buitengewoon dat je mij de 
gelegenheid hebt geboden om mij in een zeer gemotiveerd en tegelijkertijd zeer gezellig team 
te ontwikkelen. Jouw kennis is bijzonder groot, jouw oordeel nauwkeurig afgewogen en jouw 
“rode potlood” ligt altijd scherp geslepen klaar: vandaag een stuk “ingeleverd”, morgen 
gereviseerd terug! Grondigheid en degelijkheid kenmerken jouw aanpak. Ik heb heel veel van 
je geleerd. En daardoor veranderde gaandeweg jouw rol van leermeester in die van metgezel. 
Samen discussiërend achter de computer heeft het laatste deel van dit proefschrift vorm 
gekregen. 
En natuurlijk mijn hartelijke dank aan jou en Marianne voor de gastvrijheid en 
gezelligheid bij jullie thuis, de vele kopjes koffie en thee om de intellectuele arbeid te 
ondersteunen. Maar nu, hoe moet het nu verder? Ik mis de saucijzenbroodjes op 30 april en 
denk met weemoed aan de kroketten in Wenen, samen met Marianne en Elisabeth: misschien 
dat we dat (ook) nog kunnen oplossen? 
Professor Hoogendijk, beste Witte, mijn grote dank voor jouw inzet bij de 
totstandkoming van dit proefschrift en de gastvrijheid genoten in het Erasmus MC. Het was 
leerzaam en inspirerend om regelmatig mijn plannen en bevindingen te bespreken in de 
onderzoekswerkgroep van de afdeling Psychiatrie van het Erasmus Universitair Medisch 
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Dr. Koehler, beste co-promotor, beste Peter, sommige dingen veranderen nooit! 
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het jou lukte om aan het einde van de middag jouw bureau helemaal “leeg” te hebben. Jij had 
duizend dingen gedaan, de patiëntenzorg was prima op orde, ontslagbrieven waren 
gedicteerd, onderzoeksgegevens bijgewerkt en manuscripten voltooid. Je deelde graag je 
kennis met een ieder die geïnteresseerd was en altijd was je bereid om “bij te springen in de 
kliniek”. Nog steeds ben je een “duizendpoot”, actief op veel (wetenschappelijke) domeinen. 
Heel hartelijk dank voor jouw stimulerende begeleiding en de inzet van jouw bijzondere 
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Tijdens onze opleidingstijd in het Leyenburg Ziekenhuis zag ik steeds weer met verbazing hoe 
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Alle leden van de grote en de kleine commissie zeg ik hartelijk dank voor hun 
bereidheid om dit proefschrift kritisch te beoordelen. 
Dr. Ott, beste Alewijn, naar aanleiding van de diagnose neurosyfilis bij drie 
psychiatrische patiënten sprak ik als allereerste met jou over mijn idee om onderzoek te 
verrichten naar neurosyfilis in Nederland. Jij was direct geïnteresseerd en samen 
ontwikkelden we de eerste plannen. Vele overlegmomenten zijn gevolgd. Heel hartelijk dank 
voor de bijzonder prettige samenwerking, gedurende alle jaren, voor jouw zorgvuldige 
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Professor Kremer, beste Berry, door de samenwerking met Certe in Groningen, 
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neuropsychiatrie, voor jouw vaak kernachtige inbreng bij de beoordeling van 
onderzoeksbevindingen en jouw vermogen om je vinger precies op het interessantste 
resultaat (of de zwakste plek in de onderzoeksopzet!) te leggen: dat werkt zeer verhelderend. 
Dr. Thijs, beste Roland, dank voor jouw onmisbare bijdrage aan het tot stand komen 
van hoofdstuk 6 van dit proefschrift en voor de gelegenheid om mij niet alleen in epilepsie 
maar ook in syncope te bekwamen. Hoofdstuk 6 vormt een mooie brug tussen neurosyfilis en 
epilepsie. Nu breekt de tijd aan dat ik mijn volledige aandacht kan richten op de wonderlijke 
wereld van de wegrakingen: ik verheug mij er op! 
Professor Hovens, beste Hans, dankjewel dat je met jouw brede kennis van de 
psychiatrie en van de geschiedenis van de neurowetenschappen dit proefschrift wilt 
beoordelen. 
Jhr. Drs. van Nispen tot Pannerden, beste Alphons, met veel plezier denk ik terug aan 
onze samenwerking bij Vincent van Gogh en aan alles wat ik met en door jou heb geleerd met 
name tijdens de jarenlange nascholing “Reading Freud”. Mijn bijzondere dank aan jou en 
Monique voor het schrijven van de Franstalige samenvatting voor dit proefschrift. 
 
Mijn bijzondere dank gaat uit naar mijn twee paranymfen. 
Beste Aernoud, samen hebben we heel veel meegemaakt en heel veel geleerd! Ooit 
raakte je ”op de Neuropsychiatrie” geïnteresseerd in mijn onderzoek en tot op de dag van 
vandaag werken we samen. Jouw analytische vaardigheden en enorme inzet zijn van 
doorslaggevend belang geweest. En hoewel ik, vooral dankzij jou, enige digitale vaardigheden 
heb ontwikkeld, zijn activiteiten zoals het opzetten, bewaken en analyseren van grote 
databestanden zonder twijfel bij jou in betere handen. We hebben heel hard gewerkt, in de 
loop der jaren veel lief en leed gedeeld en gelukkig ook vaak gelachen. Ik wens jou heel veel 
succes met je eigen promotie-onderzoek. Maar het blijft jammer dat jouw hart meer bij de 
cardiologie dan de neurologie ligt….. 
Lieve Elisabeth, dankzij jouw bijzondere interesse in de opkomst van de 
natuurwetenschappen, de industrialisatie en de verstedelijking, hebben we met veel plezier 
gelezen en gediscussieerd over “het leven in de stad” als bijdragende factor aan het ontstaan 
van ziektebeelden, de opkomst van de genetica en de latere ontsporing van de eugenetica. 
Aan de hand van “temperatuurstaten” trachtten wij de exacte samenhang tussen 
grootheidswanen, malaria en arsenicum te doorgronden. Jij groeide uit van geïnteresseerde 
dochter tot volwaardig mede-onderzoeker bij het historische deel van dit onderzoek, met 
eigen posterpresentaties en voordrachten. Het is een voorrecht om fascinatie voor dergelijk 
onderzoek met je dochter te kunnen delen. Heel hartelijk dank hiervoor en voor jouw inzet bij 
de totstandkoming van dit proefschrift. 
Ik dank alle betrokken collega’s voor zinvolle discussies, alle co-auteurs voor de 
prettige samenwerking, en natuurlijk Annie en Henny, voormalig medewerkers van de 
bibliotheek van Vincent van Gogh, die zo succesvol bergen literatuur voor mij verzamelden. 
Aan Lod en alle stafleden van het museum voor de geschiedenis van Vincent van Gogh ben ik 
dank verschuldigd voor het speuren in de uitgebreide archieven en het samenstellen van 
lijsten waar ik mee aan de slag kon. 
Lieve Ellen, ik mis de momenten van samen filosoferen over de relatie tussen hersenen 
en gedrag, al dan niet in combinatie met een praktische toepassing bij “onze” patiënten. 
Gelukkig, met dank ook aan Jos, hebben we nog ons jaarlijkse onderwijsmoment bij het RINO. 
 
De medewerkers van het bureau van de pedel bedank ik graag hartelijk voor hun 
inspanningen om in de overgangsfase van “Hora Est” naar “Hora Finita” mij met raad en daad 
bij te staan om de administratieve kant van het promotietraject op de juiste wijze vorm te 
geven. Zonder jullie hulp was ik ongetwijfeld “Definitief Digitaal Verdwaald”. 
 
Gedurende dit onderzoek heb ik met zeer veel mensen uit uiteenlopende disciplines 
en diverse organisaties samengewerkt en ik ben ervan overtuigd dat een dergelijke 
interdisciplinaire samenwerking de meest effectieve en de meest inspirerende werkwijze is bij 
het oplossen van complexe vraagstukken. Dank aan een ieder die op één of andere manier 
heeft bijgedragen aan het tot stand komen van dit proefschrift, helaas is het niet mogelijk om 
alle namen te noemen, maar ik maak graag nog één uitzondering... 
Lieve Henriëtte, als geen ander bezorgde jij mij, en Falco!, en mijn gezin een tweede 
thuis in Limburg, een plek waar ik vele uren aan dit proefschrift heb gewerkt. Bovendien stond 
je altijd klaar om mij te ondersteunen: om het even of het ging om bellen, typen, faxen, zoeken 
naar gaatjes in agenda’s of uitblazen onder het genot van heerlijke “home-made” 
aspergesoep! Hartelijk dank! 
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Alle patiënten die ik tijdens mijn werkzaamheden heb ontmoet, ben ik dankbaar voor 
het in mij gestelde vertrouwen en voor de inspiratie die zij mij schonken om te blijven leren. 
 
Lieve Daniël, bij jou kan ik altijd terecht om te filosoferen over rechtvaardigheid, 
ethiek, het belang van politieke keuzes en onze maatschappelijke verantwoordelijkheid voor 
mensen voor wie onze wereld te complex is. Dankzij jou weet ik nu tenminste iets over Plato, 
Nietzsche en Dworkin, maar het meeste houd ik toch van de wereldvisie van Franciscus van 
Assisi! 
Lieve Julia, tijdens onze wandelingen met Falco over de North Sea Trail hebben we veel 
gepraat over “onze benen” en “het leven”, malle avonturen meegemaakt en heel veel plezier 
gehad. De mooiste herinneringen bewaar ik aan het samen kijken naar de zonsondergang 
boven de Noordzee, een “magisch” beeld dat alles in een ander perspectief plaatst. Ik hoop 
op nog veel van zulke momenten. 
Liefste Peter, mijn “Rots” in de branding, al 40 jaar ben jij er altijd, en mijn allergrootste 
dank gaat uit naar jou. We delen een passie voor de geneeskunde, in het bijzonder voor de 
neuropsychiatrie. Als trouwe metgezel heb je meegeleefd met alle “ups” en “downs” die bij 
een promotietraject horen. Maar bovenal heb je mijn vertrouwen gesterkt en mij 
onvoorwaardelijk gesteund bij het uitvoeren van mijn plannen. Jouw fantastische zorgen voor 
onze kinderen, onze huisdieren en voor mij (compleet met de onmisbare cappuccino bij het 
ontwaken en Tony Chocolonely na de avondmaaltijd) hebben het mogelijk gemaakt om dit 
onderzoek te verrichten en te voltooien. 
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